#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Generalizability of machine learning for classification of schizophrenia based on resting‐state functional MRI data
#Text=Abstract
#Text=Machine learning has increasingly been applied to classification of schizophrenia in neuroimaging research.
1-1	0-16	Generalizability	_
1-2	17-19	of	_
1-3	20-27	machine	_
1-4	28-36	learning	_
1-5	37-40	for	_
1-6	41-55	classification	_
1-7	56-58	of	_
1-8	59-72	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-9	73-78	based	_
1-10	79-81	on	_
1-11	82-95	resting‐state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]
1-12	96-106	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]
1-13	107-110	MRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[1]
1-14	111-115	data	_
1-15	116-124	Abstract	_
1-16	125-132	Machine	_
1-17	133-141	learning	_
1-18	142-145	has	_
1-19	146-158	increasingly	_
1-20	159-163	been	_
1-21	164-171	applied	_
1-22	172-174	to	_
1-23	175-189	classification	_
1-24	190-192	of	_
1-25	193-206	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-26	207-209	in	_
1-27	210-222	neuroimaging	_
1-28	223-231	research	_
1-29	231-232	.	_

#Text=However, direct replication studies and studies seeking to investigate generalizability are scarce.
2-1	233-240	However	_
2-2	240-241	,	_
2-3	242-248	direct	_
2-4	249-260	replication	_
2-5	261-268	studies	_
2-6	269-272	and	_
2-7	273-280	studies	_
2-8	281-288	seeking	_
2-9	289-291	to	_
2-10	292-303	investigate	_
2-11	304-320	generalizability	_
2-12	321-324	are	_
2-13	325-331	scarce	_
2-14	331-332	.	_

#Text=To address these issues, we assessed within‐site and between‐site generalizability of a machine learning classification framework which achieved excellent performance in a previous study using two independent resting‐state functional magnetic resonance imaging data sets collected from different sites and scanners.
3-1	333-335	To	_
3-2	336-343	address	_
3-3	344-349	these	_
3-4	350-356	issues	_
3-5	356-357	,	_
3-6	358-360	we	_
3-7	361-369	assessed	_
3-8	370-381	within‐site	_
3-9	382-385	and	_
3-10	386-398	between‐site	_
3-11	399-415	generalizability	_
3-12	416-418	of	_
3-13	419-420	a	_
3-14	421-428	machine	_
3-15	429-437	learning	_
3-16	438-452	classification	_
3-17	453-462	framework	_
3-18	463-468	which	_
3-19	469-477	achieved	_
3-20	478-487	excellent	_
3-21	488-499	performance	_
3-22	500-502	in	_
3-23	503-504	a	_
3-24	505-513	previous	_
3-25	514-519	study	_
3-26	520-525	using	_
3-27	526-529	two	_
3-28	530-541	independent	_
3-29	542-555	resting‐state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[2]
3-30	556-566	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[2]
3-31	567-575	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[2]
3-32	576-585	resonance	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[2]
3-33	586-593	imaging	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging[2]
3-34	594-598	data	_
3-35	599-603	sets	_
3-36	604-613	collected	_
3-37	614-618	from	_
3-38	619-628	different	_
3-39	629-634	sites	_
3-40	635-638	and	_
3-41	639-647	scanners	_
3-42	647-648	.	_

#Text=We established within‐site generalizability of the classification framework in the main data set using cross‐validation.
4-1	649-651	We	_
4-2	652-663	established	_
4-3	664-675	within‐site	_
4-4	676-692	generalizability	_
4-5	693-695	of	_
4-6	696-699	the	_
4-7	700-714	classification	_
4-8	715-724	framework	_
4-9	725-727	in	_
4-10	728-731	the	_
4-11	732-736	main	_
4-12	737-741	data	_
4-13	742-745	set	_
4-14	746-751	using	_
4-15	752-768	cross‐validation	_
4-16	768-769	.	_

#Text=Then, we trained a model in the main data set and investigated between‐site generalization in the validated data set using external validation.
5-1	770-774	Then	_
5-2	774-775	,	_
5-3	776-778	we	_
5-4	779-786	trained	_
5-5	787-788	a	_
5-6	789-794	model	_
5-7	795-797	in	_
5-8	798-801	the	_
5-9	802-806	main	_
5-10	807-811	data	_
5-11	812-815	set	_
5-12	816-819	and	_
5-13	820-832	investigated	_
5-14	833-845	between‐site	_
5-15	846-860	generalization	_
5-16	861-863	in	_
5-17	864-867	the	_
5-18	868-877	validated	_
5-19	878-882	data	_
5-20	883-886	set	_
5-21	887-892	using	_
5-22	893-901	external	_
5-23	902-912	validation	_
5-24	912-913	.	_

#Text=Finally, recognizing the poor between‐site generalization performance, we updated the unsupervised algorithm to investigate if transfer learning using additional unlabeled data were able to improve between‐site classification performance.
6-1	914-921	Finally	_
6-2	921-922	,	_
6-3	923-934	recognizing	_
6-4	935-938	the	_
6-5	939-943	poor	_
6-6	944-956	between‐site	_
6-7	957-971	generalization	_
6-8	972-983	performance	_
6-9	983-984	,	_
6-10	985-987	we	_
6-11	988-995	updated	_
6-12	996-999	the	_
6-13	1000-1012	unsupervised	_
6-14	1013-1022	algorithm	_
6-15	1023-1025	to	_
6-16	1026-1037	investigate	_
6-17	1038-1040	if	_
6-18	1041-1049	transfer	_
6-19	1050-1058	learning	_
6-20	1059-1064	using	_
6-21	1065-1075	additional	_
6-22	1076-1085	unlabeled	_
6-23	1086-1090	data	_
6-24	1091-1095	were	_
6-25	1096-1100	able	_
6-26	1101-1103	to	_
6-27	1104-1111	improve	_
6-28	1112-1124	between‐site	_
6-29	1125-1139	classification	_
6-30	1140-1151	performance	_
6-31	1151-1152	.	_

#Text=Cross‐validation showed that the published classification procedure achieved an accuracy of 0.73 using majority voting across all selected components.
7-1	1153-1169	Cross‐validation	_
7-2	1170-1176	showed	_
7-3	1177-1181	that	_
7-4	1182-1185	the	_
7-5	1186-1195	published	_
7-6	1196-1210	classification	_
7-7	1211-1220	procedure	_
7-8	1221-1229	achieved	_
7-9	1230-1232	an	_
7-10	1233-1241	accuracy	_
7-11	1242-1244	of	_
7-12	1245-1249	0.73	_
7-13	1250-1255	using	_
7-14	1256-1264	majority	_
7-15	1265-1271	voting	_
7-16	1272-1278	across	_
7-17	1279-1282	all	_
7-18	1283-1291	selected	_
7-19	1292-1302	components	_
7-20	1302-1303	.	_

#Text=External validation found a classification accuracy of 0.55 (not significant) and 0.70 (significant) using the direct and transfer learning procedures, respectively.
8-1	1304-1312	External	_
8-2	1313-1323	validation	_
8-3	1324-1329	found	_
8-4	1330-1331	a	_
8-5	1332-1346	classification	_
8-6	1347-1355	accuracy	_
8-7	1356-1358	of	_
8-8	1359-1363	0.55	_
8-9	1364-1365	(	_
8-10	1365-1368	not	_
8-11	1369-1380	significant	_
8-12	1380-1381	)	_
8-13	1382-1385	and	_
8-14	1386-1390	0.70	_
8-15	1391-1392	(	_
8-16	1392-1403	significant	_
8-17	1403-1404	)	_
8-18	1405-1410	using	_
8-19	1411-1414	the	_
8-20	1415-1421	direct	_
8-21	1422-1425	and	_
8-22	1426-1434	transfer	_
8-23	1435-1443	learning	_
8-24	1444-1454	procedures	_
8-25	1454-1455	,	_
8-26	1456-1468	respectively	_
8-27	1468-1469	.	_

#Text=The failure of direct generalization from one site to another demonstrates the limitation of within‐site cross‐validation and points toward the need to incorporate efforts to facilitate application of machine learning across multiple data sets.
9-1	1470-1473	The	_
9-2	1474-1481	failure	_
9-3	1482-1484	of	_
9-4	1485-1491	direct	_
9-5	1492-1506	generalization	_
9-6	1507-1511	from	_
9-7	1512-1515	one	_
9-8	1516-1520	site	_
9-9	1521-1523	to	_
9-10	1524-1531	another	_
9-11	1532-1544	demonstrates	_
9-12	1545-1548	the	_
9-13	1549-1559	limitation	_
9-14	1560-1562	of	_
9-15	1563-1574	within‐site	_
9-16	1575-1591	cross‐validation	_
9-17	1592-1595	and	_
9-18	1596-1602	points	_
9-19	1603-1609	toward	_
9-20	1610-1613	the	_
9-21	1614-1618	need	_
9-22	1619-1621	to	_
9-23	1622-1633	incorporate	_
9-24	1634-1641	efforts	_
9-25	1642-1644	to	_
9-26	1645-1655	facilitate	_
9-27	1656-1667	application	_
9-28	1668-1670	of	_
9-29	1671-1678	machine	_
9-30	1679-1687	learning	_
9-31	1688-1694	across	_
9-32	1695-1703	multiple	_
9-33	1704-1708	data	_
9-34	1709-1713	sets	_
9-35	1713-1714	.	_

#Text=The improvement in performance with transfer learning highlights the importance of taking into account the properties of data when constructing predictive models across samples and sites.
10-1	1715-1718	The	_
10-2	1719-1730	improvement	_
10-3	1731-1733	in	_
10-4	1734-1745	performance	_
10-5	1746-1750	with	_
10-6	1751-1759	transfer	_
10-7	1760-1768	learning	_
10-8	1769-1779	highlights	_
10-9	1780-1783	the	_
10-10	1784-1794	importance	_
10-11	1795-1797	of	_
10-12	1798-1804	taking	_
10-13	1805-1809	into	_
10-14	1810-1817	account	_
10-15	1818-1821	the	_
10-16	1822-1832	properties	_
10-17	1833-1835	of	_
10-18	1836-1840	data	_
10-19	1841-1845	when	_
10-20	1846-1858	constructing	_
10-21	1859-1869	predictive	_
10-22	1870-1876	models	_
10-23	1877-1883	across	_
10-24	1884-1891	samples	_
10-25	1892-1895	and	_
10-26	1896-1901	sites	_
10-27	1901-1902	.	_

#Text=Our findings suggest that machine learning classification result based on a single study should be interpreted cautiously.
11-1	1903-1906	Our	_
11-2	1907-1915	findings	_
11-3	1916-1923	suggest	_
11-4	1924-1928	that	_
11-5	1929-1936	machine	_
11-6	1937-1945	learning	_
11-7	1946-1960	classification	_
11-8	1961-1967	result	_
11-9	1968-1973	based	_
11-10	1974-1976	on	_
11-11	1977-1978	a	_
11-12	1979-1985	single	_
11-13	1986-1991	study	_
11-14	1992-1998	should	_
11-15	1999-2001	be	_
11-16	2002-2013	interpreted	_
11-17	2014-2024	cautiously	_
11-18	2024-2025	.	_

#Text=INTRODUCTION
#Text=Schizophrenia is a serious mental disorder that imposes a significant burden on society around the world (Charlson, Baxter, Cheng, Shidhaye, & Whiteford, 2016).
12-1	2026-2038	INTRODUCTION	_
12-2	2039-2052	Schizophrenia	_
12-3	2053-2055	is	_
12-4	2056-2057	a	_
12-5	2058-2065	serious	_
12-6	2066-2072	mental	_
12-7	2073-2081	disorder	_
12-8	2082-2086	that	_
12-9	2087-2094	imposes	_
12-10	2095-2096	a	_
12-11	2097-2108	significant	_
12-12	2109-2115	burden	_
12-13	2116-2118	on	_
12-14	2119-2126	society	_
12-15	2127-2133	around	_
12-16	2134-2137	the	_
12-17	2138-2143	world	_
12-18	2144-2145	(	_
12-19	2145-2153	Charlson	_
12-20	2153-2154	,	_
12-21	2155-2161	Baxter	_
12-22	2161-2162	,	_
12-23	2163-2168	Cheng	_
12-24	2168-2169	,	_
12-25	2170-2178	Shidhaye	_
12-26	2178-2179	,	_
12-27	2180-2181	&	_
12-28	2182-2191	Whiteford	_
12-29	2191-2192	,	_
12-30	2193-2197	2016	_
12-31	2197-2198	)	_
12-32	2198-2199	.	_

#Text=The clinical symptoms of schizophrenia are heterogeneous (Arango & Carpenter, 2011; Owen, 2014), and its diagnosis is still dependent on the subjective report from patients and assessment by clinicians (Frances, 1994).
13-1	2200-2203	The	_
13-2	2204-2212	clinical	_
13-3	2213-2221	symptoms	_
13-4	2222-2224	of	_
13-5	2225-2238	schizophrenia	_
13-6	2239-2242	are	_
13-7	2243-2256	heterogeneous	_
13-8	2257-2258	(	_
13-9	2258-2264	Arango	_
13-10	2265-2266	&	_
13-11	2267-2276	Carpenter	_
13-12	2276-2277	,	_
13-13	2278-2282	2011	_
13-14	2282-2283	;	_
13-15	2284-2288	Owen	_
13-16	2288-2289	,	_
13-17	2290-2294	2014	_
13-18	2294-2295	)	_
13-19	2295-2296	,	_
13-20	2297-2300	and	_
13-21	2301-2304	its	_
13-22	2305-2314	diagnosis	_
13-23	2315-2317	is	_
13-24	2318-2323	still	_
13-25	2324-2333	dependent	_
13-26	2334-2336	on	_
13-27	2337-2340	the	_
13-28	2341-2351	subjective	_
13-29	2352-2358	report	_
13-30	2359-2363	from	_
13-31	2364-2372	patients	_
13-32	2373-2376	and	_
13-33	2377-2387	assessment	_
13-34	2388-2390	by	_
13-35	2391-2401	clinicians	_
13-36	2402-2403	(	_
13-37	2403-2410	Frances	_
13-38	2410-2411	,	_
13-39	2412-2416	1994	_
13-40	2416-2417	)	_
13-41	2417-2418	.	_

#Text=With the aim to provide objective assessment to guide clinical practice, integrative psychobiological approaches including the Research Domain Criteria initiative (Kozak & Cuthbert, 2016) and the Hierarchical Taxonomy of Psychopathology (Kotov et al., 2017) suggest breaking the symptom‐oriented approach down to different levels of neuroscientific analysis for mental disorders.
14-1	2419-2423	With	_
14-2	2424-2427	the	_
14-3	2428-2431	aim	_
14-4	2432-2434	to	_
14-5	2435-2442	provide	_
14-6	2443-2452	objective	_
14-7	2453-2463	assessment	_
14-8	2464-2466	to	_
14-9	2467-2472	guide	_
14-10	2473-2481	clinical	_
14-11	2482-2490	practice	_
14-12	2490-2491	,	_
14-13	2492-2503	integrative	_
14-14	2504-2520	psychobiological	_
14-15	2521-2531	approaches	_
14-16	2532-2541	including	_
14-17	2542-2545	the	_
14-18	2546-2554	Research	_
14-19	2555-2561	Domain	_
14-20	2562-2570	Criteria	_
14-21	2571-2581	initiative	_
14-22	2582-2583	(	_
14-23	2583-2588	Kozak	_
14-24	2589-2590	&	_
14-25	2591-2599	Cuthbert	_
14-26	2599-2600	,	_
14-27	2601-2605	2016	_
14-28	2605-2606	)	_
14-29	2607-2610	and	_
14-30	2611-2614	the	_
14-31	2615-2627	Hierarchical	_
14-32	2628-2636	Taxonomy	_
14-33	2637-2639	of	_
14-34	2640-2655	Psychopathology	_
14-35	2656-2657	(	_
14-36	2657-2662	Kotov	_
14-37	2663-2665	et	_
14-38	2666-2668	al	_
14-39	2668-2669	.	_
14-40	2669-2670	,	_
14-41	2671-2675	2017	_
14-42	2675-2676	)	_
14-43	2677-2684	suggest	_
14-44	2685-2693	breaking	_
14-45	2694-2697	the	_
14-46	2698-2714	symptom‐oriented	_
14-47	2715-2723	approach	_
14-48	2724-2728	down	_
14-49	2729-2731	to	_
14-50	2732-2741	different	_
14-51	2742-2748	levels	_
14-52	2749-2751	of	_
14-53	2752-2767	neuroscientific	_
14-54	2768-2776	analysis	_
14-55	2777-2780	for	_
14-56	2781-2787	mental	_
14-57	2788-2797	disorders	_
14-58	2797-2798	.	_

#Text=In line with these new approaches, patients with schizophrenia have been demonstrated to have functional and structural brain alterations from magnetic resonance imaging (MRI) research (Cheng, Newman, et al., 2015; Cheng, Palaniyappan, et al., 2015; Ellison‐Wright & Bullmore, 2009; Haijma et al., 2013).
15-1	2799-2801	In	_
15-2	2802-2806	line	_
15-3	2807-2811	with	_
15-4	2812-2817	these	_
15-5	2818-2821	new	_
15-6	2822-2832	approaches	_
15-7	2832-2833	,	_
15-8	2834-2842	patients	_
15-9	2843-2847	with	_
15-10	2848-2861	schizophrenia	_
15-11	2862-2866	have	_
15-12	2867-2871	been	_
15-13	2872-2884	demonstrated	_
15-14	2885-2887	to	_
15-15	2888-2892	have	_
15-16	2893-2903	functional	_
15-17	2904-2907	and	_
15-18	2908-2918	structural	_
15-19	2919-2924	brain	_
15-20	2925-2936	alterations	_
15-21	2937-2941	from	_
15-22	2942-2950	magnetic	_
15-23	2951-2960	resonance	_
15-24	2961-2968	imaging	_
15-25	2969-2970	(	_
15-26	2970-2973	MRI	_
15-27	2973-2974	)	_
15-28	2975-2983	research	_
15-29	2984-2985	(	_
15-30	2985-2990	Cheng	_
15-31	2990-2991	,	_
15-32	2992-2998	Newman	_
15-33	2998-2999	,	_
15-34	3000-3002	et	_
15-35	3003-3005	al	_
15-36	3005-3006	.	_
15-37	3006-3007	,	_
15-38	3008-3012	2015	_
15-39	3012-3013	;	_
15-40	3014-3019	Cheng	_
15-41	3019-3020	,	_
15-42	3021-3033	Palaniyappan	_
15-43	3033-3034	,	_
15-44	3035-3037	et	_
15-45	3038-3040	al	_
15-46	3040-3041	.	_
15-47	3041-3042	,	_
15-48	3043-3047	2015	_
15-49	3047-3048	;	_
15-50	3049-3063	Ellison‐Wright	_
15-51	3064-3065	&	_
15-52	3066-3074	Bullmore	_
15-53	3074-3075	,	_
15-54	3076-3080	2009	_
15-55	3080-3081	;	_
15-56	3082-3088	Haijma	_
15-57	3089-3091	et	_
15-58	3092-3094	al	_
15-59	3094-3095	.	_
15-60	3095-3096	,	_
15-61	3097-3101	2013	_
15-62	3101-3102	)	_
15-63	3102-3103	.	_

#Text=Among the various MRI techniques, resting‐state functional MRI (rsfMRI) has been widely applied and aberrant brain activity has been reported in schizophrenia patients (Cheng, Newman, et al., 2015; Cheng, Palaniyappan, et al., 2015; Tang et al., 2013; Xu & Lipsky, 2014).
16-1	3104-3109	Among	_
16-2	3110-3113	the	_
16-3	3114-3121	various	_
16-4	3122-3125	MRI	_
16-5	3126-3136	techniques	_
16-6	3136-3137	,	_
16-7	3138-3151	resting‐state	_
16-8	3152-3162	functional	_
16-9	3163-3166	MRI	_
16-10	3167-3168	(	_
16-11	3168-3174	rsfMRI	_
16-12	3174-3175	)	_
16-13	3176-3179	has	_
16-14	3180-3184	been	_
16-15	3185-3191	widely	_
16-16	3192-3199	applied	_
16-17	3200-3203	and	_
16-18	3204-3212	aberrant	_
16-19	3213-3218	brain	_
16-20	3219-3227	activity	_
16-21	3228-3231	has	_
16-22	3232-3236	been	_
16-23	3237-3245	reported	_
16-24	3246-3248	in	_
16-25	3249-3262	schizophrenia	_
16-26	3263-3271	patients	_
16-27	3272-3273	(	_
16-28	3273-3278	Cheng	_
16-29	3278-3279	,	_
16-30	3280-3286	Newman	_
16-31	3286-3287	,	_
16-32	3288-3290	et	_
16-33	3291-3293	al	_
16-34	3293-3294	.	_
16-35	3294-3295	,	_
16-36	3296-3300	2015	_
16-37	3300-3301	;	_
16-38	3302-3307	Cheng	_
16-39	3307-3308	,	_
16-40	3309-3321	Palaniyappan	_
16-41	3321-3322	,	_
16-42	3323-3325	et	_
16-43	3326-3328	al	_
16-44	3328-3329	.	_
16-45	3329-3330	,	_
16-46	3331-3335	2015	_
16-47	3335-3336	;	_
16-48	3337-3341	Tang	_
16-49	3342-3344	et	_
16-50	3345-3347	al	_
16-51	3347-3348	.	_
16-52	3348-3349	,	_
16-53	3350-3354	2013	_
16-54	3354-3355	;	_
16-55	3356-3358	Xu	_
16-56	3359-3360	&	_
16-57	3361-3367	Lipsky	_
16-58	3367-3368	,	_
16-59	3369-3373	2014	_
16-60	3373-3374	)	_
16-61	3374-3375	.	_

#Text=However, results from traditional MRI studies are group‐level data and have limited clinical applications.
17-1	3376-3383	However	_
17-2	3383-3384	,	_
17-3	3385-3392	results	_
17-4	3393-3397	from	_
17-5	3398-3409	traditional	_
17-6	3410-3413	MRI	_
17-7	3414-3421	studies	_
17-8	3422-3425	are	_
17-9	3426-3437	group‐level	_
17-10	3438-3442	data	_
17-11	3443-3446	and	_
17-12	3447-3451	have	_
17-13	3452-3459	limited	_
17-14	3460-3468	clinical	_
17-15	3469-3481	applications	_
17-16	3481-3482	.	_

#Text=More recently, machine learning has been increasingly utilized to optimize the use of brain imaging data in clinical classification and build predictive models for individualized diagnosis for different psychiatric disorders (Arbabshirani, Plis, Sui, & Calhoun, 2017).
18-1	3483-3487	More	_
18-2	3488-3496	recently	_
18-3	3496-3497	,	_
18-4	3498-3505	machine	_
18-5	3506-3514	learning	_
18-6	3515-3518	has	_
18-7	3519-3523	been	_
18-8	3524-3536	increasingly	_
18-9	3537-3545	utilized	_
18-10	3546-3548	to	_
18-11	3549-3557	optimize	_
18-12	3558-3561	the	_
18-13	3562-3565	use	_
18-14	3566-3568	of	_
18-15	3569-3574	brain	_
18-16	3575-3582	imaging	_
18-17	3583-3587	data	_
18-18	3588-3590	in	_
18-19	3591-3599	clinical	_
18-20	3600-3614	classification	_
18-21	3615-3618	and	_
18-22	3619-3624	build	_
18-23	3625-3635	predictive	_
18-24	3636-3642	models	_
18-25	3643-3646	for	_
18-26	3647-3661	individualized	_
18-27	3662-3671	diagnosis	_
18-28	3672-3675	for	_
18-29	3676-3685	different	_
18-30	3686-3697	psychiatric	_
18-31	3698-3707	disorders	_
18-32	3708-3709	(	_
18-33	3709-3721	Arbabshirani	_
18-34	3721-3722	,	_
18-35	3723-3727	Plis	_
18-36	3727-3728	,	_
18-37	3729-3732	Sui	_
18-38	3732-3733	,	_
18-39	3734-3735	&	_
18-40	3736-3743	Calhoun	_
18-41	3743-3744	,	_
18-42	3745-3749	2017	_
18-43	3749-3750	)	_
18-44	3750-3751	.	_

#Text=Machine learning is defined as the process of enabling computers to acquire the ability to learn patterns of data without being explicitly programmed to do so (Samuel, 1959).
19-1	3752-3759	Machine	_
19-2	3760-3768	learning	_
19-3	3769-3771	is	_
19-4	3772-3779	defined	_
19-5	3780-3782	as	_
19-6	3783-3786	the	_
19-7	3787-3794	process	_
19-8	3795-3797	of	_
19-9	3798-3806	enabling	_
19-10	3807-3816	computers	_
19-11	3817-3819	to	_
19-12	3820-3827	acquire	_
19-13	3828-3831	the	_
19-14	3832-3839	ability	_
19-15	3840-3842	to	_
19-16	3843-3848	learn	_
19-17	3849-3857	patterns	_
19-18	3858-3860	of	_
19-19	3861-3865	data	_
19-20	3866-3873	without	_
19-21	3874-3879	being	_
19-22	3880-3890	explicitly	_
19-23	3891-3901	programmed	_
19-24	3902-3904	to	_
19-25	3905-3907	do	_
19-26	3908-3910	so	_
19-27	3911-3912	(	_
19-28	3912-3918	Samuel	_
19-29	3918-3919	,	_
19-30	3920-3924	1959	_
19-31	3924-3925	)	_
19-32	3925-3926	.	_

#Text=Multivariate machine learning approaches are algorithms specialized in recognizing patterns from high‐dimensional data like brain imaging data, which can capture the complex relationships between brain regions compared with univariate methods (Davatzikos, 2004).
20-1	3927-3939	Multivariate	_
20-2	3940-3947	machine	_
20-3	3948-3956	learning	_
20-4	3957-3967	approaches	_
20-5	3968-3971	are	_
20-6	3972-3982	algorithms	_
20-7	3983-3994	specialized	_
20-8	3995-3997	in	_
20-9	3998-4009	recognizing	_
20-10	4010-4018	patterns	_
20-11	4019-4023	from	_
20-12	4024-4040	high‐dimensional	_
20-13	4041-4045	data	_
20-14	4046-4050	like	_
20-15	4051-4056	brain	_
20-16	4057-4064	imaging	_
20-17	4065-4069	data	_
20-18	4069-4070	,	_
20-19	4071-4076	which	_
20-20	4077-4080	can	_
20-21	4081-4088	capture	_
20-22	4089-4092	the	_
20-23	4093-4100	complex	_
20-24	4101-4114	relationships	_
20-25	4115-4122	between	_
20-26	4123-4128	brain	_
20-27	4129-4136	regions	_
20-28	4137-4145	compared	_
20-29	4146-4150	with	_
20-30	4151-4161	univariate	_
20-31	4162-4169	methods	_
20-32	4170-4171	(	_
20-33	4171-4181	Davatzikos	_
20-34	4181-4182	,	_
20-35	4183-4187	2004	_
20-36	4187-4188	)	_
20-37	4188-4189	.	_

#Text=The general machine learning framework with rsfMRI data for computational psychiatry includes: (a) preprocessing the imaging data; (b) separating the training data and the testing data completely; (c) extracting and selecting features from the training data; (d) training the predictive model; and (e) generalizing the predictive model to the testing data.
21-1	4190-4193	The	_
21-2	4194-4201	general	_
21-3	4202-4209	machine	_
21-4	4210-4218	learning	_
21-5	4219-4228	framework	_
21-6	4229-4233	with	_
21-7	4234-4240	rsfMRI	_
21-8	4241-4245	data	_
21-9	4246-4249	for	_
21-10	4250-4263	computational	_
21-11	4264-4274	psychiatry	_
21-12	4275-4283	includes	_
21-13	4283-4284	:	_
21-14	4285-4286	(	_
21-15	4286-4287	a	_
21-16	4287-4288	)	_
21-17	4289-4302	preprocessing	_
21-18	4303-4306	the	_
21-19	4307-4314	imaging	_
21-20	4315-4319	data	_
21-21	4319-4320	;	_
21-22	4321-4322	(	_
21-23	4322-4323	b	_
21-24	4323-4324	)	_
21-25	4325-4335	separating	_
21-26	4336-4339	the	_
21-27	4340-4348	training	_
21-28	4349-4353	data	_
21-29	4354-4357	and	_
21-30	4358-4361	the	_
21-31	4362-4369	testing	_
21-32	4370-4374	data	_
21-33	4375-4385	completely	_
21-34	4385-4386	;	_
21-35	4387-4388	(	_
21-36	4388-4389	c	_
21-37	4389-4390	)	_
21-38	4391-4401	extracting	_
21-39	4402-4405	and	_
21-40	4406-4415	selecting	_
21-41	4416-4424	features	_
21-42	4425-4429	from	_
21-43	4430-4433	the	_
21-44	4434-4442	training	_
21-45	4443-4447	data	_
21-46	4447-4448	;	_
21-47	4449-4450	(	_
21-48	4450-4451	d	_
21-49	4451-4452	)	_
21-50	4453-4461	training	_
21-51	4462-4465	the	_
21-52	4466-4476	predictive	_
21-53	4477-4482	model	_
21-54	4482-4483	;	_
21-55	4484-4487	and	_
21-56	4488-4489	(	_
21-57	4489-4490	e	_
21-58	4490-4491	)	_
21-59	4492-4504	generalizing	_
21-60	4505-4508	the	_
21-61	4509-4519	predictive	_
21-62	4520-4525	model	_
21-63	4526-4528	to	_
21-64	4529-4532	the	_
21-65	4533-4540	testing	_
21-66	4541-4545	data	_
21-67	4545-4546	.	_

#Text=In this framework, assessing generalizability is one of the most important steps in evaluating predictive models, which simulates the real‐world context.
22-1	4547-4549	In	_
22-2	4550-4554	this	_
22-3	4555-4564	framework	_
22-4	4564-4565	,	_
22-5	4566-4575	assessing	_
22-6	4576-4592	generalizability	_
22-7	4593-4595	is	_
22-8	4596-4599	one	_
22-9	4600-4602	of	_
22-10	4603-4606	the	_
22-11	4607-4611	most	_
22-12	4612-4621	important	_
22-13	4622-4627	steps	_
22-14	4628-4630	in	_
22-15	4631-4641	evaluating	_
22-16	4642-4652	predictive	_
22-17	4653-4659	models	_
22-18	4659-4660	,	_
22-19	4661-4666	which	_
22-20	4667-4676	simulates	_
22-21	4677-4680	the	_
22-22	4681-4691	real‐world	_
22-23	4692-4699	context	_
22-24	4699-4700	.	_

#Text=Generalizability is assessed in two distinct settings: within‐site and between‐site.
23-1	4701-4717	Generalizability	_
23-2	4718-4720	is	_
23-3	4721-4729	assessed	_
23-4	4730-4732	in	_
23-5	4733-4736	two	_
23-6	4737-4745	distinct	_
23-7	4746-4754	settings	_
23-8	4754-4755	:	_
23-9	4756-4767	within‐site	_
23-10	4768-4771	and	_
23-11	4772-4784	between‐site	_
23-12	4784-4785	.	_

#Text=Two main strategies, internal validation (or cross‐validation) and external validation, have been used to assess generalizability.
24-1	4786-4789	Two	_
24-2	4790-4794	main	_
24-3	4795-4805	strategies	_
24-4	4805-4806	,	_
24-5	4807-4815	internal	_
24-6	4816-4826	validation	_
24-7	4827-4828	(	_
24-8	4828-4830	or	_
24-9	4831-4847	cross‐validation	_
24-10	4847-4848	)	_
24-11	4849-4852	and	_
24-12	4853-4861	external	_
24-13	4862-4872	validation	_
24-14	4872-4873	,	_
24-15	4874-4878	have	_
24-16	4879-4883	been	_
24-17	4884-4888	used	_
24-18	4889-4891	to	_
24-19	4892-4898	assess	_
24-20	4899-4915	generalizability	_
24-21	4915-4916	.	_

#Text=Within‐site generalizability is typically established using cross‐validation.
25-1	4917-4928	Within‐site	_
25-2	4929-4945	generalizability	_
25-3	4946-4948	is	_
25-4	4949-4958	typically	_
25-5	4959-4970	established	_
25-6	4971-4976	using	_
25-7	4977-4993	cross‐validation	_
25-8	4993-4994	.	_

#Text=In this setting, a data set collected from a single site is repeatedly split into independent training and test data sets, and the performance of the model is assessed in the training set for each split.
26-1	4995-4997	In	_
26-2	4998-5002	this	_
26-3	5003-5010	setting	_
26-4	5010-5011	,	_
26-5	5012-5013	a	_
26-6	5014-5018	data	_
26-7	5019-5022	set	_
26-8	5023-5032	collected	_
26-9	5033-5037	from	_
26-10	5038-5039	a	_
26-11	5040-5046	single	_
26-12	5047-5051	site	_
26-13	5052-5054	is	_
26-14	5055-5065	repeatedly	_
26-15	5066-5071	split	_
26-16	5072-5076	into	_
26-17	5077-5088	independent	_
26-18	5089-5097	training	_
26-19	5098-5101	and	_
26-20	5102-5106	test	_
26-21	5107-5111	data	_
26-22	5112-5116	sets	_
26-23	5116-5117	,	_
26-24	5118-5121	and	_
26-25	5122-5125	the	_
26-26	5126-5137	performance	_
26-27	5138-5140	of	_
26-28	5141-5144	the	_
26-29	5145-5150	model	_
26-30	5151-5153	is	_
26-31	5154-5162	assessed	_
26-32	5163-5165	in	_
26-33	5166-5169	the	_
26-34	5170-5178	training	_
26-35	5179-5182	set	_
26-36	5183-5186	for	_
26-37	5187-5191	each	_
26-38	5192-5197	split	_
26-39	5197-5198	.	_

#Text=However, to assess between‐site generalizability, the predictive model is trained on a data set from one site and then applied to an independent data set collected in a separate site using external validation.
27-1	5199-5206	However	_
27-2	5206-5207	,	_
27-3	5208-5210	to	_
27-4	5211-5217	assess	_
27-5	5218-5230	between‐site	_
27-6	5231-5247	generalizability	_
27-7	5247-5248	,	_
27-8	5249-5252	the	_
27-9	5253-5263	predictive	_
27-10	5264-5269	model	_
27-11	5270-5272	is	_
27-12	5273-5280	trained	_
27-13	5281-5283	on	_
27-14	5284-5285	a	_
27-15	5286-5290	data	_
27-16	5291-5294	set	_
27-17	5295-5299	from	_
27-18	5300-5303	one	_
27-19	5304-5308	site	_
27-20	5309-5312	and	_
27-21	5313-5317	then	_
27-22	5318-5325	applied	_
27-23	5326-5328	to	_
27-24	5329-5331	an	_
27-25	5332-5343	independent	_
27-26	5344-5348	data	_
27-27	5349-5352	set	_
27-28	5353-5362	collected	_
27-29	5363-5365	in	_
27-30	5366-5367	a	_
27-31	5368-5376	separate	_
27-32	5377-5381	site	_
27-33	5382-5387	using	_
27-34	5388-5396	external	_
27-35	5397-5407	validation	_
27-36	5407-5408	.	_

#Text=Using internal validation is practical considering the difficulty in collecting data from different sites, but it could lead to an overestimation of performance due to overfitting of the predictive model to one specific data set, compared with external validation which considers generalizability across different data sets (Woo, Chang, Lindquist, & Wager, 2017).
28-1	5409-5414	Using	_
28-2	5415-5423	internal	_
28-3	5424-5434	validation	_
28-4	5435-5437	is	_
28-5	5438-5447	practical	_
28-6	5448-5459	considering	_
28-7	5460-5463	the	_
28-8	5464-5474	difficulty	_
28-9	5475-5477	in	_
28-10	5478-5488	collecting	_
28-11	5489-5493	data	_
28-12	5494-5498	from	_
28-13	5499-5508	different	_
28-14	5509-5514	sites	_
28-15	5514-5515	,	_
28-16	5516-5519	but	_
28-17	5520-5522	it	_
28-18	5523-5528	could	_
28-19	5529-5533	lead	_
28-20	5534-5536	to	_
28-21	5537-5539	an	_
28-22	5540-5554	overestimation	_
28-23	5555-5557	of	_
28-24	5558-5569	performance	_
28-25	5570-5573	due	_
28-26	5574-5576	to	_
28-27	5577-5588	overfitting	_
28-28	5589-5591	of	_
28-29	5592-5595	the	_
28-30	5596-5606	predictive	_
28-31	5607-5612	model	_
28-32	5613-5615	to	_
28-33	5616-5619	one	_
28-34	5620-5628	specific	_
28-35	5629-5633	data	_
28-36	5634-5637	set	_
28-37	5637-5638	,	_
28-38	5639-5647	compared	_
28-39	5648-5652	with	_
28-40	5653-5661	external	_
28-41	5662-5672	validation	_
28-42	5673-5678	which	_
28-43	5679-5688	considers	_
28-44	5689-5705	generalizability	_
28-45	5706-5712	across	_
28-46	5713-5722	different	_
28-47	5723-5727	data	_
28-48	5728-5732	sets	_
28-49	5733-5734	(	_
28-50	5734-5737	Woo	_
28-51	5737-5738	,	_
28-52	5739-5744	Chang	_
28-53	5744-5745	,	_
28-54	5746-5755	Lindquist	_
28-55	5755-5756	,	_
28-56	5757-5758	&	_
28-57	5759-5764	Wager	_
28-58	5764-5765	,	_
28-59	5766-5770	2017	_
28-60	5770-5771	)	_
28-61	5771-5772	.	_

#Text=It is therefore important to assess generalizability using both internal and external validation methods.
29-1	5773-5775	It	_
29-2	5776-5778	is	_
29-3	5779-5788	therefore	_
29-4	5789-5798	important	_
29-5	5799-5801	to	_
29-6	5802-5808	assess	_
29-7	5809-5825	generalizability	_
29-8	5826-5831	using	_
29-9	5832-5836	both	_
29-10	5837-5845	internal	_
29-11	5846-5849	and	_
29-12	5850-5858	external	_
29-13	5859-5869	validation	_
29-14	5870-5877	methods	_
29-15	5877-5878	.	_

#Text=A number of promising studies have successfully classified patients with schizophrenia from healthy controls based on rsfMRI data using machine learning approaches.
30-1	5879-5880	A	_
30-2	5881-5887	number	_
30-3	5888-5890	of	_
30-4	5891-5900	promising	_
30-5	5901-5908	studies	_
30-6	5909-5913	have	_
30-7	5914-5926	successfully	_
30-8	5927-5937	classified	_
30-9	5938-5946	patients	_
30-10	5947-5951	with	_
30-11	5952-5965	schizophrenia	_
30-12	5966-5970	from	_
30-13	5971-5978	healthy	_
30-14	5979-5987	controls	_
30-15	5988-5993	based	_
30-16	5994-5996	on	_
30-17	5997-6003	rsfMRI	_
30-18	6004-6008	data	_
30-19	6009-6014	using	_
30-20	6015-6022	machine	_
30-21	6023-6031	learning	_
30-22	6032-6042	approaches	_
30-23	6042-6043	.	_

#Text=As shown in Table 1, accumulated studies have utilized machine learning as a tool to analyze rsfMRI data, investigate the underlying neural mechanisms, recognize specific brain patterns, and classify patients with schizophrenia from healthy controls at the individual level with accuracies ranging from 65 to 95% (Arbabshirani, Kiehl, Pearlson, & Calhoun, 2013; Cao et al., 2018; Cheng, Newman, et al., 2015; Cheng, Palaniyappan, et al., 2015; Du et al., 2012; Venkataraman et al., 2012).
31-1	6044-6046	As	_
31-2	6047-6052	shown	_
31-3	6053-6055	in	_
31-4	6056-6061	Table	_
31-5	6062-6063	1	_
31-6	6063-6064	,	_
31-7	6065-6076	accumulated	_
31-8	6077-6084	studies	_
31-9	6085-6089	have	_
31-10	6090-6098	utilized	_
31-11	6099-6106	machine	_
31-12	6107-6115	learning	_
31-13	6116-6118	as	_
31-14	6119-6120	a	_
31-15	6121-6125	tool	_
31-16	6126-6128	to	_
31-17	6129-6136	analyze	_
31-18	6137-6143	rsfMRI	_
31-19	6144-6148	data	_
31-20	6148-6149	,	_
31-21	6150-6161	investigate	_
31-22	6162-6165	the	_
31-23	6166-6176	underlying	_
31-24	6177-6183	neural	_
31-25	6184-6194	mechanisms	_
31-26	6194-6195	,	_
31-27	6196-6205	recognize	_
31-28	6206-6214	specific	_
31-29	6215-6220	brain	_
31-30	6221-6229	patterns	_
31-31	6229-6230	,	_
31-32	6231-6234	and	_
31-33	6235-6243	classify	_
31-34	6244-6252	patients	_
31-35	6253-6257	with	_
31-36	6258-6271	schizophrenia	_
31-37	6272-6276	from	_
31-38	6277-6284	healthy	_
31-39	6285-6293	controls	_
31-40	6294-6296	at	_
31-41	6297-6300	the	_
31-42	6301-6311	individual	_
31-43	6312-6317	level	_
31-44	6318-6322	with	_
31-45	6323-6333	accuracies	_
31-46	6334-6341	ranging	_
31-47	6342-6346	from	_
31-48	6347-6349	65	_
31-49	6350-6352	to	_
31-50	6353-6356	95%	_
31-51	6357-6358	(	_
31-52	6358-6370	Arbabshirani	_
31-53	6370-6371	,	_
31-54	6372-6377	Kiehl	_
31-55	6377-6378	,	_
31-56	6379-6387	Pearlson	_
31-57	6387-6388	,	_
31-58	6389-6390	&	_
31-59	6391-6398	Calhoun	_
31-60	6398-6399	,	_
31-61	6400-6404	2013	_
31-62	6404-6405	;	_
31-63	6406-6409	Cao	_
31-64	6410-6412	et	_
31-65	6413-6415	al	_
31-66	6415-6416	.	_
31-67	6416-6417	,	_
31-68	6418-6422	2018	_
31-69	6422-6423	;	_
31-70	6424-6429	Cheng	_
31-71	6429-6430	,	_
31-72	6431-6437	Newman	_
31-73	6437-6438	,	_
31-74	6439-6441	et	_
31-75	6442-6444	al	_
31-76	6444-6445	.	_
31-77	6445-6446	,	_
31-78	6447-6451	2015	_
31-79	6451-6452	;	_
31-80	6453-6458	Cheng	_
31-81	6458-6459	,	_
31-82	6460-6472	Palaniyappan	_
31-83	6472-6473	,	_
31-84	6474-6476	et	_
31-85	6477-6479	al	_
31-86	6479-6480	.	_
31-87	6480-6481	,	_
31-88	6482-6486	2015	_
31-89	6486-6487	;	_
31-90	6488-6490	Du	_
31-91	6491-6493	et	_
31-92	6494-6496	al	_
31-93	6496-6497	.	_
31-94	6497-6498	,	_
31-95	6499-6503	2012	_
31-96	6503-6504	;	_
31-97	6505-6517	Venkataraman	_
31-98	6518-6520	et	_
31-99	6521-6523	al	_
31-100	6523-6524	.	_
31-101	6524-6525	,	_
31-102	6526-6530	2012	_
31-103	6530-6531	)	_
31-104	6531-6532	.	_

#Text=However, most of these studies have only assessed generalizability using internal validation methods.
32-1	6533-6540	However	_
32-2	6540-6541	,	_
32-3	6542-6546	most	_
32-4	6547-6549	of	_
32-5	6550-6555	these	_
32-6	6556-6563	studies	_
32-7	6564-6568	have	_
32-8	6569-6573	only	_
32-9	6574-6582	assessed	_
32-10	6583-6599	generalizability	_
32-11	6600-6605	using	_
32-12	6606-6614	internal	_
32-13	6615-6625	validation	_
32-14	6626-6633	methods	_
32-15	6633-6634	.	_

#Text=While two studies have used external validation to assess the generalizability of their classification methods, they did so in independent rsfMRI data sets (Cui, Liu, Song, et al., 2018; Cui, Liu, Wang, et al., 2018; Skatun et al., 2017) and no study has independently replicated the machine learning procedure from a previous study.
33-1	6635-6640	While	_
33-2	6641-6644	two	_
33-3	6645-6652	studies	_
33-4	6653-6657	have	_
33-5	6658-6662	used	_
33-6	6663-6671	external	_
33-7	6672-6682	validation	_
33-8	6683-6685	to	_
33-9	6686-6692	assess	_
33-10	6693-6696	the	_
33-11	6697-6713	generalizability	_
33-12	6714-6716	of	_
33-13	6717-6722	their	_
33-14	6723-6737	classification	_
33-15	6738-6745	methods	_
33-16	6745-6746	,	_
33-17	6747-6751	they	_
33-18	6752-6755	did	_
33-19	6756-6758	so	_
33-20	6759-6761	in	_
33-21	6762-6773	independent	_
33-22	6774-6780	rsfMRI	_
33-23	6781-6785	data	_
33-24	6786-6790	sets	_
33-25	6791-6792	(	_
33-26	6792-6795	Cui	_
33-27	6795-6796	,	_
33-28	6797-6800	Liu	_
33-29	6800-6801	,	_
33-30	6802-6806	Song	_
33-31	6806-6807	,	_
33-32	6808-6810	et	_
33-33	6811-6813	al	_
33-34	6813-6814	.	_
33-35	6814-6815	,	_
33-36	6816-6820	2018	_
33-37	6820-6821	;	_
33-38	6822-6825	Cui	_
33-39	6825-6826	,	_
33-40	6827-6830	Liu	_
33-41	6830-6831	,	_
33-42	6832-6836	Wang	_
33-43	6836-6837	,	_
33-44	6838-6840	et	_
33-45	6841-6843	al	_
33-46	6843-6844	.	_
33-47	6844-6845	,	_
33-48	6846-6850	2018	_
33-49	6850-6851	;	_
33-50	6852-6858	Skatun	_
33-51	6859-6861	et	_
33-52	6862-6864	al	_
33-53	6864-6865	.	_
33-54	6865-6866	,	_
33-55	6867-6871	2017	_
33-56	6871-6872	)	_
33-57	6873-6876	and	_
33-58	6877-6879	no	_
33-59	6880-6885	study	_
33-60	6886-6889	has	_
33-61	6890-6903	independently	_
33-62	6904-6914	replicated	_
33-63	6915-6918	the	_
33-64	6919-6926	machine	_
33-65	6927-6935	learning	_
33-66	6936-6945	procedure	_
33-67	6946-6950	from	_
33-68	6951-6952	a	_
33-69	6953-6961	previous	_
33-70	6962-6967	study	_
33-71	6967-6968	.	_

#Text=Summary of machine learning studies in schizophrenia based on rsfMRI
#Text=Reference\tParticipants\tFeature\tFeature extraction\tClassifier\tAccuracy (%)\t \tShen, Wang, Liu, and Hu (2010)\tSZ = 32, HC = 20\tFC among 116 regions\tCorrelation coefficient rank; LLE\tC‐means clustering\t86.5\t \tFan et al. (2011)\tSZ = 31, HC = 31\tFunctional brain networks from ICA\tICA, Grassmann manifold analysis\tSVM\t85.5\t \tDu et al. (2012)\tSZ = 28, HC = 28\tSpatial components from ICA\tt test; PCA; FLD\tMajority voting\t93\t \tTang, Wang, Cao, and Tan (2012)\tSZ = 22, HC = 22\tFC by 90 regions\tCorrelation coefficient rank; PCA\tLinear SVM\t93.2\t \tBassett, Nelson, Mueller, Camchong, and Lim (2012)\tSZ = 15, HC = 14\tFC by the graph\tNo\tLinear kernel SVM\t75\t \tVenkataraman, Whitford, Westin, Golland, and Kubicki (2012)\tSZ = 18, HC = 18\tFC by 77 ROIs\tSelect by prior knowledge and random forest\tMajority voting\t75\t \tAnderson and Cohen (2013)\tSZ = 72, HC = 74\tFNC by the graph\tICA\tSVM\t65\t \tArbabshirani et al. (2013)\tSZ = 28, HC = 28\tFNC\tICA; visually inspect\tK‐nearest neighbors\t96\t \tFekete et al. (2013)\tSZ = 8, HC = 10\tFNC by the graph\tNo\tMulti kernel block diagonal optimization\t100\t \tSu, Wang, Shen, Feng, and Hu (2013)\tSZ = 32, HC = 32\tFC\tCorrelation coefficient rank\tLinear kernel SVM\t81.2\t \tWatanabe, Kessler, Scott, Angstadt, and Sripada (2014)\tSZ = 54, HC = 67\tFC by 347 ROIs\tElastic‐net\tSVM\t73.5\t \tCheng, Newman, et al. (2015) and Cheng, Palaniyappan, et al. (2015)\tSZ = 415, HC = 405\tFC by BWAS\tNo\tSVM\t75.8\t \tChyzhyk, Savio, and Grana (2015)\tSZ = 74, HC = 72\tFC/ local activity\tPearson's correlation coefficient\tSVM\t91.2/100\t \tSavio and Grana (2015)\tSZ = 72, HC = 74\tALFF, fALFF, VMHC, ReHo\tVoxel site saliency measures\tSVM; RF\t80\t \tCheng, Newman, et al. (2015) and Cheng, Palaniyappan, et al. (2015)\tSZ = 27, HC = 36\tBC of FC\tRank BC\tSVM\t79\t \tKaufmann et al. (2015)\tSZ = 71, HC = 196\tFC from ICA\tNo\tRegularized LDA\t84.4\t \tKim et al. (2016)\tSZ = 50, HC = 50\tFC among 116 regions\tNo\tDeep neural network\t86\t \tSkatun et al. (2017)\tSZ = 182, HC = 348\tFC from ICA\tNo\tRegularized LDA\t78.3\t \tCui, Liu, Song, et al. (2018) and Cui, Liu, Wang, et al. (2018)\tSZ = 108, HC = 121\tFC by 90 ROIs\tTwo sample t tests, LASSO\tSVM\t82.6\t \tCao et al. (2018)\tSZ = 43, HC = 29\tMI and FC between STC and other cortical regions\tTop 10 features\tSVM\t78.6\t \t
#Text=Abbreviations: BC, betweenness centrality; BWAS, brain‐wide association study; FLD, Fisher linear discriminant; FNC, functional network connectivity; HC, healthy controls; LASSO, least absolute shrinkage and selection operator; LDA, linear discriminative analysis; LLE, locally linear embedding; MI, mutual information; PCA, principle component analysis; RF, random forest; ROI, region of interest; STC, superior temporal cortex; SZ, patients with schizophrenia; VMHC, voxel‐mirrored homotopic connectivity.
34-1	6969-6976	Summary	_
34-2	6977-6979	of	_
34-3	6980-6987	machine	_
34-4	6988-6996	learning	_
34-5	6997-7004	studies	_
34-6	7005-7007	in	_
34-7	7008-7021	schizophrenia	_
34-8	7022-7027	based	_
34-9	7028-7030	on	_
34-10	7031-7037	rsfMRI	_
34-11	7038-7047	Reference	_
34-12	7048-7060	Participants	_
34-13	7061-7068	Feature	_
34-14	7069-7076	Feature	_
34-15	7077-7087	extraction	_
34-16	7088-7098	Classifier	_
34-17	7099-7107	Accuracy	_
34-18	7108-7109	(	_
34-19	7109-7110	%	_
34-20	7110-7111	)	_
34-21	7114-7118	Shen	_
34-22	7118-7119	,	_
34-23	7120-7124	Wang	_
34-24	7124-7125	,	_
34-25	7126-7129	Liu	_
34-26	7129-7130	,	_
34-27	7131-7134	and	_
34-28	7135-7137	Hu	_
34-29	7138-7139	(	_
34-30	7139-7143	2010	_
34-31	7143-7144	)	_
34-32	7145-7147	SZ	_
34-33	7148-7149	=	_
34-34	7150-7152	32	_
34-35	7152-7153	,	_
34-36	7154-7156	HC	_
34-37	7157-7158	=	_
34-38	7159-7161	20	_
34-39	7162-7164	FC	_
34-40	7165-7170	among	_
34-41	7171-7174	116	_
34-42	7175-7182	regions	_
34-43	7183-7194	Correlation	_
34-44	7195-7206	coefficient	_
34-45	7207-7211	rank	_
34-46	7211-7212	;	_
34-47	7213-7216	LLE	_
34-48	7217-7224	C‐means	_
34-49	7225-7235	clustering	_
34-50	7236-7240	86.5	_
34-51	7243-7246	Fan	_
34-52	7247-7249	et	_
34-53	7250-7252	al	_
34-54	7252-7253	.	_
34-55	7254-7255	(	_
34-56	7255-7259	2011	_
34-57	7259-7260	)	_
34-58	7261-7263	SZ	_
34-59	7264-7265	=	_
34-60	7266-7268	31	_
34-61	7268-7269	,	_
34-62	7270-7272	HC	_
34-63	7273-7274	=	_
34-64	7275-7277	31	_
34-65	7278-7288	Functional	_
34-66	7289-7294	brain	_
34-67	7295-7303	networks	_
34-68	7304-7308	from	_
34-69	7309-7312	ICA	_
34-70	7313-7316	ICA	_
34-71	7316-7317	,	_
34-72	7318-7327	Grassmann	_
34-73	7328-7336	manifold	_
34-74	7337-7345	analysis	_
34-75	7346-7349	SVM	_
34-76	7350-7354	85.5	_
34-77	7357-7359	Du	_
34-78	7360-7362	et	_
34-79	7363-7365	al	_
34-80	7365-7366	.	_
34-81	7367-7368	(	_
34-82	7368-7372	2012	_
34-83	7372-7373	)	_
34-84	7374-7376	SZ	_
34-85	7377-7378	=	_
34-86	7379-7381	28	_
34-87	7381-7382	,	_
34-88	7383-7385	HC	_
34-89	7386-7387	=	_
34-90	7388-7390	28	_
34-91	7391-7398	Spatial	_
34-92	7399-7409	components	_
34-93	7410-7414	from	_
34-94	7415-7418	ICA	_
34-95	7419-7420	t	_
34-96	7421-7425	test	_
34-97	7425-7426	;	_
34-98	7427-7430	PCA	_
34-99	7430-7431	;	_
34-100	7432-7435	FLD	_
34-101	7436-7444	Majority	_
34-102	7445-7451	voting	_
34-103	7452-7454	93	_
34-104	7457-7461	Tang	_
34-105	7461-7462	,	_
34-106	7463-7467	Wang	_
34-107	7467-7468	,	_
34-108	7469-7472	Cao	_
34-109	7472-7473	,	_
34-110	7474-7477	and	_
34-111	7478-7481	Tan	_
34-112	7482-7483	(	_
34-113	7483-7487	2012	_
34-114	7487-7488	)	_
34-115	7489-7491	SZ	_
34-116	7492-7493	=	_
34-117	7494-7496	22	_
34-118	7496-7497	,	_
34-119	7498-7500	HC	_
34-120	7501-7502	=	_
34-121	7503-7505	22	_
34-122	7506-7508	FC	_
34-123	7509-7511	by	_
34-124	7512-7514	90	_
34-125	7515-7522	regions	_
34-126	7523-7534	Correlation	_
34-127	7535-7546	coefficient	_
34-128	7547-7551	rank	_
34-129	7551-7552	;	_
34-130	7553-7556	PCA	_
34-131	7557-7563	Linear	_
34-132	7564-7567	SVM	_
34-133	7568-7572	93.2	_
34-134	7575-7582	Bassett	_
34-135	7582-7583	,	_
34-136	7584-7590	Nelson	_
34-137	7590-7591	,	_
34-138	7592-7599	Mueller	_
34-139	7599-7600	,	_
34-140	7601-7609	Camchong	_
34-141	7609-7610	,	_
34-142	7611-7614	and	_
34-143	7615-7618	Lim	_
34-144	7619-7620	(	_
34-145	7620-7624	2012	_
34-146	7624-7625	)	_
34-147	7626-7628	SZ	_
34-148	7629-7630	=	_
34-149	7631-7633	15	_
34-150	7633-7634	,	_
34-151	7635-7637	HC	_
34-152	7638-7639	=	_
34-153	7640-7642	14	_
34-154	7643-7645	FC	_
34-155	7646-7648	by	_
34-156	7649-7652	the	_
34-157	7653-7658	graph	_
34-158	7659-7661	No	_
34-159	7662-7668	Linear	_
34-160	7669-7675	kernel	_
34-161	7676-7679	SVM	_
34-162	7680-7682	75	_
34-163	7685-7697	Venkataraman	_
34-164	7697-7698	,	_
34-165	7699-7707	Whitford	_
34-166	7707-7708	,	_
34-167	7709-7715	Westin	_
34-168	7715-7716	,	_
34-169	7717-7724	Golland	_
34-170	7724-7725	,	_
34-171	7726-7729	and	_
34-172	7730-7737	Kubicki	_
34-173	7738-7739	(	_
34-174	7739-7743	2012	_
34-175	7743-7744	)	_
34-176	7745-7747	SZ	_
34-177	7748-7749	=	_
34-178	7750-7752	18	_
34-179	7752-7753	,	_
34-180	7754-7756	HC	_
34-181	7757-7758	=	_
34-182	7759-7761	18	_
34-183	7762-7764	FC	_
34-184	7765-7767	by	_
34-185	7768-7770	77	_
34-186	7771-7775	ROIs	_
34-187	7776-7782	Select	_
34-188	7783-7785	by	_
34-189	7786-7791	prior	_
34-190	7792-7801	knowledge	_
34-191	7802-7805	and	_
34-192	7806-7812	random	_
34-193	7813-7819	forest	_
34-194	7820-7828	Majority	_
34-195	7829-7835	voting	_
34-196	7836-7838	75	_
34-197	7841-7849	Anderson	_
34-198	7850-7853	and	_
34-199	7854-7859	Cohen	_
34-200	7860-7861	(	_
34-201	7861-7865	2013	_
34-202	7865-7866	)	_
34-203	7867-7869	SZ	_
34-204	7870-7871	=	_
34-205	7872-7874	72	_
34-206	7874-7875	,	_
34-207	7876-7878	HC	_
34-208	7879-7880	=	_
34-209	7881-7883	74	_
34-210	7884-7887	FNC	_
34-211	7888-7890	by	_
34-212	7891-7894	the	_
34-213	7895-7900	graph	_
34-214	7901-7904	ICA	_
34-215	7905-7908	SVM	_
34-216	7909-7911	65	_
34-217	7914-7926	Arbabshirani	_
34-218	7927-7929	et	_
34-219	7930-7932	al	_
34-220	7932-7933	.	_
34-221	7934-7935	(	_
34-222	7935-7939	2013	_
34-223	7939-7940	)	_
34-224	7941-7943	SZ	_
34-225	7944-7945	=	_
34-226	7946-7948	28	_
34-227	7948-7949	,	_
34-228	7950-7952	HC	_
34-229	7953-7954	=	_
34-230	7955-7957	28	_
34-231	7958-7961	FNC	_
34-232	7962-7965	ICA	_
34-233	7965-7966	;	_
34-234	7967-7975	visually	_
34-235	7976-7983	inspect	_
34-236	7984-7993	K‐nearest	_
34-237	7994-8003	neighbors	_
34-238	8004-8006	96	_
34-239	8009-8015	Fekete	_
34-240	8016-8018	et	_
34-241	8019-8021	al	_
34-242	8021-8022	.	_
34-243	8023-8024	(	_
34-244	8024-8028	2013	_
34-245	8028-8029	)	_
34-246	8030-8032	SZ	_
34-247	8033-8034	=	_
34-248	8035-8036	8	_
34-249	8036-8037	,	_
34-250	8038-8040	HC	_
34-251	8041-8042	=	_
34-252	8043-8045	10	_
34-253	8046-8049	FNC	_
34-254	8050-8052	by	_
34-255	8053-8056	the	_
34-256	8057-8062	graph	_
34-257	8063-8065	No	_
34-258	8066-8071	Multi	_
34-259	8072-8078	kernel	_
34-260	8079-8084	block	_
34-261	8085-8093	diagonal	_
34-262	8094-8106	optimization	_
34-263	8107-8110	100	_
34-264	8113-8115	Su	_
34-265	8115-8116	,	_
34-266	8117-8121	Wang	_
34-267	8121-8122	,	_
34-268	8123-8127	Shen	_
34-269	8127-8128	,	_
34-270	8129-8133	Feng	_
34-271	8133-8134	,	_
34-272	8135-8138	and	_
34-273	8139-8141	Hu	_
34-274	8142-8143	(	_
34-275	8143-8147	2013	_
34-276	8147-8148	)	_
34-277	8149-8151	SZ	_
34-278	8152-8153	=	_
34-279	8154-8156	32	_
34-280	8156-8157	,	_
34-281	8158-8160	HC	_
34-282	8161-8162	=	_
34-283	8163-8165	32	_
34-284	8166-8168	FC	_
34-285	8169-8180	Correlation	_
34-286	8181-8192	coefficient	_
34-287	8193-8197	rank	_
34-288	8198-8204	Linear	_
34-289	8205-8211	kernel	_
34-290	8212-8215	SVM	_
34-291	8216-8220	81.2	_
34-292	8223-8231	Watanabe	_
34-293	8231-8232	,	_
34-294	8233-8240	Kessler	_
34-295	8240-8241	,	_
34-296	8242-8247	Scott	_
34-297	8247-8248	,	_
34-298	8249-8257	Angstadt	_
34-299	8257-8258	,	_
34-300	8259-8262	and	_
34-301	8263-8270	Sripada	_
34-302	8271-8272	(	_
34-303	8272-8276	2014	_
34-304	8276-8277	)	_
34-305	8278-8280	SZ	_
34-306	8281-8282	=	_
34-307	8283-8285	54	_
34-308	8285-8286	,	_
34-309	8287-8289	HC	_
34-310	8290-8291	=	_
34-311	8292-8294	67	_
34-312	8295-8297	FC	_
34-313	8298-8300	by	_
34-314	8301-8304	347	_
34-315	8305-8309	ROIs	_
34-316	8310-8321	Elastic‐net	_
34-317	8322-8325	SVM	_
34-318	8326-8330	73.5	_
34-319	8333-8338	Cheng	_
34-320	8338-8339	,	_
34-321	8340-8346	Newman	_
34-322	8346-8347	,	_
34-323	8348-8350	et	_
34-324	8351-8353	al	_
34-325	8353-8354	.	_
34-326	8355-8356	(	_
34-327	8356-8360	2015	_
34-328	8360-8361	)	_
34-329	8362-8365	and	_
34-330	8366-8371	Cheng	_
34-331	8371-8372	,	_
34-332	8373-8385	Palaniyappan	_
34-333	8385-8386	,	_
34-334	8387-8389	et	_
34-335	8390-8392	al	_
34-336	8392-8393	.	_
34-337	8394-8395	(	_
34-338	8395-8399	2015	_
34-339	8399-8400	)	_
34-340	8401-8403	SZ	_
34-341	8404-8405	=	_
34-342	8406-8409	415	_
34-343	8409-8410	,	_
34-344	8411-8413	HC	_
34-345	8414-8415	=	_
34-346	8416-8419	405	_
34-347	8420-8422	FC	_
34-348	8423-8425	by	_
34-349	8426-8430	BWAS	_
34-350	8431-8433	No	_
34-351	8434-8437	SVM	_
34-352	8438-8442	75.8	_
34-353	8445-8452	Chyzhyk	_
34-354	8452-8453	,	_
34-355	8454-8459	Savio	_
34-356	8459-8460	,	_
34-357	8461-8464	and	_
34-358	8465-8470	Grana	_
34-359	8471-8472	(	_
34-360	8472-8476	2015	_
34-361	8476-8477	)	_
34-362	8478-8480	SZ	_
34-363	8481-8482	=	_
34-364	8483-8485	74	_
34-365	8485-8486	,	_
34-366	8487-8489	HC	_
34-367	8490-8491	=	_
34-368	8492-8494	72	_
34-369	8495-8497	FC	_
34-370	8497-8498	/	_
34-371	8499-8504	local	_
34-372	8505-8513	activity	_
34-373	8514-8523	Pearson's	_
34-374	8524-8535	correlation	_
34-375	8536-8547	coefficient	_
34-376	8548-8551	SVM	_
34-377	8552-8556	91.2	_
34-378	8556-8557	/	_
34-379	8557-8560	100	_
34-380	8563-8568	Savio	_
34-381	8569-8572	and	_
34-382	8573-8578	Grana	_
34-383	8579-8580	(	_
34-384	8580-8584	2015	_
34-385	8584-8585	)	_
34-386	8586-8588	SZ	_
34-387	8589-8590	=	_
34-388	8591-8593	72	_
34-389	8593-8594	,	_
34-390	8595-8597	HC	_
34-391	8598-8599	=	_
34-392	8600-8602	74	_
34-393	8603-8607	ALFF	_
34-394	8607-8608	,	_
34-395	8609-8614	fALFF	_
34-396	8614-8615	,	_
34-397	8616-8620	VMHC	_
34-398	8620-8621	,	_
34-399	8622-8626	ReHo	_
34-400	8627-8632	Voxel	_
34-401	8633-8637	site	_
34-402	8638-8646	saliency	_
34-403	8647-8655	measures	_
34-404	8656-8659	SVM	_
34-405	8659-8660	;	_
34-406	8661-8663	RF	_
34-407	8664-8666	80	_
34-408	8669-8674	Cheng	_
34-409	8674-8675	,	_
34-410	8676-8682	Newman	_
34-411	8682-8683	,	_
34-412	8684-8686	et	_
34-413	8687-8689	al	_
34-414	8689-8690	.	_
34-415	8691-8692	(	_
34-416	8692-8696	2015	_
34-417	8696-8697	)	_
34-418	8698-8701	and	_
34-419	8702-8707	Cheng	_
34-420	8707-8708	,	_
34-421	8709-8721	Palaniyappan	_
34-422	8721-8722	,	_
34-423	8723-8725	et	_
34-424	8726-8728	al	_
34-425	8728-8729	.	_
34-426	8730-8731	(	_
34-427	8731-8735	2015	_
34-428	8735-8736	)	_
34-429	8737-8739	SZ	_
34-430	8740-8741	=	_
34-431	8742-8744	27	_
34-432	8744-8745	,	_
34-433	8746-8748	HC	_
34-434	8749-8750	=	_
34-435	8751-8753	36	_
34-436	8754-8756	BC	_
34-437	8757-8759	of	_
34-438	8760-8762	FC	_
34-439	8763-8767	Rank	_
34-440	8768-8770	BC	_
34-441	8771-8774	SVM	_
34-442	8775-8777	79	_
34-443	8780-8788	Kaufmann	_
34-444	8789-8791	et	_
34-445	8792-8794	al	_
34-446	8794-8795	.	_
34-447	8796-8797	(	_
34-448	8797-8801	2015	_
34-449	8801-8802	)	_
34-450	8803-8805	SZ	_
34-451	8806-8807	=	_
34-452	8808-8810	71	_
34-453	8810-8811	,	_
34-454	8812-8814	HC	_
34-455	8815-8816	=	_
34-456	8817-8820	196	_
34-457	8821-8823	FC	_
34-458	8824-8828	from	_
34-459	8829-8832	ICA	_
34-460	8833-8835	No	_
34-461	8836-8847	Regularized	_
34-462	8848-8851	LDA	_
34-463	8852-8856	84.4	_
34-464	8859-8862	Kim	_
34-465	8863-8865	et	_
34-466	8866-8868	al	_
34-467	8868-8869	.	_
34-468	8870-8871	(	_
34-469	8871-8875	2016	_
34-470	8875-8876	)	_
34-471	8877-8879	SZ	_
34-472	8880-8881	=	_
34-473	8882-8884	50	_
34-474	8884-8885	,	_
34-475	8886-8888	HC	_
34-476	8889-8890	=	_
34-477	8891-8893	50	_
34-478	8894-8896	FC	_
34-479	8897-8902	among	_
34-480	8903-8906	116	_
34-481	8907-8914	regions	_
34-482	8915-8917	No	_
34-483	8918-8922	Deep	_
34-484	8923-8929	neural	_
34-485	8930-8937	network	_
34-486	8938-8940	86	_
34-487	8943-8949	Skatun	_
34-488	8950-8952	et	_
34-489	8953-8955	al	_
34-490	8955-8956	.	_
34-491	8957-8958	(	_
34-492	8958-8962	2017	_
34-493	8962-8963	)	_
34-494	8964-8966	SZ	_
34-495	8967-8968	=	_
34-496	8969-8972	182	_
34-497	8972-8973	,	_
34-498	8974-8976	HC	_
34-499	8977-8978	=	_
34-500	8979-8982	348	_
34-501	8983-8985	FC	_
34-502	8986-8990	from	_
34-503	8991-8994	ICA	_
34-504	8995-8997	No	_
34-505	8998-9009	Regularized	_
34-506	9010-9013	LDA	_
34-507	9014-9018	78.3	_
34-508	9021-9024	Cui	_
34-509	9024-9025	,	_
34-510	9026-9029	Liu	_
34-511	9029-9030	,	_
34-512	9031-9035	Song	_
34-513	9035-9036	,	_
34-514	9037-9039	et	_
34-515	9040-9042	al	_
34-516	9042-9043	.	_
34-517	9044-9045	(	_
34-518	9045-9049	2018	_
34-519	9049-9050	)	_
34-520	9051-9054	and	_
34-521	9055-9058	Cui	_
34-522	9058-9059	,	_
34-523	9060-9063	Liu	_
34-524	9063-9064	,	_
34-525	9065-9069	Wang	_
34-526	9069-9070	,	_
34-527	9071-9073	et	_
34-528	9074-9076	al	_
34-529	9076-9077	.	_
34-530	9078-9079	(	_
34-531	9079-9083	2018	_
34-532	9083-9084	)	_
34-533	9085-9087	SZ	_
34-534	9088-9089	=	_
34-535	9090-9093	108	_
34-536	9093-9094	,	_
34-537	9095-9097	HC	_
34-538	9098-9099	=	_
34-539	9100-9103	121	_
34-540	9104-9106	FC	_
34-541	9107-9109	by	_
34-542	9110-9112	90	_
34-543	9113-9117	ROIs	_
34-544	9118-9121	Two	_
34-545	9122-9128	sample	_
34-546	9129-9130	t	_
34-547	9131-9136	tests	_
34-548	9136-9137	,	_
34-549	9138-9143	LASSO	_
34-550	9144-9147	SVM	_
34-551	9148-9152	82.6	_
34-552	9155-9158	Cao	_
34-553	9159-9161	et	_
34-554	9162-9164	al	_
34-555	9164-9165	.	_
34-556	9166-9167	(	_
34-557	9167-9171	2018	_
34-558	9171-9172	)	_
34-559	9173-9175	SZ	_
34-560	9176-9177	=	_
34-561	9178-9180	43	_
34-562	9180-9181	,	_
34-563	9182-9184	HC	_
34-564	9185-9186	=	_
34-565	9187-9189	29	_
34-566	9190-9192	MI	_
34-567	9193-9196	and	_
34-568	9197-9199	FC	_
34-569	9200-9207	between	_
34-570	9208-9211	STC	_
34-571	9212-9215	and	_
34-572	9216-9221	other	_
34-573	9222-9230	cortical	_
34-574	9231-9238	regions	_
34-575	9239-9242	Top	_
34-576	9243-9245	10	_
34-577	9246-9254	features	_
34-578	9255-9258	SVM	_
34-579	9259-9263	78.6	_
34-580	9267-9280	Abbreviations	_
34-581	9280-9281	:	_
34-582	9282-9284	BC	_
34-583	9284-9285	,	_
34-584	9286-9297	betweenness	_
34-585	9298-9308	centrality	_
34-586	9308-9309	;	_
34-587	9310-9314	BWAS	_
34-588	9314-9315	,	_
34-589	9316-9326	brain‐wide	_
34-590	9327-9338	association	_
34-591	9339-9344	study	_
34-592	9344-9345	;	_
34-593	9346-9349	FLD	_
34-594	9349-9350	,	_
34-595	9351-9357	Fisher	_
34-596	9358-9364	linear	_
34-597	9365-9377	discriminant	_
34-598	9377-9378	;	_
34-599	9379-9382	FNC	_
34-600	9382-9383	,	_
34-601	9384-9394	functional	_
34-602	9395-9402	network	_
34-603	9403-9415	connectivity	_
34-604	9415-9416	;	_
34-605	9417-9419	HC	_
34-606	9419-9420	,	_
34-607	9421-9428	healthy	_
34-608	9429-9437	controls	_
34-609	9437-9438	;	_
34-610	9439-9444	LASSO	_
34-611	9444-9445	,	_
34-612	9446-9451	least	_
34-613	9452-9460	absolute	_
34-614	9461-9470	shrinkage	_
34-615	9471-9474	and	_
34-616	9475-9484	selection	_
34-617	9485-9493	operator	_
34-618	9493-9494	;	_
34-619	9495-9498	LDA	_
34-620	9498-9499	,	_
34-621	9500-9506	linear	_
34-622	9507-9521	discriminative	_
34-623	9522-9530	analysis	_
34-624	9530-9531	;	_
34-625	9532-9535	LLE	_
34-626	9535-9536	,	_
34-627	9537-9544	locally	_
34-628	9545-9551	linear	_
34-629	9552-9561	embedding	_
34-630	9561-9562	;	_
34-631	9563-9565	MI	_
34-632	9565-9566	,	_
34-633	9567-9573	mutual	_
34-634	9574-9585	information	_
34-635	9585-9586	;	_
34-636	9587-9590	PCA	_
34-637	9590-9591	,	_
34-638	9592-9601	principle	_
34-639	9602-9611	component	_
34-640	9612-9620	analysis	_
34-641	9620-9621	;	_
34-642	9622-9624	RF	_
34-643	9624-9625	,	_
34-644	9626-9632	random	_
34-645	9633-9639	forest	_
34-646	9639-9640	;	_
34-647	9641-9644	ROI	_
34-648	9644-9645	,	_
34-649	9646-9652	region	_
34-650	9653-9655	of	_
34-651	9656-9664	interest	_
34-652	9664-9665	;	_
34-653	9666-9669	STC	_
34-654	9669-9670	,	_
34-655	9671-9679	superior	_
34-656	9680-9688	temporal	_
34-657	9689-9695	cortex	_
34-658	9695-9696	;	_
34-659	9697-9699	SZ	_
34-660	9699-9700	,	_
34-661	9701-9709	patients	_
34-662	9710-9714	with	_
34-663	9715-9728	schizophrenia	_
34-664	9728-9729	;	_
34-665	9730-9734	VMHC	_
34-666	9734-9735	,	_
34-667	9736-9750	voxel‐mirrored	_
34-668	9751-9760	homotopic	_
34-669	9761-9773	connectivity	_
34-670	9773-9774	.	_

#Text=In this study, the overall aim was to assess the within‐site and between‐site generalizability of a previous machine learning framework of rsfMRI data that have shown promising performance using both internal and external validation methods.
35-1	9775-9777	In	_
35-2	9778-9782	this	_
35-3	9783-9788	study	_
35-4	9788-9789	,	_
35-5	9790-9793	the	_
35-6	9794-9801	overall	_
35-7	9802-9805	aim	_
35-8	9806-9809	was	_
35-9	9810-9812	to	_
35-10	9813-9819	assess	_
35-11	9820-9823	the	_
35-12	9824-9835	within‐site	_
35-13	9836-9839	and	_
35-14	9840-9852	between‐site	_
35-15	9853-9869	generalizability	_
35-16	9870-9872	of	_
35-17	9873-9874	a	_
35-18	9875-9883	previous	_
35-19	9884-9891	machine	_
35-20	9892-9900	learning	_
35-21	9901-9910	framework	_
35-22	9911-9913	of	_
35-23	9914-9920	rsfMRI	_
35-24	9921-9925	data	_
35-25	9926-9930	that	_
35-26	9931-9935	have	_
35-27	9936-9941	shown	_
35-28	9942-9951	promising	_
35-29	9952-9963	performance	_
35-30	9964-9969	using	_
35-31	9970-9974	both	_
35-32	9975-9983	internal	_
35-33	9984-9987	and	_
35-34	9988-9996	external	_
35-35	9997-10007	validation	_
35-36	10008-10015	methods	_
35-37	10015-10016	.	_

#Text=Among the various previous studies, Du et al. (2012) have reported an excellent classification accuracy of 0.93 using rsfMRI data and 0.98 using fMRI data in identifying schizophrenia patients from healthy controls based on their own machine learning procedure.
36-1	10017-10022	Among	_
36-2	10023-10026	the	_
36-3	10027-10034	various	_
36-4	10035-10043	previous	_
36-5	10044-10051	studies	_
36-6	10051-10052	,	_
36-7	10053-10055	Du	_
36-8	10056-10058	et	_
36-9	10059-10061	al	_
36-10	10061-10062	.	_
36-11	10063-10064	(	_
36-12	10064-10068	2012	_
36-13	10068-10069	)	_
36-14	10070-10074	have	_
36-15	10075-10083	reported	_
36-16	10084-10086	an	_
36-17	10087-10096	excellent	_
36-18	10097-10111	classification	_
36-19	10112-10120	accuracy	_
36-20	10121-10123	of	_
36-21	10124-10128	0.93	_
36-22	10129-10134	using	_
36-23	10135-10141	rsfMRI	_
36-24	10142-10146	data	_
36-25	10147-10150	and	_
36-26	10151-10155	0.98	_
36-27	10156-10161	using	_
36-28	10162-10166	fMRI	_
36-29	10167-10171	data	_
36-30	10172-10174	in	_
36-31	10175-10186	identifying	_
36-32	10187-10200	schizophrenia	_
36-33	10201-10209	patients	_
36-34	10210-10214	from	_
36-35	10215-10222	healthy	_
36-36	10223-10231	controls	_
36-37	10232-10237	based	_
36-38	10238-10240	on	_
36-39	10241-10246	their	_
36-40	10247-10250	own	_
36-41	10251-10258	machine	_
36-42	10259-10267	learning	_
36-43	10268-10277	procedure	_
36-44	10277-10278	.	_

#Text=Therefore, we examined the generalizability of this machine learning procedure in the present study.
37-1	10279-10288	Therefore	_
37-2	10288-10289	,	_
37-3	10290-10292	we	_
37-4	10293-10301	examined	_
37-5	10302-10305	the	_
37-6	10306-10322	generalizability	_
37-7	10323-10325	of	_
37-8	10326-10330	this	_
37-9	10331-10338	machine	_
37-10	10339-10347	learning	_
37-11	10348-10357	procedure	_
37-12	10358-10360	in	_
37-13	10361-10364	the	_
37-14	10365-10372	present	_
37-15	10373-10378	study	_
37-16	10378-10379	.	_

#Text=We first investigated the generalizability of the classification procedure in a main data set from a single site (internal validation) following the exact steps from Du et al.'
38-1	10380-10382	We	_
38-2	10383-10388	first	_
38-3	10389-10401	investigated	_
38-4	10402-10405	the	_
38-5	10406-10422	generalizability	_
38-6	10423-10425	of	_
38-7	10426-10429	the	_
38-8	10430-10444	classification	_
38-9	10445-10454	procedure	_
38-10	10455-10457	in	_
38-11	10458-10459	a	_
38-12	10460-10464	main	_
38-13	10465-10469	data	_
38-14	10470-10473	set	_
38-15	10474-10478	from	_
38-16	10479-10480	a	_
38-17	10481-10487	single	_
38-18	10488-10492	site	_
38-19	10493-10494	(	_
38-20	10494-10502	internal	_
38-21	10503-10513	validation	_
38-22	10513-10514	)	_
38-23	10515-10524	following	_
38-24	10525-10528	the	_
38-25	10529-10534	exact	_
38-26	10535-10540	steps	_
38-27	10541-10545	from	_
38-28	10546-10548	Du	_
38-29	10549-10551	et	_
38-30	10552-10554	al	_
38-31	10554-10555	.	_
38-32	10555-10556	'	_

#Text=s study.
39-1	10556-10557	s	_
39-2	10558-10563	study	_
39-3	10563-10564	.	_

#Text=Then, we assessed the between‐site generalizability to a completely independent data set (validated data set) from a different site (external validation) to test whether factors from different sites, such as scanning setting and procedure, would influence generalizability.
40-1	10565-10569	Then	_
40-2	10569-10570	,	_
40-3	10571-10573	we	_
40-4	10574-10582	assessed	_
40-5	10583-10586	the	_
40-6	10587-10599	between‐site	_
40-7	10600-10616	generalizability	_
40-8	10617-10619	to	_
40-9	10620-10621	a	_
40-10	10622-10632	completely	_
40-11	10633-10644	independent	_
40-12	10645-10649	data	_
40-13	10650-10653	set	_
40-14	10654-10655	(	_
40-15	10655-10664	validated	_
40-16	10665-10669	data	_
40-17	10670-10673	set	_
40-18	10673-10674	)	_
40-19	10675-10679	from	_
40-20	10680-10681	a	_
40-21	10682-10691	different	_
40-22	10692-10696	site	_
40-23	10697-10698	(	_
40-24	10698-10706	external	_
40-25	10707-10717	validation	_
40-26	10717-10718	)	_
40-27	10719-10721	to	_
40-28	10722-10726	test	_
40-29	10727-10734	whether	_
40-30	10735-10742	factors	_
40-31	10743-10747	from	_
40-32	10748-10757	different	_
40-33	10758-10763	sites	_
40-34	10763-10764	,	_
40-35	10765-10769	such	_
40-36	10770-10772	as	_
40-37	10773-10781	scanning	_
40-38	10782-10789	setting	_
40-39	10790-10793	and	_
40-40	10794-10803	procedure	_
40-41	10803-10804	,	_
40-42	10805-10810	would	_
40-43	10811-10820	influence	_
40-44	10821-10837	generalizability	_
40-45	10837-10838	.	_

#Text=To further explore the generalizability of the procedure rather than the algorithm itself, we updated the unsupervised part of the algorithm to investigate the degree to which the performance of between‐site generalizability could be improved in the new setting.
41-1	10839-10841	To	_
41-2	10842-10849	further	_
41-3	10850-10857	explore	_
41-4	10858-10861	the	_
41-5	10862-10878	generalizability	_
41-6	10879-10881	of	_
41-7	10882-10885	the	_
41-8	10886-10895	procedure	_
41-9	10896-10902	rather	_
41-10	10903-10907	than	_
41-11	10908-10911	the	_
41-12	10912-10921	algorithm	_
41-13	10922-10928	itself	_
41-14	10928-10929	,	_
41-15	10930-10932	we	_
41-16	10933-10940	updated	_
41-17	10941-10944	the	_
41-18	10945-10957	unsupervised	_
41-19	10958-10962	part	_
41-20	10963-10965	of	_
41-21	10966-10969	the	_
41-22	10970-10979	algorithm	_
41-23	10980-10982	to	_
41-24	10983-10994	investigate	_
41-25	10995-10998	the	_
41-26	10999-11005	degree	_
41-27	11006-11008	to	_
41-28	11009-11014	which	_
41-29	11015-11018	the	_
41-30	11019-11030	performance	_
41-31	11031-11033	of	_
41-32	11034-11046	between‐site	_
41-33	11047-11063	generalizability	_
41-34	11064-11069	could	_
41-35	11070-11072	be	_
41-36	11073-11081	improved	_
41-37	11082-11084	in	_
41-38	11085-11088	the	_
41-39	11089-11092	new	_
41-40	11093-11100	setting	_
41-41	11100-11101	.	_

#Text=Importantly, the labels (schizophrenia or healthy control) of the testing data set were not used when training the predictive model in the last step, which served to determine the between‐site generalizability of the procedure from independent data sets.
42-1	11102-11113	Importantly	_
42-2	11113-11114	,	_
42-3	11115-11118	the	_
42-4	11119-11125	labels	_
42-5	11126-11127	(	_
42-6	11127-11140	schizophrenia	_
42-7	11141-11143	or	_
42-8	11144-11151	healthy	_
42-9	11152-11159	control	_
42-10	11159-11160	)	_
42-11	11161-11163	of	_
42-12	11164-11167	the	_
42-13	11168-11175	testing	_
42-14	11176-11180	data	_
42-15	11181-11184	set	_
42-16	11185-11189	were	_
42-17	11190-11193	not	_
42-18	11194-11198	used	_
42-19	11199-11203	when	_
42-20	11204-11212	training	_
42-21	11213-11216	the	_
42-22	11217-11227	predictive	_
42-23	11228-11233	model	_
42-24	11234-11236	in	_
42-25	11237-11240	the	_
42-26	11241-11245	last	_
42-27	11246-11250	step	_
42-28	11250-11251	,	_
42-29	11252-11257	which	_
42-30	11258-11264	served	_
42-31	11265-11267	to	_
42-32	11268-11277	determine	_
42-33	11278-11281	the	_
42-34	11282-11294	between‐site	_
42-35	11295-11311	generalizability	_
42-36	11312-11314	of	_
42-37	11315-11318	the	_
42-38	11319-11328	procedure	_
42-39	11329-11333	from	_
42-40	11334-11345	independent	_
42-41	11346-11350	data	_
42-42	11351-11355	sets	_
42-43	11355-11356	.	_

#Text=Given the excellent performance of the procedure reported by Du et al. (2012), we hypothesized that this machine learning procedure could discriminate patients with schizophrenia from healthy controls with promising classification performance with good within‐site generalizability.
43-1	11357-11362	Given	_
43-2	11363-11366	the	_
43-3	11367-11376	excellent	_
43-4	11377-11388	performance	_
43-5	11389-11391	of	_
43-6	11392-11395	the	_
43-7	11396-11405	procedure	_
43-8	11406-11414	reported	_
43-9	11415-11417	by	_
43-10	11418-11420	Du	_
43-11	11421-11423	et	_
43-12	11424-11426	al	_
43-13	11426-11427	.	_
43-14	11428-11429	(	_
43-15	11429-11433	2012	_
43-16	11433-11434	)	_
43-17	11434-11435	,	_
43-18	11436-11438	we	_
43-19	11439-11451	hypothesized	_
43-20	11452-11456	that	_
43-21	11457-11461	this	_
43-22	11462-11469	machine	_
43-23	11470-11478	learning	_
43-24	11479-11488	procedure	_
43-25	11489-11494	could	_
43-26	11495-11507	discriminate	_
43-27	11508-11516	patients	_
43-28	11517-11521	with	_
43-29	11522-11535	schizophrenia	_
43-30	11536-11540	from	_
43-31	11541-11548	healthy	_
43-32	11549-11557	controls	_
43-33	11558-11562	with	_
43-34	11563-11572	promising	_
43-35	11573-11587	classification	_
43-36	11588-11599	performance	_
43-37	11600-11604	with	_
43-38	11605-11609	good	_
43-39	11610-11621	within‐site	_
43-40	11622-11638	generalizability	_
43-41	11638-11639	.	_

#Text=Due to the effect of site on rsfMRI data (Dansereau et al., 2017), we further hypothesized that the cross‐site generalizability of the procedure would be compromised.
44-1	11640-11643	Due	_
44-2	11644-11646	to	_
44-3	11647-11650	the	_
44-4	11651-11657	effect	_
44-5	11658-11660	of	_
44-6	11661-11665	site	_
44-7	11666-11668	on	_
44-8	11669-11675	rsfMRI	_
44-9	11676-11680	data	_
44-10	11681-11682	(	_
44-11	11682-11691	Dansereau	_
44-12	11692-11694	et	_
44-13	11695-11697	al	_
44-14	11697-11698	.	_
44-15	11698-11699	,	_
44-16	11700-11704	2017	_
44-17	11704-11705	)	_
44-18	11705-11706	,	_
44-19	11707-11709	we	_
44-20	11710-11717	further	_
44-21	11718-11730	hypothesized	_
44-22	11731-11735	that	_
44-23	11736-11739	the	_
44-24	11740-11750	cross‐site	_
44-25	11751-11767	generalizability	_
44-26	11768-11770	of	_
44-27	11771-11774	the	_
44-28	11775-11784	procedure	_
44-29	11785-11790	would	_
44-30	11791-11793	be	_
44-31	11794-11805	compromised	_
44-32	11805-11806	.	_

#Text=Moreover, because some site effects could be taken into account when updating the unsupervised last step of the procedure, we further hypothesized that the between‐site generalizability would improve in the new setting.
45-1	11807-11815	Moreover	_
45-2	11815-11816	,	_
45-3	11817-11824	because	_
45-4	11825-11829	some	_
45-5	11830-11834	site	_
45-6	11835-11842	effects	_
45-7	11843-11848	could	_
45-8	11849-11851	be	_
45-9	11852-11857	taken	_
45-10	11858-11862	into	_
45-11	11863-11870	account	_
45-12	11871-11875	when	_
45-13	11876-11884	updating	_
45-14	11885-11888	the	_
45-15	11889-11901	unsupervised	_
45-16	11902-11906	last	_
45-17	11907-11911	step	_
45-18	11912-11914	of	_
45-19	11915-11918	the	_
45-20	11919-11928	procedure	_
45-21	11928-11929	,	_
45-22	11930-11932	we	_
45-23	11933-11940	further	_
45-24	11941-11953	hypothesized	_
45-25	11954-11958	that	_
45-26	11959-11962	the	_
45-27	11963-11975	between‐site	_
45-28	11976-11992	generalizability	_
45-29	11993-11998	would	_
45-30	11999-12006	improve	_
45-31	12007-12009	in	_
45-32	12010-12013	the	_
45-33	12014-12017	new	_
45-34	12018-12025	setting	_
45-35	12025-12026	.	_

#Text=METHODS
#Text=Participants
#Text=Two data sets of patients with schizophrenia and healthy controls were included in this study.
46-1	12027-12034	METHODS	http://www.case.edu/ProvCaRe/provcare#StudyMethod
46-2	12035-12047	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
46-3	12048-12051	Two	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
46-4	12052-12056	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
46-5	12057-12061	sets	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
46-6	12062-12064	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
46-7	12065-12073	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
46-8	12074-12078	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
46-9	12079-12092	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]
46-10	12093-12096	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
46-11	12097-12104	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]
46-12	12105-12113	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]
46-13	12114-12118	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
46-14	12119-12127	included	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
46-15	12128-12130	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
46-16	12131-12135	this	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
46-17	12136-12141	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]
46-18	12141-12142	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]

#Text=In the main data set, 51 patients with schizophrenia and 51 healthy controls were recruited (Table 2).
47-1	12143-12145	In	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-2	12146-12149	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-3	12150-12154	main	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-4	12155-12159	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-5	12160-12163	set	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-6	12163-12164	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-7	12165-12167	51	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-8	12168-12176	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-9	12177-12181	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-10	12182-12195	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[7]
47-11	12196-12199	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-12	12200-12202	51	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-13	12203-12210	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]
47-14	12211-12219	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]
47-15	12220-12224	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-16	12225-12234	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-17	12235-12236	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-18	12236-12241	Table	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-19	12242-12243	2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-20	12243-12244	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
47-21	12244-12245	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]

#Text=Schizophrenia patients were recruited from the Community Health Service Centre of the Institute of Mental Health (the sixth Affiliated Hospital of Peking University) in the Haidian District of Beijing, China.
48-1	12246-12259	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[9]
48-2	12260-12268	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-3	12269-12273	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-4	12274-12283	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-5	12284-12288	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-6	12289-12292	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-7	12293-12302	Community	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-8	12303-12309	Health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-9	12310-12317	Service	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-10	12318-12324	Centre	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-11	12325-12327	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-12	12328-12331	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-13	12332-12341	Institute	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-14	12342-12344	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-15	12345-12351	Mental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-16	12352-12358	Health	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-17	12359-12360	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-18	12360-12363	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-19	12364-12369	sixth	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-20	12370-12380	Affiliated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-21	12381-12389	Hospital	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-22	12390-12392	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-23	12393-12399	Peking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-24	12400-12410	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-25	12410-12411	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-26	12412-12414	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-27	12415-12418	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-28	12419-12426	Haidian	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-29	12427-12435	District	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-30	12436-12438	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-31	12439-12446	Beijing	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-32	12446-12447	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-33	12448-12453	China	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]
48-34	12453-12454	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]

#Text=In the validated data set, 34 patients with schizophrenia and 27 healthy controls were recruited (Table 2).
49-1	12455-12457	In	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-2	12458-12461	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-3	12462-12471	validated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-4	12472-12476	data	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-5	12477-12480	set	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-6	12480-12481	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-7	12482-12484	34	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-8	12485-12493	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-9	12494-12498	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-10	12499-12512	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[11]
49-11	12513-12516	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-12	12517-12519	27	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-13	12520-12527	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[12]
49-14	12528-12536	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[12]
49-15	12537-12541	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-16	12542-12551	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-17	12552-12553	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-18	12553-12558	Table	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-19	12559-12560	2	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-20	12560-12561	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]
49-21	12561-12562	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[10]

#Text=The patients with schizophrenia were recruited from the Changsha Psychiatric Hospital, Changsha, Hunan province, China.
50-1	12563-12566	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-2	12567-12575	patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-3	12576-12580	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-4	12581-12594	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[14]
50-5	12595-12599	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-6	12600-12609	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-7	12610-12614	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-8	12615-12618	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-9	12619-12627	Changsha	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-10	12628-12639	Psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-11	12640-12648	Hospital	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-12	12648-12649	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-13	12650-12658	Changsha	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-14	12658-12659	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-15	12660-12665	Hunan	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-16	12666-12674	province	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-17	12674-12675	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-18	12676-12681	China	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]
50-19	12681-12682	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[13]

#Text=The diagnosis of schizophrenia was ascertained with the Structural Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV), Fourth Edition (Frances, 1994).
51-1	12683-12686	The	_
51-2	12687-12696	diagnosis	_
51-3	12697-12699	of	_
51-4	12700-12713	schizophrenia	_
51-5	12714-12717	was	_
51-6	12718-12729	ascertained	_
51-7	12730-12734	with	_
51-8	12735-12738	the	_
51-9	12739-12749	Structural	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-10	12750-12758	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-11	12759-12768	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-12	12769-12772	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-13	12773-12776	the	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-14	12777-12787	Diagnostic	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-15	12788-12791	and	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-16	12792-12803	Statistical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-17	12804-12810	Manual	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-18	12811-12813	of	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-19	12814-12820	Mental	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-20	12821-12830	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-21	12831-12832	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-22	12832-12838	DSM‐IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-23	12838-12839	)	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewfortheDiagnosticStatisticalManualofMentalDisorder[15]
51-24	12839-12840	,	_
51-25	12841-12847	Fourth	_
51-26	12848-12855	Edition	_
51-27	12856-12857	(	_
51-28	12857-12864	Frances	_
51-29	12864-12865	,	_
51-30	12866-12870	1994	_
51-31	12870-12871	)	_
51-32	12871-12872	.	_

#Text=The Positive and Negative Syndrome Scale (PANSS) (Kay, Fiszbein, & Opler, 1987) was used to assess the severity of schizophrenia symptoms.
52-1	12873-12876	The	_
52-2	12877-12885	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[16]
52-3	12886-12889	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[16]
52-4	12890-12898	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[16]
52-5	12899-12907	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[16]
52-6	12908-12913	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[16]
52-7	12914-12915	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[16]
52-8	12915-12920	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[16]
52-9	12920-12921	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale[16]
52-10	12922-12923	(	_
52-11	12923-12926	Kay	_
52-12	12926-12927	,	_
52-13	12928-12936	Fiszbein	_
52-14	12936-12937	,	_
52-15	12938-12939	&	_
52-16	12940-12945	Opler	_
52-17	12945-12946	,	_
52-18	12947-12951	1987	_
52-19	12951-12952	)	_
52-20	12953-12956	was	_
52-21	12957-12961	used	_
52-22	12962-12964	to	_
52-23	12965-12971	assess	_
52-24	12972-12975	the	_
52-25	12976-12984	severity	_
52-26	12985-12987	of	_
52-27	12988-13001	schizophrenia	_
52-28	13002-13010	symptoms	_
52-29	13010-13011	.	_

#Text=Both the clinical assessment and the diagnostic interviews were conducted by experienced psychiatrists.
53-1	13012-13016	Both	_
53-2	13017-13020	the	_
53-3	13021-13029	clinical	_
53-4	13030-13040	assessment	_
53-5	13041-13044	and	_
53-6	13045-13048	the	_
53-7	13049-13059	diagnostic	_
53-8	13060-13070	interviews	_
53-9	13071-13075	were	_
53-10	13076-13085	conducted	_
53-11	13086-13088	by	_
53-12	13089-13100	experienced	_
53-13	13101-13114	psychiatrists	_
53-14	13114-13115	.	_

#Text=All patients were taking antipsychotic medications.
54-1	13116-13119	All	_
54-2	13120-13128	patients	_
54-3	13129-13133	were	_
54-4	13134-13140	taking	_
54-5	13141-13154	antipsychotic	_
54-6	13155-13166	medications	_
54-7	13166-13167	.	_

#Text=Healthy controls were recruited from the local community via advertisements.
55-1	13168-13175	Healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[18]
55-2	13176-13184	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[18]
55-3	13185-13189	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
55-4	13190-13199	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
55-5	13200-13204	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
55-6	13205-13208	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
55-7	13209-13214	local	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
55-8	13215-13224	community	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
55-9	13225-13228	via	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
55-10	13229-13243	advertisements	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]
55-11	13243-13244	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[17]

#Text=They had no personal and family history of mental disorders.
56-1	13245-13249	They	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]
56-2	13250-13253	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]
56-3	13254-13256	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]
56-4	13257-13265	personal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]
56-5	13266-13269	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]
56-6	13270-13276	family	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]
56-7	13277-13284	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]
56-8	13285-13287	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]
56-9	13288-13294	mental	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]
56-10	13295-13304	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]
56-11	13304-13305	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[19]

#Text=Participants with neurological disorders, substance abuse, and/or dependence or head injuries were excluded.
57-1	13306-13318	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-2	13319-13323	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-3	13324-13336	neurological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-4	13337-13346	disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-5	13346-13347	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-6	13348-13357	substance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-7	13358-13363	abuse	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-8	13363-13364	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-9	13365-13368	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-10	13368-13369	/	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-11	13369-13371	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-12	13372-13382	dependence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-13	13383-13385	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-14	13386-13390	head	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-15	13391-13399	injuries	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-16	13400-13404	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-17	13405-13413	excluded	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]
57-18	13413-13414	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[20]

#Text=The short form of the Chinese version of the Wechsler Adult Intelligence Scale (Gong, 1992) was used to estimate the IQ of all participants.
58-1	13415-13418	The	_
58-2	13419-13424	short	_
58-3	13425-13429	form	_
58-4	13430-13432	of	_
58-5	13433-13436	the	_
58-6	13437-13444	Chinese	_
58-7	13445-13452	version	_
58-8	13453-13455	of	_
58-9	13456-13459	the	_
58-10	13460-13468	Wechsler	_
58-11	13469-13474	Adult	_
58-12	13475-13487	Intelligence	_
58-13	13488-13493	Scale	_
58-14	13494-13495	(	_
58-15	13495-13499	Gong	_
58-16	13499-13500	,	_
58-17	13501-13505	1992	_
58-18	13505-13506	)	_
58-19	13507-13510	was	_
58-20	13511-13515	used	_
58-21	13516-13518	to	_
58-22	13519-13527	estimate	_
58-23	13528-13531	the	_
58-24	13532-13534	IQ	_
58-25	13535-13537	of	_
58-26	13538-13541	all	_
58-27	13542-13554	participants	_
58-28	13554-13555	.	_

#Text=Demographic and clinical information of two data sets
#Text=\tHC\tSZ\tt/χ 2\tp\t \tThe main data set\t \tDemographics\t \tAge (years)\t42.04 (12.165)\t43.22 (10.885)\t−.515\t.608\t \tGender (male%)\t35.29%\t41.18%\t.374\t.684\t \tEducation (years)\t12.80 (3.731)\t12.07 (2.946)\t1.105\t.272\t \tEstimated IQ*\t119.76 (11.735)\t107.68 (14.215)\t4.663\t.000\t \tClinical characteristics\t \tOnset age (years)\t\t25.41 (9.185)\t\t\t \tCourse (years)\t\t16.66 (8.067)\t\t\t \tPANSS total\t\t51.69 (14.771)\t\t\t \tPANSS positive\t\t11.63 (4.858)\t\t\t \tPANSS negative\t\t13.39 (5.783)\t\t\t \tPANSS general\t\t26.67 (7.618)\t\t\t \tCPZ equivalent dose (mg)\t\t236.56 (172.208)\t\t\t \tThe validated data set\t \tDemographics\t \tAge* (years)\t27.37 (7.344)\t36.5 (7.140)\t−4.898\t.000\t \tGender* (male%)\t44.44%\t82.35%\t9.580\t.003\t \tEducation* (years)\t13.93 (2.814)\t12.18 (2.208)\t2.722\t.009\t \tEstimated IQ\t108.00 (20.196)\t93.94 (24.799)\t1.970\t.055\t \tClinical characteristics\t \tOnset age (years)\t\t24.17 (6.644)\t\t\t \tCourse (years)\t\t10.54 (7.868)\t\t\t \tPANSS total\t\t67.72 (12.378)\t\t\t \tPANSS positive\t\t10.00 (3.873)\t\t\t \tPANSS negative\t\t23.16 (3.118)\t\t\t \tPANSS general\t\t30.84 (7.238)\t\t\t \tCPZ equivalent dose (mg)\t\t287.05 (193.830)\t\t\t \t
#Text=
#Text=Note.
59-1	13556-13567	Demographic	_
59-2	13568-13571	and	_
59-3	13572-13580	clinical	_
59-4	13581-13592	information	_
59-5	13593-13595	of	_
59-6	13596-13599	two	_
59-7	13600-13604	data	_
59-8	13605-13609	sets	_
59-9	13611-13613	HC	_
59-10	13614-13616	SZ	_
59-11	13617-13618	t	_
59-12	13618-13619	/	_
59-13	13619-13620	χ	_
59-14	13621-13622	2	_
59-15	13623-13624	p	_
59-16	13627-13630	The	_
59-17	13631-13635	main	_
59-18	13636-13640	data	_
59-19	13641-13644	set	_
59-20	13647-13659	Demographics	_
59-21	13662-13665	Age	_
59-22	13666-13667	(	_
59-23	13667-13672	years	_
59-24	13672-13673	)	_
59-25	13674-13679	42.04	_
59-26	13680-13681	(	_
59-27	13681-13687	12.165	_
59-28	13687-13688	)	_
59-29	13689-13694	43.22	_
59-30	13695-13696	(	_
59-31	13696-13702	10.885	_
59-32	13702-13703	)	_
59-33	13704-13705	−	_
59-34	13705-13709	.515	_
59-35	13710-13714	.608	_
59-36	13717-13723	Gender	_
59-37	13724-13725	(	_
59-38	13725-13729	male	_
59-39	13729-13730	%	_
59-40	13730-13731	)	_
59-41	13732-13738	35.29%	_
59-42	13739-13745	41.18%	_
59-43	13746-13750	.374	_
59-44	13751-13755	.684	_
59-45	13758-13767	Education	_
59-46	13768-13769	(	_
59-47	13769-13774	years	_
59-48	13774-13775	)	_
59-49	13776-13781	12.80	_
59-50	13782-13783	(	_
59-51	13783-13788	3.731	_
59-52	13788-13789	)	_
59-53	13790-13795	12.07	_
59-54	13796-13797	(	_
59-55	13797-13802	2.946	_
59-56	13802-13803	)	_
59-57	13804-13809	1.105	_
59-58	13810-13814	.272	_
59-59	13817-13826	Estimated	_
59-60	13827-13829	IQ	_
59-61	13829-13830	*	_
59-62	13831-13837	119.76	_
59-63	13838-13839	(	_
59-64	13839-13845	11.735	_
59-65	13845-13846	)	_
59-66	13847-13853	107.68	_
59-67	13854-13855	(	_
59-68	13855-13861	14.215	_
59-69	13861-13862	)	_
59-70	13863-13868	4.663	_
59-71	13869-13873	.000	_
59-72	13876-13884	Clinical	_
59-73	13885-13900	characteristics	_
59-74	13903-13908	Onset	_
59-75	13909-13912	age	_
59-76	13913-13914	(	_
59-77	13914-13919	years	_
59-78	13919-13920	)	_
59-79	13922-13927	25.41	_
59-80	13928-13929	(	_
59-81	13929-13934	9.185	_
59-82	13934-13935	)	_
59-83	13940-13946	Course	_
59-84	13947-13948	(	_
59-85	13948-13953	years	_
59-86	13953-13954	)	_
59-87	13956-13961	16.66	_
59-88	13962-13963	(	_
59-89	13963-13968	8.067	_
59-90	13968-13969	)	_
59-91	13974-13979	PANSS	_
59-92	13980-13985	total	_
59-93	13987-13992	51.69	_
59-94	13993-13994	(	_
59-95	13994-14000	14.771	_
59-96	14000-14001	)	_
59-97	14006-14011	PANSS	_
59-98	14012-14020	positive	_
59-99	14022-14027	11.63	_
59-100	14028-14029	(	_
59-101	14029-14034	4.858	_
59-102	14034-14035	)	_
59-103	14040-14045	PANSS	_
59-104	14046-14054	negative	_
59-105	14056-14061	13.39	_
59-106	14062-14063	(	_
59-107	14063-14068	5.783	_
59-108	14068-14069	)	_
59-109	14074-14079	PANSS	_
59-110	14080-14087	general	_
59-111	14089-14094	26.67	_
59-112	14095-14096	(	_
59-113	14096-14101	7.618	_
59-114	14101-14102	)	_
59-115	14107-14110	CPZ	_
59-116	14111-14121	equivalent	_
59-117	14122-14126	dose	_
59-118	14127-14128	(	_
59-119	14128-14130	mg	_
59-120	14130-14131	)	_
59-121	14133-14139	236.56	_
59-122	14140-14141	(	_
59-123	14141-14148	172.208	_
59-124	14148-14149	)	_
59-125	14154-14157	The	_
59-126	14158-14167	validated	_
59-127	14168-14172	data	_
59-128	14173-14176	set	_
59-129	14179-14191	Demographics	_
59-130	14194-14197	Age	_
59-131	14197-14198	*	_
59-132	14199-14200	(	_
59-133	14200-14205	years	_
59-134	14205-14206	)	_
59-135	14207-14212	27.37	_
59-136	14213-14214	(	_
59-137	14214-14219	7.344	_
59-138	14219-14220	)	_
59-139	14221-14225	36.5	_
59-140	14226-14227	(	_
59-141	14227-14232	7.140	_
59-142	14232-14233	)	_
59-143	14234-14235	−	_
59-144	14235-14240	4.898	_
59-145	14241-14245	.000	_
59-146	14248-14254	Gender	_
59-147	14254-14255	*	_
59-148	14256-14257	(	_
59-149	14257-14261	male	_
59-150	14261-14262	%	_
59-151	14262-14263	)	_
59-152	14264-14270	44.44%	_
59-153	14271-14277	82.35%	_
59-154	14278-14283	9.580	_
59-155	14284-14288	.003	_
59-156	14291-14300	Education	_
59-157	14300-14301	*	_
59-158	14302-14303	(	_
59-159	14303-14308	years	_
59-160	14308-14309	)	_
59-161	14310-14315	13.93	_
59-162	14316-14317	(	_
59-163	14317-14322	2.814	_
59-164	14322-14323	)	_
59-165	14324-14329	12.18	_
59-166	14330-14331	(	_
59-167	14331-14336	2.208	_
59-168	14336-14337	)	_
59-169	14338-14343	2.722	_
59-170	14344-14348	.009	_
59-171	14351-14360	Estimated	_
59-172	14361-14363	IQ	_
59-173	14364-14370	108.00	_
59-174	14371-14372	(	_
59-175	14372-14378	20.196	_
59-176	14378-14379	)	_
59-177	14380-14385	93.94	_
59-178	14386-14387	(	_
59-179	14387-14393	24.799	_
59-180	14393-14394	)	_
59-181	14395-14400	1.970	_
59-182	14401-14405	.055	_
59-183	14408-14416	Clinical	_
59-184	14417-14432	characteristics	_
59-185	14435-14440	Onset	_
59-186	14441-14444	age	_
59-187	14445-14446	(	_
59-188	14446-14451	years	_
59-189	14451-14452	)	_
59-190	14454-14459	24.17	_
59-191	14460-14461	(	_
59-192	14461-14466	6.644	_
59-193	14466-14467	)	_
59-194	14472-14478	Course	_
59-195	14479-14480	(	_
59-196	14480-14485	years	_
59-197	14485-14486	)	_
59-198	14488-14493	10.54	_
59-199	14494-14495	(	_
59-200	14495-14500	7.868	_
59-201	14500-14501	)	_
59-202	14506-14511	PANSS	_
59-203	14512-14517	total	_
59-204	14519-14524	67.72	_
59-205	14525-14526	(	_
59-206	14526-14532	12.378	_
59-207	14532-14533	)	_
59-208	14538-14543	PANSS	_
59-209	14544-14552	positive	_
59-210	14554-14559	10.00	_
59-211	14560-14561	(	_
59-212	14561-14566	3.873	_
59-213	14566-14567	)	_
59-214	14572-14577	PANSS	_
59-215	14578-14586	negative	_
59-216	14588-14593	23.16	_
59-217	14594-14595	(	_
59-218	14595-14600	3.118	_
59-219	14600-14601	)	_
59-220	14606-14611	PANSS	_
59-221	14612-14619	general	_
59-222	14621-14626	30.84	_
59-223	14627-14628	(	_
59-224	14628-14633	7.238	_
59-225	14633-14634	)	_
59-226	14639-14642	CPZ	_
59-227	14643-14653	equivalent	_
59-228	14654-14658	dose	_
59-229	14659-14660	(	_
59-230	14660-14662	mg	_
59-231	14662-14663	)	_
59-232	14665-14671	287.05	_
59-233	14672-14673	(	_
59-234	14673-14680	193.830	_
59-235	14680-14681	)	_
59-236	14688-14692	Note	_
59-237	14692-14693	.	_

#Text=Table values: mean (SD).
60-1	14694-14699	Table	_
60-2	14700-14706	values	_
60-3	14706-14707	:	_
60-4	14708-14712	mean	_
60-5	14713-14714	(	_
60-6	14714-14716	SD	_
60-7	14716-14717	)	_
60-8	14717-14718	.	_

#Text=Abbreviations: CPZ: chlorpromazine; HC, healthy controls; PANSS, the Positive and Negative Syndrome Scale; SZ, patients with schizophrenia.
61-1	14719-14732	Abbreviations	_
61-2	14732-14733	:	_
61-3	14734-14737	CPZ	_
61-4	14737-14738	:	_
61-5	14739-14753	chlorpromazine	_
61-6	14753-14754	;	_
61-7	14755-14757	HC	_
61-8	14757-14758	,	_
61-9	14759-14766	healthy	_
61-10	14767-14775	controls	_
61-11	14775-14776	;	_
61-12	14777-14782	PANSS	_
61-13	14782-14783	,	_
61-14	14784-14787	the	_
61-15	14788-14796	Positive	_
61-16	14797-14800	and	_
61-17	14801-14809	Negative	_
61-18	14810-14818	Syndrome	_
61-19	14819-14824	Scale	_
61-20	14824-14825	;	_
61-21	14826-14828	SZ	_
61-22	14828-14829	,	_
61-23	14830-14838	patients	_
61-24	14839-14843	with	_
61-25	14844-14857	schizophrenia	_
61-26	14857-14858	.	_

#Text=*p < 0.05.
62-1	14859-14860	*	_
62-2	14860-14861	p	_
62-3	14862-14863	<	_
62-4	14864-14868	0.05	_
62-5	14868-14869	.	_

#Text=In addition, independent sample t tests were conducted to compare age, length of education and estimated IQ between the two healthy control groups (Table 3), and the same were conducted to compare onset age, duration of illness and severity of psychotic symptoms between the two patient groups.
63-1	14870-14872	In	_
63-2	14873-14881	addition	_
63-3	14881-14882	,	_
63-4	14883-14894	independent	_
63-5	14895-14901	sample	_
63-6	14902-14903	t	_
63-7	14904-14909	tests	_
63-8	14910-14914	were	_
63-9	14915-14924	conducted	_
63-10	14925-14927	to	_
63-11	14928-14935	compare	_
63-12	14936-14939	age	_
63-13	14939-14940	,	_
63-14	14941-14947	length	_
63-15	14948-14950	of	_
63-16	14951-14960	education	_
63-17	14961-14964	and	_
63-18	14965-14974	estimated	_
63-19	14975-14977	IQ	_
63-20	14978-14985	between	_
63-21	14986-14989	the	_
63-22	14990-14993	two	_
63-23	14994-15001	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[21]
63-24	15002-15009	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[21]
63-25	15010-15016	groups	_
63-26	15017-15018	(	_
63-27	15018-15023	Table	_
63-28	15024-15025	3	_
63-29	15025-15026	)	_
63-30	15026-15027	,	_
63-31	15028-15031	and	_
63-32	15032-15035	the	_
63-33	15036-15040	same	_
63-34	15041-15045	were	_
63-35	15046-15055	conducted	_
63-36	15056-15058	to	_
63-37	15059-15066	compare	_
63-38	15067-15072	onset	_
63-39	15073-15076	age	_
63-40	15076-15077	,	_
63-41	15078-15086	duration	_
63-42	15087-15089	of	_
63-43	15090-15097	illness	_
63-44	15098-15101	and	_
63-45	15102-15110	severity	_
63-46	15111-15113	of	_
63-47	15114-15123	psychotic	_
63-48	15124-15132	symptoms	_
63-49	15133-15140	between	_
63-50	15141-15144	the	_
63-51	15145-15148	two	_
63-52	15149-15156	patient	_
63-53	15157-15163	groups	_
63-54	15163-15164	.	_

#Text=Chi‐square tests were also used to compare the gender proportion between the two healthy control groups and the two clinical groups.
64-1	15165-15175	Chi‐square	_
64-2	15176-15181	tests	_
64-3	15182-15186	were	_
64-4	15187-15191	also	_
64-5	15192-15196	used	_
64-6	15197-15199	to	_
64-7	15200-15207	compare	_
64-8	15208-15211	the	_
64-9	15212-15218	gender	_
64-10	15219-15229	proportion	_
64-11	15230-15237	between	_
64-12	15238-15241	the	_
64-13	15242-15245	two	_
64-14	15246-15253	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[22]
64-15	15254-15261	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[22]
64-16	15262-15268	groups	_
64-17	15269-15272	and	_
64-18	15273-15276	the	_
64-19	15277-15280	two	_
64-20	15281-15289	clinical	_
64-21	15290-15296	groups	_
64-22	15296-15297	.	_

#Text=Finally, a five‐factor model of the PANSS (Anderson et al., 2017; Lindenmayer, Grochowski, & Hyman, 1995) comprising negative, positive, disorganized, excited, and anxiety symptom domains was computed and compared between the two clinical groups (Table 3).
65-1	15298-15305	Finally	_
65-2	15305-15306	,	_
65-3	15307-15308	a	_
65-4	15309-15320	five‐factor	_
65-5	15321-15326	model	_
65-6	15327-15329	of	_
65-7	15330-15333	the	_
65-8	15334-15339	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
65-9	15340-15341	(	_
65-10	15341-15349	Anderson	_
65-11	15350-15352	et	_
65-12	15353-15355	al	_
65-13	15355-15356	.	_
65-14	15356-15357	,	_
65-15	15358-15362	2017	_
65-16	15362-15363	;	_
65-17	15364-15375	Lindenmayer	_
65-18	15375-15376	,	_
65-19	15377-15387	Grochowski	_
65-20	15387-15388	,	_
65-21	15389-15390	&	_
65-22	15391-15396	Hyman	_
65-23	15396-15397	,	_
65-24	15398-15402	1995	_
65-25	15402-15403	)	_
65-26	15404-15414	comprising	_
65-27	15415-15423	negative	_
65-28	15423-15424	,	_
65-29	15425-15433	positive	_
65-30	15433-15434	,	_
65-31	15435-15447	disorganized	_
65-32	15447-15448	,	_
65-33	15449-15456	excited	_
65-34	15456-15457	,	_
65-35	15458-15461	and	_
65-36	15462-15469	anxiety	_
65-37	15470-15477	symptom	_
65-38	15478-15485	domains	_
65-39	15486-15489	was	_
65-40	15490-15498	computed	_
65-41	15499-15502	and	_
65-42	15503-15511	compared	_
65-43	15512-15519	between	_
65-44	15520-15523	the	_
65-45	15524-15527	two	_
65-46	15528-15536	clinical	_
65-47	15537-15543	groups	_
65-48	15544-15545	(	_
65-49	15545-15550	Table	_
65-50	15551-15552	3	_
65-51	15552-15553	)	_
65-52	15553-15554	.	_

#Text=Comparison of demographic and clinical information between two sites
#Text=\tSZ\tHC\t \tMain\tValidated\tt/χ2\tp\tMain\tValidated\tt/χ2\tp\t \tDemographics\t \tAge (years)\t43.22 (10.885)\t36.50 (7.14)\t3.168\t.002\t42.04 (12.165)\t43.22 (10.885)\t−.515\t.608\t \tGender (male%)\t41.18%\t82.35%\t14.167\t.000\t35.29%\t44.44%\t.625\t.470\t \tEducation (years)\t12.07 (2.946)\t12.18 (2.208)\t−.182\t.856\t12.80 (3.731)\t12.07 (2.946)\t1.105\t.272\t \tEstimated IQ\t107.68 (14.215)\t93.94 (24.799)\t3.206\t.002\t119.76 (11.735)\t107.68 (14.215)\t4.663\t.000\t \tClinical characteristics\t \tOnset age (years)\t25.41 (9.185)\t24.17 (6.644)\t.594\t.554\t\t\t\t\t \tCourse (years)\t16.66 (8.067)\t10.54 (7.868)\t3.070\t.003\t\t\t\t\t \tPANSS total\t51.69 (14.771)\t67.72 (12.378)\t−4.678\t.000\t\t\t\t\t \tPANSS positive\t11.63 (4.858)\t10.00 (3.873)\t1.461\t.148\t\t\t\t\t \tPANSS negative\t13.39 (5.783)\t23.16 (3.118)\t−7.884\t.000\t\t\t\t\t \tPANSS general\t26.67 (7.618)\t30.84 (7.238)\t−2.28\t.025\t\t\t\t\t \tCPZ equivalent dose (mg)\t236.56 (172.208)\t287.05 (193.830)\t−1.024\t.310\t\t\t\t\t \tPANSS5 negative\t15.20 (6.636)\t28.17 (4.428)\t−8.544\t.000\t\t\t\t\t \tPANSS5 positive\t10.47 (4.888)\t8.17 (2.973)\t2.127\t.037\t\t\t\t\t \tPANSS5 disorganized\t15.22 (4.500)\t17.09 (4.067)\t−1.704\t.093\t\t\t\t\t \tPANSS5 excited\t5.61 (2.155)\t5.92 (2.701)\t−.533\t.596\t\t\t\t\t \tPANSS5 anxiety\t8.75 (3.918)\t8.76 (3.358)\t−.016\t.987\t\t\t\t\t \t
#Text=
#Text=Note.
66-1	15555-15565	Comparison	_
66-2	15566-15568	of	_
66-3	15569-15580	demographic	_
66-4	15581-15584	and	_
66-5	15585-15593	clinical	_
66-6	15594-15605	information	_
66-7	15606-15613	between	_
66-8	15614-15617	two	_
66-9	15618-15623	sites	_
66-10	15625-15627	SZ	_
66-11	15628-15630	HC	_
66-12	15633-15637	Main	_
66-13	15638-15647	Validated	_
66-14	15648-15649	t	_
66-15	15649-15650	/	_
66-16	15650-15652	χ2	_
66-17	15653-15654	p	_
66-18	15655-15659	Main	_
66-19	15660-15669	Validated	_
66-20	15670-15671	t	_
66-21	15671-15672	/	_
66-22	15672-15674	χ2	_
66-23	15675-15676	p	_
66-24	15679-15691	Demographics	_
66-25	15694-15697	Age	_
66-26	15698-15699	(	_
66-27	15699-15704	years	_
66-28	15704-15705	)	_
66-29	15706-15711	43.22	_
66-30	15712-15713	(	_
66-31	15713-15719	10.885	_
66-32	15719-15720	)	_
66-33	15721-15726	36.50	_
66-34	15727-15728	(	_
66-35	15728-15732	7.14	_
66-36	15732-15733	)	_
66-37	15734-15739	3.168	_
66-38	15740-15744	.002	_
66-39	15745-15750	42.04	_
66-40	15751-15752	(	_
66-41	15752-15758	12.165	_
66-42	15758-15759	)	_
66-43	15760-15765	43.22	_
66-44	15766-15767	(	_
66-45	15767-15773	10.885	_
66-46	15773-15774	)	_
66-47	15775-15776	−	_
66-48	15776-15780	.515	_
66-49	15781-15785	.608	_
66-50	15788-15794	Gender	_
66-51	15795-15796	(	_
66-52	15796-15800	male	_
66-53	15800-15801	%	_
66-54	15801-15802	)	_
66-55	15803-15809	41.18%	_
66-56	15810-15816	82.35%	_
66-57	15817-15823	14.167	_
66-58	15824-15828	.000	_
66-59	15829-15835	35.29%	_
66-60	15836-15842	44.44%	_
66-61	15843-15847	.625	_
66-62	15848-15852	.470	_
66-63	15855-15864	Education	_
66-64	15865-15866	(	_
66-65	15866-15871	years	_
66-66	15871-15872	)	_
66-67	15873-15878	12.07	_
66-68	15879-15880	(	_
66-69	15880-15885	2.946	_
66-70	15885-15886	)	_
66-71	15887-15892	12.18	_
66-72	15893-15894	(	_
66-73	15894-15899	2.208	_
66-74	15899-15900	)	_
66-75	15901-15902	−	_
66-76	15902-15906	.182	_
66-77	15907-15911	.856	_
66-78	15912-15917	12.80	_
66-79	15918-15919	(	_
66-80	15919-15924	3.731	_
66-81	15924-15925	)	_
66-82	15926-15931	12.07	_
66-83	15932-15933	(	_
66-84	15933-15938	2.946	_
66-85	15938-15939	)	_
66-86	15940-15945	1.105	_
66-87	15946-15950	.272	_
66-88	15953-15962	Estimated	_
66-89	15963-15965	IQ	_
66-90	15966-15972	107.68	_
66-91	15973-15974	(	_
66-92	15974-15980	14.215	_
66-93	15980-15981	)	_
66-94	15982-15987	93.94	_
66-95	15988-15989	(	_
66-96	15989-15995	24.799	_
66-97	15995-15996	)	_
66-98	15997-16002	3.206	_
66-99	16003-16007	.002	_
66-100	16008-16014	119.76	_
66-101	16015-16016	(	_
66-102	16016-16022	11.735	_
66-103	16022-16023	)	_
66-104	16024-16030	107.68	_
66-105	16031-16032	(	_
66-106	16032-16038	14.215	_
66-107	16038-16039	)	_
66-108	16040-16045	4.663	_
66-109	16046-16050	.000	_
66-110	16053-16061	Clinical	_
66-111	16062-16077	characteristics	_
66-112	16080-16085	Onset	_
66-113	16086-16089	age	_
66-114	16090-16091	(	_
66-115	16091-16096	years	_
66-116	16096-16097	)	_
66-117	16098-16103	25.41	_
66-118	16104-16105	(	_
66-119	16105-16110	9.185	_
66-120	16110-16111	)	_
66-121	16112-16117	24.17	_
66-122	16118-16119	(	_
66-123	16119-16124	6.644	_
66-124	16124-16125	)	_
66-125	16126-16130	.594	_
66-126	16131-16135	.554	_
66-127	16142-16148	Course	_
66-128	16149-16150	(	_
66-129	16150-16155	years	_
66-130	16155-16156	)	_
66-131	16157-16162	16.66	_
66-132	16163-16164	(	_
66-133	16164-16169	8.067	_
66-134	16169-16170	)	_
66-135	16171-16176	10.54	_
66-136	16177-16178	(	_
66-137	16178-16183	7.868	_
66-138	16183-16184	)	_
66-139	16185-16190	3.070	_
66-140	16191-16195	.003	_
66-141	16202-16207	PANSS	_
66-142	16208-16213	total	_
66-143	16214-16219	51.69	_
66-144	16220-16221	(	_
66-145	16221-16227	14.771	_
66-146	16227-16228	)	_
66-147	16229-16234	67.72	_
66-148	16235-16236	(	_
66-149	16236-16242	12.378	_
66-150	16242-16243	)	_
66-151	16244-16245	−	_
66-152	16245-16250	4.678	_
66-153	16251-16255	.000	_
66-154	16262-16267	PANSS	_
66-155	16268-16276	positive	_
66-156	16277-16282	11.63	_
66-157	16283-16284	(	_
66-158	16284-16289	4.858	_
66-159	16289-16290	)	_
66-160	16291-16296	10.00	_
66-161	16297-16298	(	_
66-162	16298-16303	3.873	_
66-163	16303-16304	)	_
66-164	16305-16310	1.461	_
66-165	16311-16315	.148	_
66-166	16322-16327	PANSS	_
66-167	16328-16336	negative	_
66-168	16337-16342	13.39	_
66-169	16343-16344	(	_
66-170	16344-16349	5.783	_
66-171	16349-16350	)	_
66-172	16351-16356	23.16	_
66-173	16357-16358	(	_
66-174	16358-16363	3.118	_
66-175	16363-16364	)	_
66-176	16365-16366	−	_
66-177	16366-16371	7.884	_
66-178	16372-16376	.000	_
66-179	16383-16388	PANSS	_
66-180	16389-16396	general	_
66-181	16397-16402	26.67	_
66-182	16403-16404	(	_
66-183	16404-16409	7.618	_
66-184	16409-16410	)	_
66-185	16411-16416	30.84	_
66-186	16417-16418	(	_
66-187	16418-16423	7.238	_
66-188	16423-16424	)	_
66-189	16425-16426	−	_
66-190	16426-16430	2.28	_
66-191	16431-16435	.025	_
66-192	16442-16445	CPZ	_
66-193	16446-16456	equivalent	_
66-194	16457-16461	dose	_
66-195	16462-16463	(	_
66-196	16463-16465	mg	_
66-197	16465-16466	)	_
66-198	16467-16473	236.56	_
66-199	16474-16475	(	_
66-200	16475-16482	172.208	_
66-201	16482-16483	)	_
66-202	16484-16490	287.05	_
66-203	16491-16492	(	_
66-204	16492-16499	193.830	_
66-205	16499-16500	)	_
66-206	16501-16502	−	_
66-207	16502-16507	1.024	_
66-208	16508-16512	.310	_
66-209	16519-16525	PANSS5	_
66-210	16526-16534	negative	_
66-211	16535-16540	15.20	_
66-212	16541-16542	(	_
66-213	16542-16547	6.636	_
66-214	16547-16548	)	_
66-215	16549-16554	28.17	_
66-216	16555-16556	(	_
66-217	16556-16561	4.428	_
66-218	16561-16562	)	_
66-219	16563-16564	−	_
66-220	16564-16569	8.544	_
66-221	16570-16574	.000	_
66-222	16581-16587	PANSS5	_
66-223	16588-16596	positive	_
66-224	16597-16602	10.47	_
66-225	16603-16604	(	_
66-226	16604-16609	4.888	_
66-227	16609-16610	)	_
66-228	16611-16615	8.17	_
66-229	16616-16617	(	_
66-230	16617-16622	2.973	_
66-231	16622-16623	)	_
66-232	16624-16629	2.127	_
66-233	16630-16634	.037	_
66-234	16641-16647	PANSS5	_
66-235	16648-16660	disorganized	_
66-236	16661-16666	15.22	_
66-237	16667-16668	(	_
66-238	16668-16673	4.500	_
66-239	16673-16674	)	_
66-240	16675-16680	17.09	_
66-241	16681-16682	(	_
66-242	16682-16687	4.067	_
66-243	16687-16688	)	_
66-244	16689-16690	−	_
66-245	16690-16695	1.704	_
66-246	16696-16700	.093	_
66-247	16707-16713	PANSS5	_
66-248	16714-16721	excited	_
66-249	16722-16726	5.61	_
66-250	16727-16728	(	_
66-251	16728-16733	2.155	_
66-252	16733-16734	)	_
66-253	16735-16739	5.92	_
66-254	16740-16741	(	_
66-255	16741-16746	2.701	_
66-256	16746-16747	)	_
66-257	16748-16749	−	_
66-258	16749-16753	.533	_
66-259	16754-16758	.596	_
66-260	16765-16771	PANSS5	_
66-261	16772-16779	anxiety	_
66-262	16780-16784	8.75	_
66-263	16785-16786	(	_
66-264	16786-16791	3.918	_
66-265	16791-16792	)	_
66-266	16793-16797	8.76	_
66-267	16798-16799	(	_
66-268	16799-16804	3.358	_
66-269	16804-16805	)	_
66-270	16806-16807	−	_
66-271	16807-16811	.016	_
66-272	16812-16816	.987	_
66-273	16825-16829	Note	_
66-274	16829-16830	.	_

#Text=Table values: mean (SD).
67-1	16831-16836	Table	_
67-2	16837-16843	values	_
67-3	16843-16844	:	_
67-4	16845-16849	mean	_
67-5	16850-16851	(	_
67-6	16851-16853	SD	_
67-7	16853-16854	)	_
67-8	16854-16855	.	_

#Text=Abbreviations: CPZ, chlorpromazine; HC, healthy controls; main, main data set; PANSS, the Positive and Negative Syndrome Scale; PANSS5, the symptom domains calculated by the five‐factor model; SZ, patients with schizophrenia; validated: validated data set.
68-1	16856-16869	Abbreviations	_
68-2	16869-16870	:	_
68-3	16871-16874	CPZ	_
68-4	16874-16875	,	_
68-5	16876-16890	chlorpromazine	_
68-6	16890-16891	;	_
68-7	16892-16894	HC	_
68-8	16894-16895	,	_
68-9	16896-16903	healthy	_
68-10	16904-16912	controls	_
68-11	16912-16913	;	_
68-12	16914-16918	main	_
68-13	16918-16919	,	_
68-14	16920-16924	main	_
68-15	16925-16929	data	_
68-16	16930-16933	set	_
68-17	16933-16934	;	_
68-18	16935-16940	PANSS	_
68-19	16940-16941	,	_
68-20	16942-16945	the	_
68-21	16946-16954	Positive	_
68-22	16955-16958	and	_
68-23	16959-16967	Negative	_
68-24	16968-16976	Syndrome	_
68-25	16977-16982	Scale	_
68-26	16982-16983	;	_
68-27	16984-16990	PANSS5	_
68-28	16990-16991	,	_
68-29	16992-16995	the	_
68-30	16996-17003	symptom	_
68-31	17004-17011	domains	_
68-32	17012-17022	calculated	_
68-33	17023-17025	by	_
68-34	17026-17029	the	_
68-35	17030-17041	five‐factor	_
68-36	17042-17047	model	_
68-37	17047-17048	;	_
68-38	17049-17051	SZ	_
68-39	17051-17052	,	_
68-40	17053-17061	patients	_
68-41	17062-17066	with	_
68-42	17067-17080	schizophrenia	_
68-43	17080-17081	;	_
68-44	17082-17091	validated	_
68-45	17091-17092	:	_
68-46	17093-17102	validated	_
68-47	17103-17107	data	_
68-48	17108-17111	set	_
68-49	17111-17112	.	_

#Text=The study was approved by the Ethics Committee of the Institute of Psychology, the Chinese Academy of Sciences.
69-1	17113-17116	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-2	17117-17122	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-3	17123-17126	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-4	17127-17135	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-5	17136-17138	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-6	17139-17142	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-7	17143-17149	Ethics	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-8	17150-17159	Committee	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-9	17160-17162	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-10	17163-17166	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-11	17167-17176	Institute	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-12	17177-17179	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-13	17180-17190	Psychology	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-14	17190-17191	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-15	17192-17195	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-16	17196-17203	Chinese	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-17	17204-17211	Academy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-18	17212-17214	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-19	17215-17223	Sciences	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
69-20	17223-17224	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]

#Text=All participants gave written informed consent.
70-1	17225-17228	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
70-2	17229-17241	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
70-3	17242-17246	gave	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
70-4	17247-17254	written	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
70-5	17255-17263	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
70-6	17264-17271	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]
70-7	17271-17272	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[23]

#Text=Image acquisition
#Text=For the main data set, all participants were scanned in a 3‐T Siemens Tim Trio scanner at the Chaoyang Hospital, Beijing, China.
71-1	17273-17278	Image	_
71-2	17279-17290	acquisition	_
71-3	17291-17294	For	_
71-4	17295-17298	the	_
71-5	17299-17303	main	_
71-6	17304-17308	data	_
71-7	17309-17312	set	_
71-8	17312-17313	,	_
71-9	17314-17317	all	_
71-10	17318-17330	participants	_
71-11	17331-17335	were	_
71-12	17336-17343	scanned	_
71-13	17344-17346	in	_
71-14	17347-17348	a	_
71-15	17349-17350	3	_
71-16	17350-17351	‐	_
71-17	17351-17352	T	_
71-18	17353-17360	Siemens	_
71-19	17361-17364	Tim	_
71-20	17365-17369	Trio	_
71-21	17370-17377	scanner	_
71-22	17378-17380	at	_
71-23	17381-17384	the	_
71-24	17385-17393	Chaoyang	_
71-25	17394-17402	Hospital	_
71-26	17402-17403	,	_
71-27	17404-17411	Beijing	_
71-28	17411-17412	,	_
71-29	17413-17418	China	_
71-30	17418-17419	.	_

#Text=The rsfMRI data were collected by an echo‐planar imaging (EPI) sequence utilizing gradient echo.
72-1	17420-17423	The	_
72-2	17424-17430	rsfMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
72-3	17431-17435	data	_
72-4	17436-17440	were	_
72-5	17441-17450	collected	_
72-6	17451-17453	by	_
72-7	17454-17456	an	_
72-8	17457-17468	echo‐planar	_
72-9	17469-17476	imaging	_
72-10	17477-17478	(	_
72-11	17478-17481	EPI	_
72-12	17481-17482	)	_
72-13	17483-17491	sequence	_
72-14	17492-17501	utilizing	_
72-15	17502-17510	gradient	_
72-16	17511-17515	echo	_
72-17	17515-17516	.	_

#Text=Slices were acquired in interleaved order and the data consisted of 200 whole‐brain volumes (repetition time (TR) = 2,500 ms, echo time (TE) = 21 ms, flip angle = 90°, slice number = 42, slice thickness = 3.5 mm, matrix size = 64 × 64, field of view (FOV) = 200 mm, and voxel size = 3.1 × 3.1 × 3.5 mm3).
73-1	17517-17523	Slices	_
73-2	17524-17528	were	_
73-3	17529-17537	acquired	_
73-4	17538-17540	in	_
73-5	17541-17552	interleaved	_
73-6	17553-17558	order	_
73-7	17559-17562	and	_
73-8	17563-17566	the	_
73-9	17567-17571	data	_
73-10	17572-17581	consisted	_
73-11	17582-17584	of	_
73-12	17585-17588	200	_
73-13	17589-17600	whole‐brain	_
73-14	17601-17608	volumes	_
73-15	17609-17610	(	_
73-16	17610-17620	repetition	_
73-17	17621-17625	time	_
73-18	17626-17627	(	_
73-19	17627-17629	TR	_
73-20	17629-17630	)	_
73-21	17631-17632	=	_
73-22	17633-17638	2,500	_
73-23	17639-17641	ms	_
73-24	17641-17642	,	_
73-25	17643-17647	echo	_
73-26	17648-17652	time	_
73-27	17653-17654	(	_
73-28	17654-17656	TE	_
73-29	17656-17657	)	_
73-30	17658-17659	=	_
73-31	17660-17662	21	_
73-32	17663-17665	ms	_
73-33	17665-17666	,	_
73-34	17667-17671	flip	_
73-35	17672-17677	angle	_
73-36	17678-17679	=	_
73-37	17680-17682	90	_
73-38	17682-17683	°	_
73-39	17683-17684	,	_
73-40	17685-17690	slice	_
73-41	17691-17697	number	_
73-42	17698-17699	=	_
73-43	17700-17702	42	_
73-44	17702-17703	,	_
73-45	17704-17709	slice	_
73-46	17710-17719	thickness	_
73-47	17720-17721	=	_
73-48	17722-17725	3.5	_
73-49	17726-17728	mm	_
73-50	17728-17729	,	_
73-51	17730-17736	matrix	_
73-52	17737-17741	size	_
73-53	17742-17743	=	_
73-54	17744-17746	64	_
73-55	17747-17748	×	_
73-56	17749-17751	64	_
73-57	17751-17752	,	_
73-58	17753-17758	field	_
73-59	17759-17761	of	_
73-60	17762-17766	view	_
73-61	17767-17768	(	_
73-62	17768-17771	FOV	_
73-63	17771-17772	)	_
73-64	17773-17774	=	_
73-65	17775-17778	200	_
73-66	17779-17781	mm	_
73-67	17781-17782	,	_
73-68	17783-17786	and	_
73-69	17787-17792	voxel	_
73-70	17793-17797	size	_
73-71	17798-17799	=	_
73-72	17800-17803	3.1	_
73-73	17804-17805	×	_
73-74	17806-17809	3.1	_
73-75	17810-17811	×	_
73-76	17812-17815	3.5	_
73-77	17816-17819	mm3	_
73-78	17819-17820	)	_
73-79	17820-17821	.	_

#Text=T1‐weighted structural image data were collected for anatomical reference using a 3D magnetization‐prepared rapid gradient‐echo (MPRAGE) sequence (TR = 2,530 ms, TE = 2.34 ms, flip angle = 7°, FOV = 256 mm, slice thickness = 1 mm, slice number = 176, in‐plane matrix resolution = 256 × 256, and voxel size = 1 × 1 × 1 mm3).
74-1	17822-17824	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[24]
74-2	17824-17825	‐	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[24]
74-3	17825-17833	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[24]
74-4	17834-17844	structural	_
74-5	17845-17850	image	_
74-6	17851-17855	data	_
74-7	17856-17860	were	_
74-8	17861-17870	collected	_
74-9	17871-17874	for	_
74-10	17875-17885	anatomical	_
74-11	17886-17895	reference	_
74-12	17896-17901	using	_
74-13	17902-17903	a	_
74-14	17904-17906	3D	_
74-15	17907-17929	magnetization‐prepared	_
74-16	17930-17935	rapid	_
74-17	17936-17949	gradient‐echo	_
74-18	17950-17951	(	_
74-19	17951-17957	MPRAGE	_
74-20	17957-17958	)	_
74-21	17959-17967	sequence	_
74-22	17968-17969	(	_
74-23	17969-17971	TR	_
74-24	17972-17973	=	_
74-25	17974-17979	2,530	_
74-26	17980-17982	ms	_
74-27	17982-17983	,	_
74-28	17984-17986	TE	_
74-29	17987-17988	=	_
74-30	17989-17993	2.34	_
74-31	17994-17996	ms	_
74-32	17996-17997	,	_
74-33	17998-18002	flip	_
74-34	18003-18008	angle	_
74-35	18009-18010	=	_
74-36	18011-18012	7	_
74-37	18012-18013	°	_
74-38	18013-18014	,	_
74-39	18015-18018	FOV	_
74-40	18019-18020	=	_
74-41	18021-18024	256	_
74-42	18025-18027	mm	_
74-43	18027-18028	,	_
74-44	18029-18034	slice	_
74-45	18035-18044	thickness	_
74-46	18045-18046	=	_
74-47	18047-18048	1	_
74-48	18049-18051	mm	_
74-49	18051-18052	,	_
74-50	18053-18058	slice	_
74-51	18059-18065	number	_
74-52	18066-18067	=	_
74-53	18068-18071	176	_
74-54	18071-18072	,	_
74-55	18073-18081	in‐plane	_
74-56	18082-18088	matrix	_
74-57	18089-18099	resolution	_
74-58	18100-18101	=	_
74-59	18102-18105	256	_
74-60	18106-18107	×	_
74-61	18108-18111	256	_
74-62	18111-18112	,	_
74-63	18113-18116	and	_
74-64	18117-18122	voxel	_
74-65	18123-18127	size	_
74-66	18128-18129	=	_
74-67	18130-18131	1	_
74-68	18132-18133	×	_
74-69	18134-18135	1	_
74-70	18136-18137	×	_
74-71	18138-18139	1	_
74-72	18140-18143	mm3	_
74-73	18143-18144	)	_
74-74	18144-18145	.	_

#Text=For the validated data set, all participants were scanned in a 3‐T Siemens TIM Trio scanner in the Hunan Provincial People's Hospital, Changsha, Hunan province, China.
75-1	18146-18149	For	_
75-2	18150-18153	the	_
75-3	18154-18163	validated	_
75-4	18164-18168	data	_
75-5	18169-18172	set	_
75-6	18172-18173	,	_
75-7	18174-18177	all	_
75-8	18178-18190	participants	_
75-9	18191-18195	were	_
75-10	18196-18203	scanned	_
75-11	18204-18206	in	_
75-12	18207-18208	a	_
75-13	18209-18210	3	_
75-14	18210-18211	‐	_
75-15	18211-18212	T	_
75-16	18213-18220	Siemens	_
75-17	18221-18224	TIM	_
75-18	18225-18229	Trio	_
75-19	18230-18237	scanner	_
75-20	18238-18240	in	_
75-21	18241-18244	the	_
75-22	18245-18250	Hunan	_
75-23	18251-18261	Provincial	_
75-24	18262-18270	People's	_
75-25	18271-18279	Hospital	_
75-26	18279-18280	,	_
75-27	18281-18289	Changsha	_
75-28	18289-18290	,	_
75-29	18291-18296	Hunan	_
75-30	18297-18305	province	_
75-31	18305-18306	,	_
75-32	18307-18312	China	_
75-33	18312-18313	.	_

#Text=The rsfMRI data were collected by an EPI sequence utilizing gradient echo.
76-1	18314-18317	The	_
76-2	18318-18324	rsfMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
76-3	18325-18329	data	_
76-4	18330-18334	were	_
76-5	18335-18344	collected	_
76-6	18345-18347	by	_
76-7	18348-18350	an	_
76-8	18351-18354	EPI	_
76-9	18355-18363	sequence	_
76-10	18364-18373	utilizing	_
76-11	18374-18382	gradient	_
76-12	18383-18387	echo	_
76-13	18387-18388	.	_

#Text=Slices were acquired in interleaved order and the data consisted of 180 whole‐brain volumes (TR = 2,000 ms, TE = 25 ms, flip angle = 80°, slice number = 32, slice thickness = 4.5 mm, matrix size = 64 × 64, FOV = 240 mm, and voxel size = 3.75 × 3.75 × 4.5 mm3).
77-1	18389-18395	Slices	_
77-2	18396-18400	were	_
77-3	18401-18409	acquired	_
77-4	18410-18412	in	_
77-5	18413-18424	interleaved	_
77-6	18425-18430	order	_
77-7	18431-18434	and	_
77-8	18435-18438	the	_
77-9	18439-18443	data	_
77-10	18444-18453	consisted	_
77-11	18454-18456	of	_
77-12	18457-18460	180	_
77-13	18461-18472	whole‐brain	_
77-14	18473-18480	volumes	_
77-15	18481-18482	(	_
77-16	18482-18484	TR	_
77-17	18485-18486	=	_
77-18	18487-18492	2,000	_
77-19	18493-18495	ms	_
77-20	18495-18496	,	_
77-21	18497-18499	TE	_
77-22	18500-18501	=	_
77-23	18502-18504	25	_
77-24	18505-18507	ms	_
77-25	18507-18508	,	_
77-26	18509-18513	flip	_
77-27	18514-18519	angle	_
77-28	18520-18521	=	_
77-29	18522-18524	80	_
77-30	18524-18525	°	_
77-31	18525-18526	,	_
77-32	18527-18532	slice	_
77-33	18533-18539	number	_
77-34	18540-18541	=	_
77-35	18542-18544	32	_
77-36	18544-18545	,	_
77-37	18546-18551	slice	_
77-38	18552-18561	thickness	_
77-39	18562-18563	=	_
77-40	18564-18567	4.5	_
77-41	18568-18570	mm	_
77-42	18570-18571	,	_
77-43	18572-18578	matrix	_
77-44	18579-18583	size	_
77-45	18584-18585	=	_
77-46	18586-18588	64	_
77-47	18589-18590	×	_
77-48	18591-18593	64	_
77-49	18593-18594	,	_
77-50	18595-18598	FOV	_
77-51	18599-18600	=	_
77-52	18601-18604	240	_
77-53	18605-18607	mm	_
77-54	18607-18608	,	_
77-55	18609-18612	and	_
77-56	18613-18618	voxel	_
77-57	18619-18623	size	_
77-58	18624-18625	=	_
77-59	18626-18630	3.75	_
77-60	18631-18632	×	_
77-61	18633-18637	3.75	_
77-62	18638-18639	×	_
77-63	18640-18643	4.5	_
77-64	18644-18647	mm3	_
77-65	18647-18648	)	_
77-66	18648-18649	.	_

#Text=T1‐weighted structural image data were collected using a 3D MPRAGE sequence (TR = 2,000 ms, TE = 2.26 ms, flip angle = 8°, FOV = 256 mm, slice thickness = 1 mm, slice number = 176, in‐plane matrix resolution = 256 × 256, and voxel size = 1 × 1 × 1 mm3).
78-1	18650-18652	T1	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[25]
78-2	18652-18653	‐	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[25]
78-3	18653-18661	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging[25]
78-4	18662-18672	structural	_
78-5	18673-18678	image	_
78-6	18679-18683	data	_
78-7	18684-18688	were	_
78-8	18689-18698	collected	_
78-9	18699-18704	using	_
78-10	18705-18706	a	_
78-11	18707-18709	3D	_
78-12	18710-18716	MPRAGE	_
78-13	18717-18725	sequence	_
78-14	18726-18727	(	_
78-15	18727-18729	TR	_
78-16	18730-18731	=	_
78-17	18732-18737	2,000	_
78-18	18738-18740	ms	_
78-19	18740-18741	,	_
78-20	18742-18744	TE	_
78-21	18745-18746	=	_
78-22	18747-18751	2.26	_
78-23	18752-18754	ms	_
78-24	18754-18755	,	_
78-25	18756-18760	flip	_
78-26	18761-18766	angle	_
78-27	18767-18768	=	_
78-28	18769-18770	8	_
78-29	18770-18771	°	_
78-30	18771-18772	,	_
78-31	18773-18776	FOV	_
78-32	18777-18778	=	_
78-33	18779-18782	256	_
78-34	18783-18785	mm	_
78-35	18785-18786	,	_
78-36	18787-18792	slice	_
78-37	18793-18802	thickness	_
78-38	18803-18804	=	_
78-39	18805-18806	1	_
78-40	18807-18809	mm	_
78-41	18809-18810	,	_
78-42	18811-18816	slice	_
78-43	18817-18823	number	_
78-44	18824-18825	=	_
78-45	18826-18829	176	_
78-46	18829-18830	,	_
78-47	18831-18839	in‐plane	_
78-48	18840-18846	matrix	_
78-49	18847-18857	resolution	_
78-50	18858-18859	=	_
78-51	18860-18863	256	_
78-52	18864-18865	×	_
78-53	18866-18869	256	_
78-54	18869-18870	,	_
78-55	18871-18874	and	_
78-56	18875-18880	voxel	_
78-57	18881-18885	size	_
78-58	18886-18887	=	_
78-59	18888-18889	1	_
78-60	18890-18891	×	_
78-61	18892-18893	1	_
78-62	18894-18895	×	_
78-63	18896-18897	1	_
78-64	18898-18901	mm3	_
78-65	18901-18902	)	_
78-66	18902-18903	.	_

#Text=While participants were in the scanner, they were asked to remain as stationary as possible and their heads were stabilized with foam pads.
79-1	18904-18909	While	_
79-2	18910-18922	participants	_
79-3	18923-18927	were	_
79-4	18928-18930	in	_
79-5	18931-18934	the	_
79-6	18935-18942	scanner	_
79-7	18942-18943	,	_
79-8	18944-18948	they	_
79-9	18949-18953	were	_
79-10	18954-18959	asked	_
79-11	18960-18962	to	_
79-12	18963-18969	remain	_
79-13	18970-18972	as	_
79-14	18973-18983	stationary	_
79-15	18984-18986	as	_
79-16	18987-18995	possible	_
79-17	18996-18999	and	_
79-18	19000-19005	their	_
79-19	19006-19011	heads	_
79-20	19012-19016	were	_
79-21	19017-19027	stabilized	_
79-22	19028-19032	with	_
79-23	19033-19037	foam	_
79-24	19038-19042	pads	_
79-25	19042-19043	.	_

#Text=Data preprocessing
#Text=Image preprocessing was conducted with the Statistical Parameter Mapping (SPM) software (SPM12; http://www.fil.ion.ucl.ac.uk/spm/software/spm12), Data Processing Assistant for Resting‐State fMRI (DPARSF) Software (DPARSF4.3; http://rfmri.org/DPARSF), and a plugin‐in for SPM named Temporal Filter (http://www.brain-fmri.com/tempfilter) (Madsen, Krohne, Cai, Wang, & Chan, 2018).
80-1	19044-19048	Data	_
80-2	19049-19062	preprocessing	_
80-3	19063-19068	Image	_
80-4	19069-19082	preprocessing	_
80-5	19083-19086	was	_
80-6	19087-19096	conducted	_
80-7	19097-19101	with	_
80-8	19102-19105	the	_
80-9	19106-19117	Statistical	_
80-10	19118-19127	Parameter	_
80-11	19128-19135	Mapping	_
80-12	19136-19137	(	_
80-13	19137-19140	SPM	_
80-14	19140-19141	)	_
80-15	19142-19150	software	_
80-16	19151-19152	(	_
80-17	19152-19157	SPM12	_
80-18	19157-19158	;	_
80-19	19159-19163	http	_
80-20	19163-19164	:	_
80-21	19164-19165	/	_
80-22	19165-19166	/	_
80-23	19166-19187	www.fil.ion.ucl.ac.uk	_
80-24	19187-19188	/	_
80-25	19188-19191	spm	_
80-26	19191-19192	/	_
80-27	19192-19200	software	_
80-28	19200-19201	/	_
80-29	19201-19206	spm12	_
80-30	19206-19207	)	_
80-31	19207-19208	,	_
80-32	19209-19213	Data	_
80-33	19214-19224	Processing	_
80-34	19225-19234	Assistant	_
80-35	19235-19238	for	_
80-36	19239-19252	Resting‐State	_
80-37	19253-19257	fMRI	_
80-38	19258-19259	(	_
80-39	19259-19265	DPARSF	_
80-40	19265-19266	)	_
80-41	19267-19275	Software	_
80-42	19276-19277	(	_
80-43	19277-19286	DPARSF4.3	_
80-44	19286-19287	;	_
80-45	19288-19292	http	_
80-46	19292-19293	:	_
80-47	19293-19294	/	_
80-48	19294-19295	/	_
80-49	19295-19304	rfmri.org	_
80-50	19304-19305	/	_
80-51	19305-19311	DPARSF	_
80-52	19311-19312	)	_
80-53	19312-19313	,	_
80-54	19314-19317	and	_
80-55	19318-19319	a	_
80-56	19320-19329	plugin‐in	_
80-57	19330-19333	for	_
80-58	19334-19337	SPM	_
80-59	19338-19343	named	_
80-60	19344-19352	Temporal	_
80-61	19353-19359	Filter	_
80-62	19360-19361	(	_
80-63	19361-19365	http	_
80-64	19365-19366	:	_
80-65	19366-19367	/	_
80-66	19367-19368	/	_
80-67	19368-19386	www.brain-fmri.com	_
80-68	19386-19387	/	_
80-69	19387-19397	tempfilter	_
80-70	19397-19398	)	_
80-71	19399-19400	(	_
80-72	19400-19406	Madsen	_
80-73	19406-19407	,	_
80-74	19408-19414	Krohne	_
80-75	19414-19415	,	_
80-76	19416-19419	Cai	_
80-77	19419-19420	,	_
80-78	19421-19425	Wang	_
80-79	19425-19426	,	_
80-80	19427-19428	&	_
80-81	19429-19433	Chan	_
80-82	19433-19434	,	_
80-83	19435-19439	2018	_
80-84	19439-19440	)	_
80-85	19440-19441	.	_

#Text=The two data sets were preprocessed separately with the same steps.
81-1	19442-19445	The	_
81-2	19446-19449	two	_
81-3	19450-19454	data	_
81-4	19455-19459	sets	_
81-5	19460-19464	were	_
81-6	19465-19477	preprocessed	_
81-7	19478-19488	separately	_
81-8	19489-19493	with	_
81-9	19494-19497	the	_
81-10	19498-19502	same	_
81-11	19503-19508	steps	_
81-12	19508-19509	.	_

#Text=To avoid T1 relaxation effects prior to equilibrium, the first five volumes of each resting state scan were excluded.
82-1	19510-19512	To	_
82-2	19513-19518	avoid	_
82-3	19519-19521	T1	_
82-4	19522-19532	relaxation	_
82-5	19533-19540	effects	_
82-6	19541-19546	prior	_
82-7	19547-19549	to	_
82-8	19550-19561	equilibrium	_
82-9	19561-19562	,	_
82-10	19563-19566	the	_
82-11	19567-19572	first	_
82-12	19573-19577	five	_
82-13	19578-19585	volumes	_
82-14	19586-19588	of	_
82-15	19589-19593	each	_
82-16	19594-19601	resting	_
82-17	19602-19607	state	_
82-18	19608-19612	scan	_
82-19	19613-19617	were	_
82-20	19618-19626	excluded	_
82-21	19626-19627	.	_

#Text=Then, the remaining volumes for each of the functional imaging sessions were processed using DPARSF, including slice timing, realignment, and coregistration to the structural images.
83-1	19628-19632	Then	_
83-2	19632-19633	,	_
83-3	19634-19637	the	_
83-4	19638-19647	remaining	_
83-5	19648-19655	volumes	_
83-6	19656-19659	for	_
83-7	19660-19664	each	_
83-8	19665-19667	of	_
83-9	19668-19671	the	_
83-10	19672-19682	functional	_
83-11	19683-19690	imaging	_
83-12	19691-19699	sessions	_
83-13	19700-19704	were	_
83-14	19705-19714	processed	_
83-15	19715-19720	using	_
83-16	19721-19727	DPARSF	_
83-17	19727-19728	,	_
83-18	19729-19738	including	_
83-19	19739-19744	slice	_
83-20	19745-19751	timing	_
83-21	19751-19752	,	_
83-22	19753-19764	realignment	_
83-23	19764-19765	,	_
83-24	19766-19769	and	_
83-25	19770-19784	coregistration	_
83-26	19785-19787	to	_
83-27	19788-19791	the	_
83-28	19792-19802	structural	_
83-29	19803-19809	images	_
83-30	19809-19810	.	_

#Text=Mean frame‐wise displacement (FD) was calculated (Power, Barnes, Snyder, Schlaggar, & Petersen, 2012) for each participant.
84-1	19811-19815	Mean	_
84-2	19816-19826	frame‐wise	_
84-3	19827-19839	displacement	_
84-4	19840-19841	(	_
84-5	19841-19843	FD	_
84-6	19843-19844	)	_
84-7	19845-19848	was	_
84-8	19849-19859	calculated	_
84-9	19860-19861	(	_
84-10	19861-19866	Power	_
84-11	19866-19867	,	_
84-12	19868-19874	Barnes	_
84-13	19874-19875	,	_
84-14	19876-19882	Snyder	_
84-15	19882-19883	,	_
84-16	19884-19893	Schlaggar	_
84-17	19893-19894	,	_
84-18	19895-19896	&	_
84-19	19897-19905	Petersen	_
84-20	19905-19906	,	_
84-21	19907-19911	2012	_
84-22	19911-19912	)	_
84-23	19913-19916	for	_
84-24	19917-19921	each	_
84-25	19922-19933	participant	_
84-26	19933-19934	.	_

#Text=The percentage of time points with mean FD power >0.5 was lower than 10% for all participants.
85-1	19935-19938	The	_
85-2	19939-19949	percentage	_
85-3	19950-19952	of	_
85-4	19953-19957	time	_
85-5	19958-19964	points	_
85-6	19965-19969	with	_
85-7	19970-19974	mean	_
85-8	19975-19977	FD	_
85-9	19978-19983	power	_
85-10	19984-19985	>	_
85-11	19985-19988	0.5	_
85-12	19989-19992	was	_
85-13	19993-19998	lower	_
85-14	19999-20003	than	_
85-15	20004-20007	10%	_
85-16	20008-20011	for	_
85-17	20012-20015	all	_
85-18	20016-20028	participants	_
85-19	20028-20029	.	_

#Text=In order to remove nonstationary signals and other artifacts, the temporal filter toolbox (Madsen et al., 2018) was used.
86-1	20030-20032	In	_
86-2	20033-20038	order	_
86-3	20039-20041	to	_
86-4	20042-20048	remove	_
86-5	20049-20062	nonstationary	_
86-6	20063-20070	signals	_
86-7	20071-20074	and	_
86-8	20075-20080	other	_
86-9	20081-20090	artifacts	_
86-10	20090-20091	,	_
86-11	20092-20095	the	_
86-12	20096-20104	temporal	_
86-13	20105-20111	filter	_
86-14	20112-20119	toolbox	_
86-15	20120-20121	(	_
86-16	20121-20127	Madsen	_
86-17	20128-20130	et	_
86-18	20131-20133	al	_
86-19	20133-20134	.	_
86-20	20134-20135	,	_
86-21	20136-20140	2018	_
86-22	20140-20141	)	_
86-23	20142-20145	was	_
86-24	20146-20150	used	_
86-25	20150-20151	.	_

#Text=Processing steps included: despiking (Patel et al., 2014), high‐pass filtering and removal of low‐frequency drifts and motion by a 24‐parameter autoregressive model using realignment regressors and scrubbing (using a 1 mm relative movement threshold and a 1% DVARS threshold (Power et al., 2012)) (Friston, Williams, Howard, Frackowiak, & Turner, 1996).
87-1	20152-20162	Processing	_
87-2	20163-20168	steps	_
87-3	20169-20177	included	_
87-4	20177-20178	:	_
87-5	20179-20188	despiking	_
87-6	20189-20190	(	_
87-7	20190-20195	Patel	_
87-8	20196-20198	et	_
87-9	20199-20201	al	_
87-10	20201-20202	.	_
87-11	20202-20203	,	_
87-12	20204-20208	2014	_
87-13	20208-20209	)	_
87-14	20209-20210	,	_
87-15	20211-20220	high‐pass	_
87-16	20221-20230	filtering	_
87-17	20231-20234	and	_
87-18	20235-20242	removal	_
87-19	20243-20245	of	_
87-20	20246-20259	low‐frequency	_
87-21	20260-20266	drifts	_
87-22	20267-20270	and	_
87-23	20271-20277	motion	_
87-24	20278-20280	by	_
87-25	20281-20282	a	_
87-26	20283-20285	24	_
87-27	20285-20286	‐	_
87-28	20286-20295	parameter	_
87-29	20296-20310	autoregressive	_
87-30	20311-20316	model	_
87-31	20317-20322	using	_
87-32	20323-20334	realignment	_
87-33	20335-20345	regressors	_
87-34	20346-20349	and	_
87-35	20350-20359	scrubbing	_
87-36	20360-20361	(	_
87-37	20361-20366	using	_
87-38	20367-20368	a	_
87-39	20369-20370	1	_
87-40	20371-20373	mm	_
87-41	20374-20382	relative	_
87-42	20383-20391	movement	_
87-43	20392-20401	threshold	_
87-44	20402-20405	and	_
87-45	20406-20407	a	_
87-46	20408-20410	1%	_
87-47	20411-20416	DVARS	_
87-48	20417-20426	threshold	_
87-49	20427-20428	(	_
87-50	20428-20433	Power	_
87-51	20434-20436	et	_
87-52	20437-20439	al	_
87-53	20439-20440	.	_
87-54	20440-20441	,	_
87-55	20442-20446	2012	_
87-56	20446-20447	)	_
87-57	20447-20448	)	_
87-58	20449-20450	(	_
87-59	20450-20457	Friston	_
87-60	20457-20458	,	_
87-61	20459-20467	Williams	_
87-62	20467-20468	,	_
87-63	20469-20475	Howard	_
87-64	20475-20476	,	_
87-65	20477-20487	Frackowiak	_
87-66	20487-20488	,	_
87-67	20489-20490	&	_
87-68	20491-20497	Turner	_
87-69	20497-20498	,	_
87-70	20499-20503	1996	_
87-71	20503-20504	)	_
87-72	20504-20505	.	_

#Text=Subsequently, spatial normalization with DARTEL was adopted to normalize the functional images into Montreal Neurological Institute (MNI) space (Ashburner, 2009) in SPM12.
88-1	20506-20518	Subsequently	_
88-2	20518-20519	,	_
88-3	20520-20527	spatial	_
88-4	20528-20541	normalization	_
88-5	20542-20546	with	_
88-6	20547-20553	DARTEL	_
88-7	20554-20557	was	_
88-8	20558-20565	adopted	_
88-9	20566-20568	to	_
88-10	20569-20578	normalize	_
88-11	20579-20582	the	_
88-12	20583-20593	functional	_
88-13	20594-20600	images	_
88-14	20601-20605	into	_
88-15	20606-20614	Montreal	_
88-16	20615-20627	Neurological	_
88-17	20628-20637	Institute	_
88-18	20638-20639	(	_
88-19	20639-20642	MNI	_
88-20	20642-20643	)	_
88-21	20644-20649	space	_
88-22	20650-20651	(	_
88-23	20651-20660	Ashburner	_
88-24	20660-20661	,	_
88-25	20662-20666	2009	_
88-26	20666-20667	)	_
88-27	20668-20670	in	_
88-28	20671-20676	SPM12	_
88-29	20676-20677	.	_

#Text=Finally, an 8‐mm full‐width‐at‐half‐maximum isotropic Gaussian kernel was used to smooth the functional images (Table 5).
89-1	20678-20685	Finally	_
89-2	20685-20686	,	_
89-3	20687-20689	an	_
89-4	20690-20691	8	_
89-5	20691-20692	‐	_
89-6	20692-20694	mm	_
89-7	20695-20721	full‐width‐at‐half‐maximum	_
89-8	20722-20731	isotropic	_
89-9	20732-20740	Gaussian	_
89-10	20741-20747	kernel	_
89-11	20748-20751	was	_
89-12	20752-20756	used	_
89-13	20757-20759	to	_
89-14	20760-20766	smooth	_
89-15	20767-20770	the	_
89-16	20771-20781	functional	_
89-17	20782-20788	images	_
89-18	20789-20790	(	_
89-19	20790-20795	Table	_
89-20	20796-20797	5	_
89-21	20797-20798	)	_
89-22	20798-20799	.	_

#Text=Selected spatial components used for classification
#Text=Index\tComponent name\tSpatial location\tPeak MNI region\tPeak MNI coordinates (mm)\t \t(1)\tOccipital lateral cortex\tLeft calcarine sulcus + left middle occipital gyrus + lingual gyrus\tLeft calcarine sulcus\t−12, −93, −3\t \t(2)\tOccipital medial cortex\tCalcarine\tLeft calcarine sulcus\t0, −75, 9\t \t(3)\tCerebellum\tLeft lobule VIII, left crus I, and lobule VI of cerebellar hemisphere\tLobule IX of vermis\t3, −60, −39\t \t(4)\tFusiform\tFusiform gyrus + lingual gyrus\tRight lingual gyrus\t24, −60, −9\t \t(5)\tBasal ganglia\tPutamen + thalamus + caudate nucleus\tLeft putamen\t−21, 9, −3\t \t(6)\tPrecentral gyrus\tPrecentral gyrus + left postcentral gyrus\tLeft postcentral gyrus\t−51, −9, 33\t \t(7)\tAnterior DMN\tAnterior cingulate gyrus + left medial frontal gyrus\tLeft medial orbitofrontal cortex\t0, 51, −3\t \t(8)\tTemporal lobe\tMiddle temporal gyrus + right superior temporal gyrus\tRight superior temporal gyrus\t60, −42, 12\t \t(9)\tPosterior DMN\tPrecentral gyrus + left cuneus\tLeft precuneus\t0, −69, 36\t \t(10)\tMiddle cingulate\tMidcingulate area\tLeft midcingulate area\t0, −33, 45\t \t(11)\tOccipital medial cortex\tMiddle occipital gyrus + cuneus + superior occipital gyrus\tRight middle occipital gyrus\t30, −81, 24\t \t(12)\tFrontal superior cortex\tSuperior frontal gyrus + right supplementary motor area + middle frontal gyrus\tLeft supplementary motor area\t0, 6, 60\t \t(13)\tDMN\tMedial frontal gyrus\tLeft medial frontal gyrus\t0, 51, 33\t \t(14)\tCentral gyrus\tPostcentral gyrus + precentral gyrus\tUndefined\t0, −27, 66\t \t(15)\tDMN\tMiddle frontal gyrus + superior frontal gyrus\tRight midcingulate area\t3, 24, 36\t \t(16)\tPrecuneus\tPrecentral gyrus + superior parietal lobule\tLeft precuneus\t0, −57, 54\t \t
#Text=Machine learning analysis
#Text=After preprocessing, further machine learning analysis was conducted (see Figure 1 for the analysis flowchart).
90-1	20800-20808	Selected	_
90-2	20809-20816	spatial	_
90-3	20817-20827	components	_
90-4	20828-20832	used	_
90-5	20833-20836	for	_
90-6	20837-20851	classification	_
90-7	20852-20857	Index	_
90-8	20858-20867	Component	_
90-9	20868-20872	name	_
90-10	20873-20880	Spatial	_
90-11	20881-20889	location	_
90-12	20890-20894	Peak	_
90-13	20895-20898	MNI	_
90-14	20899-20905	region	_
90-15	20906-20910	Peak	_
90-16	20911-20914	MNI	_
90-17	20915-20926	coordinates	_
90-18	20927-20928	(	_
90-19	20928-20930	mm	_
90-20	20930-20931	)	_
90-21	20934-20935	(	_
90-22	20935-20936	1	_
90-23	20936-20937	)	_
90-24	20938-20947	Occipital	_
90-25	20948-20955	lateral	_
90-26	20956-20962	cortex	_
90-27	20963-20967	Left	_
90-28	20968-20977	calcarine	_
90-29	20978-20984	sulcus	_
90-30	20985-20986	+	_
90-31	20987-20991	left	_
90-32	20992-20998	middle	_
90-33	20999-21008	occipital	_
90-34	21009-21014	gyrus	_
90-35	21015-21016	+	_
90-36	21017-21024	lingual	_
90-37	21025-21030	gyrus	_
90-38	21031-21035	Left	_
90-39	21036-21045	calcarine	_
90-40	21046-21052	sulcus	_
90-41	21053-21054	−	_
90-42	21054-21056	12	_
90-43	21056-21057	,	_
90-44	21058-21059	−	_
90-45	21059-21061	93	_
90-46	21061-21062	,	_
90-47	21063-21064	−	_
90-48	21064-21065	3	_
90-49	21068-21069	(	_
90-50	21069-21070	2	_
90-51	21070-21071	)	_
90-52	21072-21081	Occipital	_
90-53	21082-21088	medial	_
90-54	21089-21095	cortex	_
90-55	21096-21105	Calcarine	_
90-56	21106-21110	Left	_
90-57	21111-21120	calcarine	_
90-58	21121-21127	sulcus	_
90-59	21128-21129	0	_
90-60	21129-21130	,	_
90-61	21131-21132	−	_
90-62	21132-21134	75	_
90-63	21134-21135	,	_
90-64	21136-21137	9	_
90-65	21140-21141	(	_
90-66	21141-21142	3	_
90-67	21142-21143	)	_
90-68	21144-21154	Cerebellum	_
90-69	21155-21159	Left	_
90-70	21160-21166	lobule	_
90-71	21167-21171	VIII	_
90-72	21171-21172	,	_
90-73	21173-21177	left	_
90-74	21178-21182	crus	_
90-75	21183-21184	I	_
90-76	21184-21185	,	_
90-77	21186-21189	and	_
90-78	21190-21196	lobule	_
90-79	21197-21199	VI	_
90-80	21200-21202	of	_
90-81	21203-21213	cerebellar	_
90-82	21214-21224	hemisphere	_
90-83	21225-21231	Lobule	_
90-84	21232-21234	IX	_
90-85	21235-21237	of	_
90-86	21238-21244	vermis	_
90-87	21245-21246	3	_
90-88	21246-21247	,	_
90-89	21248-21249	−	_
90-90	21249-21251	60	_
90-91	21251-21252	,	_
90-92	21253-21254	−	_
90-93	21254-21256	39	_
90-94	21259-21260	(	_
90-95	21260-21261	4	_
90-96	21261-21262	)	_
90-97	21263-21271	Fusiform	_
90-98	21272-21280	Fusiform	_
90-99	21281-21286	gyrus	_
90-100	21287-21288	+	_
90-101	21289-21296	lingual	_
90-102	21297-21302	gyrus	_
90-103	21303-21308	Right	_
90-104	21309-21316	lingual	_
90-105	21317-21322	gyrus	_
90-106	21323-21325	24	_
90-107	21325-21326	,	_
90-108	21327-21328	−	_
90-109	21328-21330	60	_
90-110	21330-21331	,	_
90-111	21332-21333	−	_
90-112	21333-21334	9	_
90-113	21337-21338	(	_
90-114	21338-21339	5	_
90-115	21339-21340	)	_
90-116	21341-21346	Basal	_
90-117	21347-21354	ganglia	_
90-118	21355-21362	Putamen	_
90-119	21363-21364	+	_
90-120	21365-21373	thalamus	_
90-121	21374-21375	+	_
90-122	21376-21383	caudate	_
90-123	21384-21391	nucleus	_
90-124	21392-21396	Left	_
90-125	21397-21404	putamen	_
90-126	21405-21406	−	_
90-127	21406-21408	21	_
90-128	21408-21409	,	_
90-129	21410-21411	9	_
90-130	21411-21412	,	_
90-131	21413-21414	−	_
90-132	21414-21415	3	_
90-133	21418-21419	(	_
90-134	21419-21420	6	_
90-135	21420-21421	)	_
90-136	21422-21432	Precentral	_
90-137	21433-21438	gyrus	_
90-138	21439-21449	Precentral	_
90-139	21450-21455	gyrus	_
90-140	21456-21457	+	_
90-141	21458-21462	left	_
90-142	21463-21474	postcentral	_
90-143	21475-21480	gyrus	_
90-144	21481-21485	Left	_
90-145	21486-21497	postcentral	_
90-146	21498-21503	gyrus	_
90-147	21504-21505	−	_
90-148	21505-21507	51	_
90-149	21507-21508	,	_
90-150	21509-21510	−	_
90-151	21510-21511	9	_
90-152	21511-21512	,	_
90-153	21513-21515	33	_
90-154	21518-21519	(	_
90-155	21519-21520	7	_
90-156	21520-21521	)	_
90-157	21522-21530	Anterior	_
90-158	21531-21534	DMN	_
90-159	21535-21543	Anterior	_
90-160	21544-21553	cingulate	_
90-161	21554-21559	gyrus	_
90-162	21560-21561	+	_
90-163	21562-21566	left	_
90-164	21567-21573	medial	_
90-165	21574-21581	frontal	_
90-166	21582-21587	gyrus	_
90-167	21588-21592	Left	_
90-168	21593-21599	medial	_
90-169	21600-21613	orbitofrontal	_
90-170	21614-21620	cortex	_
90-171	21621-21622	0	_
90-172	21622-21623	,	_
90-173	21624-21626	51	_
90-174	21626-21627	,	_
90-175	21628-21629	−	_
90-176	21629-21630	3	_
90-177	21633-21634	(	_
90-178	21634-21635	8	_
90-179	21635-21636	)	_
90-180	21637-21645	Temporal	_
90-181	21646-21650	lobe	_
90-182	21651-21657	Middle	_
90-183	21658-21666	temporal	_
90-184	21667-21672	gyrus	_
90-185	21673-21674	+	_
90-186	21675-21680	right	_
90-187	21681-21689	superior	_
90-188	21690-21698	temporal	_
90-189	21699-21704	gyrus	_
90-190	21705-21710	Right	_
90-191	21711-21719	superior	_
90-192	21720-21728	temporal	_
90-193	21729-21734	gyrus	_
90-194	21735-21737	60	_
90-195	21737-21738	,	_
90-196	21739-21740	−	_
90-197	21740-21742	42	_
90-198	21742-21743	,	_
90-199	21744-21746	12	_
90-200	21749-21750	(	_
90-201	21750-21751	9	_
90-202	21751-21752	)	_
90-203	21753-21762	Posterior	_
90-204	21763-21766	DMN	_
90-205	21767-21777	Precentral	_
90-206	21778-21783	gyrus	_
90-207	21784-21785	+	_
90-208	21786-21790	left	_
90-209	21791-21797	cuneus	_
90-210	21798-21802	Left	_
90-211	21803-21812	precuneus	_
90-212	21813-21814	0	_
90-213	21814-21815	,	_
90-214	21816-21817	−	_
90-215	21817-21819	69	_
90-216	21819-21820	,	_
90-217	21821-21823	36	_
90-218	21826-21827	(	_
90-219	21827-21829	10	_
90-220	21829-21830	)	_
90-221	21831-21837	Middle	_
90-222	21838-21847	cingulate	_
90-223	21848-21860	Midcingulate	_
90-224	21861-21865	area	_
90-225	21866-21870	Left	_
90-226	21871-21883	midcingulate	_
90-227	21884-21888	area	_
90-228	21889-21890	0	_
90-229	21890-21891	,	_
90-230	21892-21893	−	_
90-231	21893-21895	33	_
90-232	21895-21896	,	_
90-233	21897-21899	45	_
90-234	21902-21903	(	_
90-235	21903-21905	11	_
90-236	21905-21906	)	_
90-237	21907-21916	Occipital	_
90-238	21917-21923	medial	_
90-239	21924-21930	cortex	_
90-240	21931-21937	Middle	_
90-241	21938-21947	occipital	_
90-242	21948-21953	gyrus	_
90-243	21954-21955	+	_
90-244	21956-21962	cuneus	_
90-245	21963-21964	+	_
90-246	21965-21973	superior	_
90-247	21974-21983	occipital	_
90-248	21984-21989	gyrus	_
90-249	21990-21995	Right	_
90-250	21996-22002	middle	_
90-251	22003-22012	occipital	_
90-252	22013-22018	gyrus	_
90-253	22019-22021	30	_
90-254	22021-22022	,	_
90-255	22023-22024	−	_
90-256	22024-22026	81	_
90-257	22026-22027	,	_
90-258	22028-22030	24	_
90-259	22033-22034	(	_
90-260	22034-22036	12	_
90-261	22036-22037	)	_
90-262	22038-22045	Frontal	_
90-263	22046-22054	superior	_
90-264	22055-22061	cortex	_
90-265	22062-22070	Superior	_
90-266	22071-22078	frontal	_
90-267	22079-22084	gyrus	_
90-268	22085-22086	+	_
90-269	22087-22092	right	_
90-270	22093-22106	supplementary	_
90-271	22107-22112	motor	_
90-272	22113-22117	area	_
90-273	22118-22119	+	_
90-274	22120-22126	middle	_
90-275	22127-22134	frontal	_
90-276	22135-22140	gyrus	_
90-277	22141-22145	Left	_
90-278	22146-22159	supplementary	_
90-279	22160-22165	motor	_
90-280	22166-22170	area	_
90-281	22171-22172	0	_
90-282	22172-22173	,	_
90-283	22174-22175	6	_
90-284	22175-22176	,	_
90-285	22177-22179	60	_
90-286	22182-22183	(	_
90-287	22183-22185	13	_
90-288	22185-22186	)	_
90-289	22187-22190	DMN	_
90-290	22191-22197	Medial	_
90-291	22198-22205	frontal	_
90-292	22206-22211	gyrus	_
90-293	22212-22216	Left	_
90-294	22217-22223	medial	_
90-295	22224-22231	frontal	_
90-296	22232-22237	gyrus	_
90-297	22238-22239	0	_
90-298	22239-22240	,	_
90-299	22241-22243	51	_
90-300	22243-22244	,	_
90-301	22245-22247	33	_
90-302	22250-22251	(	_
90-303	22251-22253	14	_
90-304	22253-22254	)	_
90-305	22255-22262	Central	_
90-306	22263-22268	gyrus	_
90-307	22269-22280	Postcentral	_
90-308	22281-22286	gyrus	_
90-309	22287-22288	+	_
90-310	22289-22299	precentral	_
90-311	22300-22305	gyrus	_
90-312	22306-22315	Undefined	_
90-313	22316-22317	0	_
90-314	22317-22318	,	_
90-315	22319-22320	−	_
90-316	22320-22322	27	_
90-317	22322-22323	,	_
90-318	22324-22326	66	_
90-319	22329-22330	(	_
90-320	22330-22332	15	_
90-321	22332-22333	)	_
90-322	22334-22337	DMN	_
90-323	22338-22344	Middle	_
90-324	22345-22352	frontal	_
90-325	22353-22358	gyrus	_
90-326	22359-22360	+	_
90-327	22361-22369	superior	_
90-328	22370-22377	frontal	_
90-329	22378-22383	gyrus	_
90-330	22384-22389	Right	_
90-331	22390-22402	midcingulate	_
90-332	22403-22407	area	_
90-333	22408-22409	3	_
90-334	22409-22410	,	_
90-335	22411-22413	24	_
90-336	22413-22414	,	_
90-337	22415-22417	36	_
90-338	22420-22421	(	_
90-339	22421-22423	16	_
90-340	22423-22424	)	_
90-341	22425-22434	Precuneus	_
90-342	22435-22445	Precentral	_
90-343	22446-22451	gyrus	_
90-344	22452-22453	+	_
90-345	22454-22462	superior	_
90-346	22463-22471	parietal	_
90-347	22472-22478	lobule	_
90-348	22479-22483	Left	_
90-349	22484-22493	precuneus	_
90-350	22494-22495	0	_
90-351	22495-22496	,	_
90-352	22497-22498	−	_
90-353	22498-22500	57	_
90-354	22500-22501	,	_
90-355	22502-22504	54	_
90-356	22508-22515	Machine	_
90-357	22516-22524	learning	_
90-358	22525-22533	analysis	_
90-359	22534-22539	After	_
90-360	22540-22553	preprocessing	_
90-361	22553-22554	,	_
90-362	22555-22562	further	_
90-363	22563-22570	machine	_
90-364	22571-22579	learning	_
90-365	22580-22588	analysis	_
90-366	22589-22592	was	_
90-367	22593-22602	conducted	_
90-368	22603-22604	(	_
90-369	22604-22607	see	_
90-370	22608-22614	Figure	_
90-371	22615-22616	1	_
90-372	22617-22620	for	_
90-373	22621-22624	the	_
90-374	22625-22633	analysis	_
90-375	22634-22643	flowchart	_
90-376	22643-22644	)	_
90-377	22644-22645	.	_

#Text=To assess generalizability by internal validation, we followed the procedures from Du et al. (2012) in the main data set.
91-1	22646-22648	To	_
91-2	22649-22655	assess	_
91-3	22656-22672	generalizability	_
91-4	22673-22675	by	_
91-5	22676-22684	internal	_
91-6	22685-22695	validation	_
91-7	22695-22696	,	_
91-8	22697-22699	we	_
91-9	22700-22708	followed	_
91-10	22709-22712	the	_
91-11	22713-22723	procedures	_
91-12	22724-22728	from	_
91-13	22729-22731	Du	_
91-14	22732-22734	et	_
91-15	22735-22737	al	_
91-16	22737-22738	.	_
91-17	22739-22740	(	_
91-18	22740-22744	2012	_
91-19	22744-22745	)	_
91-20	22746-22748	in	_
91-21	22749-22752	the	_
91-22	22753-22757	main	_
91-23	22758-22762	data	_
91-24	22763-22766	set	_
91-25	22766-22767	.	_

#Text=To assess between‐site generalizability by external validation, the predictive model built in the main data set was directly applied to the validated data set.
92-1	22768-22770	To	_
92-2	22771-22777	assess	_
92-3	22778-22790	between‐site	_
92-4	22791-22807	generalizability	_
92-5	22808-22810	by	_
92-6	22811-22819	external	_
92-7	22820-22830	validation	_
92-8	22830-22831	,	_
92-9	22832-22835	the	_
92-10	22836-22846	predictive	_
92-11	22847-22852	model	_
92-12	22853-22858	built	_
92-13	22859-22861	in	_
92-14	22862-22865	the	_
92-15	22866-22870	main	_
92-16	22871-22875	data	_
92-17	22876-22879	set	_
92-18	22880-22883	was	_
92-19	22884-22892	directly	_
92-20	22893-22900	applied	_
92-21	22901-22903	to	_
92-22	22904-22907	the	_
92-23	22908-22917	validated	_
92-24	22918-22922	data	_
92-25	22923-22926	set	_
92-26	22926-22927	.	_

#Text=To establish transfer learning and to explore factors influencing between‐site generalizability, the unsupervised group independent component analysis (ICA) step was updated based on the two data sets and the between‐site generalizability was estimated again.
93-1	22928-22930	To	_
93-2	22931-22940	establish	_
93-3	22941-22949	transfer	_
93-4	22950-22958	learning	_
93-5	22959-22962	and	_
93-6	22963-22965	to	_
93-7	22966-22973	explore	_
93-8	22974-22981	factors	_
93-9	22982-22993	influencing	_
93-10	22994-23006	between‐site	_
93-11	23007-23023	generalizability	_
93-12	23023-23024	,	_
93-13	23025-23028	the	_
93-14	23029-23041	unsupervised	_
93-15	23042-23047	group	_
93-16	23048-23059	independent	_
93-17	23060-23069	component	_
93-18	23070-23078	analysis	_
93-19	23079-23080	(	_
93-20	23080-23083	ICA	_
93-21	23083-23084	)	_
93-22	23085-23089	step	_
93-23	23090-23093	was	_
93-24	23094-23101	updated	_
93-25	23102-23107	based	_
93-26	23108-23110	on	_
93-27	23111-23114	the	_
93-28	23115-23118	two	_
93-29	23119-23123	data	_
93-30	23124-23128	sets	_
93-31	23129-23132	and	_
93-32	23133-23136	the	_
93-33	23137-23149	between‐site	_
93-34	23150-23166	generalizability	_
93-35	23167-23170	was	_
93-36	23171-23180	estimated	_
93-37	23181-23186	again	_
93-38	23186-23187	.	_

#Text=In general, the machine learning framework consisted of the following steps: (a) extracting and selecting the spatial components (features) for all participants; (b) identification of features with significant differences using a two‐sample t test with thresholding; (c) kernel principal component analysis (PCA); (d) Fisher linear discriminant (FLD) analysis on individual components; and (e) majority voting across components.
94-1	23188-23190	In	_
94-2	23191-23198	general	_
94-3	23198-23199	,	_
94-4	23200-23203	the	_
94-5	23204-23211	machine	_
94-6	23212-23220	learning	_
94-7	23221-23230	framework	_
94-8	23231-23240	consisted	_
94-9	23241-23243	of	_
94-10	23244-23247	the	_
94-11	23248-23257	following	_
94-12	23258-23263	steps	_
94-13	23263-23264	:	_
94-14	23265-23266	(	_
94-15	23266-23267	a	_
94-16	23267-23268	)	_
94-17	23269-23279	extracting	_
94-18	23280-23283	and	_
94-19	23284-23293	selecting	_
94-20	23294-23297	the	_
94-21	23298-23305	spatial	_
94-22	23306-23316	components	_
94-23	23317-23318	(	_
94-24	23318-23326	features	_
94-25	23326-23327	)	_
94-26	23328-23331	for	_
94-27	23332-23335	all	_
94-28	23336-23348	participants	_
94-29	23348-23349	;	_
94-30	23350-23351	(	_
94-31	23351-23352	b	_
94-32	23352-23353	)	_
94-33	23354-23368	identification	_
94-34	23369-23371	of	_
94-35	23372-23380	features	_
94-36	23381-23385	with	_
94-37	23386-23397	significant	_
94-38	23398-23409	differences	_
94-39	23410-23415	using	_
94-40	23416-23417	a	_
94-41	23418-23428	two‐sample	_
94-42	23429-23430	t	_
94-43	23431-23435	test	_
94-44	23436-23440	with	_
94-45	23441-23453	thresholding	_
94-46	23453-23454	;	_
94-47	23455-23456	(	_
94-48	23456-23457	c	_
94-49	23457-23458	)	_
94-50	23459-23465	kernel	_
94-51	23466-23475	principal	_
94-52	23476-23485	component	_
94-53	23486-23494	analysis	_
94-54	23495-23496	(	_
94-55	23496-23499	PCA	_
94-56	23499-23500	)	_
94-57	23500-23501	;	_
94-58	23502-23503	(	_
94-59	23503-23504	d	_
94-60	23504-23505	)	_
94-61	23506-23512	Fisher	_
94-62	23513-23519	linear	_
94-63	23520-23532	discriminant	_
94-64	23533-23534	(	_
94-65	23534-23537	FLD	_
94-66	23537-23538	)	_
94-67	23539-23547	analysis	_
94-68	23548-23550	on	_
94-69	23551-23561	individual	_
94-70	23562-23572	components	_
94-71	23572-23573	;	_
94-72	23574-23577	and	_
94-73	23578-23579	(	_
94-74	23579-23580	e	_
94-75	23580-23581	)	_
94-76	23582-23590	majority	_
94-77	23591-23597	voting	_
94-78	23598-23604	across	_
94-79	23605-23615	components	_
94-80	23615-23616	.	_

#Text=The flowchart shows machine learning procedures through internal and external validation.
95-1	23617-23620	The	_
95-2	23621-23630	flowchart	_
95-3	23631-23636	shows	_
95-4	23637-23644	machine	_
95-5	23645-23653	learning	_
95-6	23654-23664	procedures	_
95-7	23665-23672	through	_
95-8	23673-23681	internal	_
95-9	23682-23685	and	_
95-10	23686-23694	external	_
95-11	23695-23705	validation	_
95-12	23705-23706	.	_

#Text=FLD, Fisher linear discrimination; GICA, group independent component analysis; PCA, principle component analysis; STR, spatial–temporal reconstruction
#Text=Assessing within‐site generalizability
#Text=Components originating from artifacts, motion, and respiratory/cardiac cycles, which were identified by considering how much regions known to be associated with these signals were represented in the components.
96-1	23707-23710	FLD	_
96-2	23710-23711	,	_
96-3	23712-23718	Fisher	_
96-4	23719-23725	linear	_
96-5	23726-23740	discrimination	_
96-6	23740-23741	;	_
96-7	23742-23746	GICA	_
96-8	23746-23747	,	_
96-9	23748-23753	group	_
96-10	23754-23765	independent	_
96-11	23766-23775	component	_
96-12	23776-23784	analysis	_
96-13	23784-23785	;	_
96-14	23786-23789	PCA	_
96-15	23789-23790	,	_
96-16	23791-23800	principle	_
96-17	23801-23810	component	_
96-18	23811-23819	analysis	_
96-19	23819-23820	;	_
96-20	23821-23824	STR	_
96-21	23824-23825	,	_
96-22	23826-23842	spatial–temporal	_
96-23	23843-23857	reconstruction	_
96-24	23858-23867	Assessing	_
96-25	23868-23879	within‐site	_
96-26	23880-23896	generalizability	_
96-27	23897-23907	Components	_
96-28	23908-23919	originating	_
96-29	23920-23924	from	_
96-30	23925-23934	artifacts	_
96-31	23934-23935	,	_
96-32	23936-23942	motion	_
96-33	23942-23943	,	_
96-34	23944-23947	and	_
96-35	23948-23959	respiratory	_
96-36	23959-23960	/	_
96-37	23960-23967	cardiac	_
96-38	23968-23974	cycles	_
96-39	23974-23975	,	_
96-40	23976-23981	which	_
96-41	23982-23986	were	_
96-42	23987-23997	identified	_
96-43	23998-24000	by	_
96-44	24001-24012	considering	_
96-45	24013-24016	how	_
96-46	24017-24021	much	_
96-47	24022-24029	regions	_
96-48	24030-24035	known	_
96-49	24036-24038	to	_
96-50	24039-24041	be	_
96-51	24042-24052	associated	_
96-52	24053-24057	with	_
96-53	24058-24063	these	_
96-54	24064-24071	signals	_
96-55	24072-24076	were	_
96-56	24077-24088	represented	_
96-57	24089-24091	in	_
96-58	24092-24095	the	_
96-59	24096-24106	components	_
96-60	24106-24107	.	_

#Text=This included edges (motion, respiration), major arteries or veins, the circle of Willis, and the sagittal sinus (cardiac cycle) as well as regions in the vicinity of field inhomogeneity (movement by field inhomogeneity interaction effects).
97-1	24108-24112	This	_
97-2	24113-24121	included	_
97-3	24122-24127	edges	_
97-4	24128-24129	(	_
97-5	24129-24135	motion	_
97-6	24135-24136	,	_
97-7	24137-24148	respiration	_
97-8	24148-24149	)	_
97-9	24149-24150	,	_
97-10	24151-24156	major	_
97-11	24157-24165	arteries	_
97-12	24166-24168	or	_
97-13	24169-24174	veins	_
97-14	24174-24175	,	_
97-15	24176-24179	the	_
97-16	24180-24186	circle	_
97-17	24187-24189	of	_
97-18	24190-24196	Willis	_
97-19	24196-24197	,	_
97-20	24198-24201	and	_
97-21	24202-24205	the	_
97-22	24206-24214	sagittal	_
97-23	24215-24220	sinus	_
97-24	24221-24222	(	_
97-25	24222-24229	cardiac	_
97-26	24230-24235	cycle	_
97-27	24235-24236	)	_
97-28	24237-24239	as	_
97-29	24240-24244	well	_
97-30	24245-24247	as	_
97-31	24248-24255	regions	_
97-32	24256-24258	in	_
97-33	24259-24262	the	_
97-34	24263-24271	vicinity	_
97-35	24272-24274	of	_
97-36	24275-24280	field	_
97-37	24281-24294	inhomogeneity	_
97-38	24295-24296	(	_
97-39	24296-24304	movement	_
97-40	24305-24307	by	_
97-41	24308-24313	field	_
97-42	24314-24327	inhomogeneity	_
97-43	24328-24339	interaction	_
97-44	24340-24347	effects	_
97-45	24347-24348	)	_
97-46	24348-24349	.	_

#Text=Components consisting of ventricles.
98-1	24350-24360	Components	_
98-2	24361-24371	consisting	_
98-3	24372-24374	of	_
98-4	24375-24385	ventricles	_
98-5	24385-24386	.	_

#Text=Components that showed low and widespread activation.
99-1	24387-24397	Components	_
99-2	24398-24402	that	_
99-3	24403-24409	showed	_
99-4	24410-24413	low	_
99-5	24414-24417	and	_
99-6	24418-24428	widespread	_
99-7	24429-24439	activation	_
99-8	24439-24440	.	_

#Text=In feature extraction and selection, spatial group ICA was first run based on the entire main data set.
100-1	24441-24443	In	_
100-2	24444-24451	feature	_
100-3	24452-24462	extraction	_
100-4	24463-24466	and	_
100-5	24467-24476	selection	_
100-6	24476-24477	,	_
100-7	24478-24485	spatial	_
100-8	24486-24491	group	_
100-9	24492-24495	ICA	_
100-10	24496-24499	was	_
100-11	24500-24505	first	_
100-12	24506-24509	run	_
100-13	24510-24515	based	_
100-14	24516-24518	on	_
100-15	24519-24522	the	_
100-16	24523-24529	entire	_
100-17	24530-24534	main	_
100-18	24535-24539	data	_
100-19	24540-24543	set	_
100-20	24543-24544	.	_

#Text=Data for all participants were concatenated across time.
101-1	24545-24549	Data	_
101-2	24550-24553	for	_
101-3	24554-24557	all	_
101-4	24558-24570	participants	_
101-5	24571-24575	were	_
101-6	24576-24588	concatenated	_
101-7	24589-24595	across	_
101-8	24596-24600	time	_
101-9	24600-24601	.	_

#Text=Then, PCA was used to reduce the data into 40 principal components at the participant level.
102-1	24602-24606	Then	_
102-2	24606-24607	,	_
102-3	24608-24611	PCA	_
102-4	24612-24615	was	_
102-5	24616-24620	used	_
102-6	24621-24623	to	_
102-7	24624-24630	reduce	_
102-8	24631-24634	the	_
102-9	24635-24639	data	_
102-10	24640-24644	into	_
102-11	24645-24647	40	_
102-12	24648-24657	principal	_
102-13	24658-24668	components	_
102-14	24669-24671	at	_
102-15	24672-24675	the	_
102-16	24676-24687	participant	_
102-17	24688-24693	level	_
102-18	24693-24694	.	_

#Text=Afterward, ICA was performed to extract 30 independent spatial components based on the resulting data from the PCA at the group level.
103-1	24695-24704	Afterward	_
103-2	24704-24705	,	_
103-3	24706-24709	ICA	_
103-4	24710-24713	was	_
103-5	24714-24723	performed	_
103-6	24724-24726	to	_
103-7	24727-24734	extract	_
103-8	24735-24737	30	_
103-9	24738-24749	independent	_
103-10	24750-24757	spatial	_
103-11	24758-24768	components	_
103-12	24769-24774	based	_
103-13	24775-24777	on	_
103-14	24778-24781	the	_
103-15	24782-24791	resulting	_
103-16	24792-24796	data	_
103-17	24797-24801	from	_
103-18	24802-24805	the	_
103-19	24806-24809	PCA	_
103-20	24810-24812	at	_
103-21	24813-24816	the	_
103-22	24817-24822	group	_
103-23	24823-24828	level	_
103-24	24828-24829	.	_

#Text=The analysis of spatial group ICA employed Infomax ICA (Bell & Sejnowski, 1995) in the GIFT software package for MATLAB (GIFT, 2011).
104-1	24830-24833	The	_
104-2	24834-24842	analysis	_
104-3	24843-24845	of	_
104-4	24846-24853	spatial	_
104-5	24854-24859	group	_
104-6	24860-24863	ICA	_
104-7	24864-24872	employed	_
104-8	24873-24880	Infomax	_
104-9	24881-24884	ICA	_
104-10	24885-24886	(	_
104-11	24886-24890	Bell	_
104-12	24891-24892	&	_
104-13	24893-24902	Sejnowski	_
104-14	24902-24903	,	_
104-15	24904-24908	1995	_
104-16	24908-24909	)	_
104-17	24910-24912	in	_
104-18	24913-24916	the	_
104-19	24917-24921	GIFT	_
104-20	24922-24930	software	_
104-21	24931-24938	package	_
104-22	24939-24942	for	_
104-23	24943-24949	MATLAB	_
104-24	24950-24951	(	_
104-25	24951-24955	GIFT	_
104-26	24955-24956	,	_
104-27	24957-24961	2011	_
104-28	24961-24962	)	_
104-29	24962-24963	.	_

#Text=Second, the 16 spatial components were selected manually according to the exclusion criteria below:
#Text=This step provided a template of spatial components to establish correspondence of components in the subsequent LOO ICA analysis.
105-1	24964-24970	Second	_
105-2	24970-24971	,	_
105-3	24972-24975	the	_
105-4	24976-24978	16	_
105-5	24979-24986	spatial	_
105-6	24987-24997	components	_
105-7	24998-25002	were	_
105-8	25003-25011	selected	_
105-9	25012-25020	manually	_
105-10	25021-25030	according	_
105-11	25031-25033	to	_
105-12	25034-25037	the	_
105-13	25038-25047	exclusion	_
105-14	25048-25056	criteria	_
105-15	25057-25062	below	_
105-16	25062-25063	:	_
105-17	25065-25069	This	_
105-18	25070-25074	step	_
105-19	25075-25083	provided	_
105-20	25084-25085	a	_
105-21	25086-25094	template	_
105-22	25095-25097	of	_
105-23	25098-25105	spatial	_
105-24	25106-25116	components	_
105-25	25117-25119	to	_
105-26	25120-25129	establish	_
105-27	25130-25144	correspondence	_
105-28	25145-25147	of	_
105-29	25148-25158	components	_
105-30	25159-25161	in	_
105-31	25162-25165	the	_
105-32	25166-25176	subsequent	_
105-33	25177-25180	LOO	_
105-34	25181-25184	ICA	_
105-35	25185-25193	analysis	_
105-36	25193-25194	.	_

#Text=Then, LOO cross‐validation was used to separate the data into a test set (one participant) and a training set (the remaining sample) and group ICA was performed for the training data.
106-1	25195-25199	Then	_
106-2	25199-25200	,	_
106-3	25201-25204	LOO	_
106-4	25205-25221	cross‐validation	_
106-5	25222-25225	was	_
106-6	25226-25230	used	_
106-7	25231-25233	to	_
106-8	25234-25242	separate	_
106-9	25243-25246	the	_
106-10	25247-25251	data	_
106-11	25252-25256	into	_
106-12	25257-25258	a	_
106-13	25259-25263	test	_
106-14	25264-25267	set	_
106-15	25268-25269	(	_
106-16	25269-25272	one	_
106-17	25273-25284	participant	_
106-18	25284-25285	)	_
106-19	25286-25289	and	_
106-20	25290-25291	a	_
106-21	25292-25300	training	_
106-22	25301-25304	set	_
106-23	25305-25306	(	_
106-24	25306-25309	the	_
106-25	25310-25319	remaining	_
106-26	25320-25326	sample	_
106-27	25326-25327	)	_
106-28	25328-25331	and	_
106-29	25332-25337	group	_
106-30	25338-25341	ICA	_
106-31	25342-25345	was	_
106-32	25346-25355	performed	_
106-33	25356-25359	for	_
106-34	25360-25363	the	_
106-35	25364-25372	training	_
106-36	25373-25377	data	_
106-37	25377-25378	.	_

#Text=In order to identify individual subject components, spatial–temporal reconstruction (Nickerson, Smith, Öngür, & Beckmann, 2017) based on the ICA model was used to obtain the spatial components for each participant in both the test and training data.
107-1	25379-25381	In	_
107-2	25382-25387	order	_
107-3	25388-25390	to	_
107-4	25391-25399	identify	_
107-5	25400-25410	individual	_
107-6	25411-25418	subject	_
107-7	25419-25429	components	_
107-8	25429-25430	,	_
107-9	25431-25447	spatial–temporal	_
107-10	25448-25462	reconstruction	_
107-11	25463-25464	(	_
107-12	25464-25473	Nickerson	_
107-13	25473-25474	,	_
107-14	25475-25480	Smith	_
107-15	25480-25481	,	_
107-16	25482-25487	Öngür	_
107-17	25487-25488	,	_
107-18	25489-25490	&	_
107-19	25491-25499	Beckmann	_
107-20	25499-25500	,	_
107-21	25501-25505	2017	_
107-22	25505-25506	)	_
107-23	25507-25512	based	_
107-24	25513-25515	on	_
107-25	25516-25519	the	_
107-26	25520-25523	ICA	_
107-27	25524-25529	model	_
107-28	25530-25533	was	_
107-29	25534-25538	used	_
107-30	25539-25541	to	_
107-31	25542-25548	obtain	_
107-32	25549-25552	the	_
107-33	25553-25560	spatial	_
107-34	25561-25571	components	_
107-35	25572-25575	for	_
107-36	25576-25580	each	_
107-37	25581-25592	participant	_
107-38	25593-25595	in	_
107-39	25596-25600	both	_
107-40	25601-25604	the	_
107-41	25605-25609	test	_
107-42	25610-25613	and	_
107-43	25614-25622	training	_
107-44	25623-25627	data	_
107-45	25627-25628	.	_

#Text=A matching procedure based on correlation with the template of spatial components was used to establish component correspondence between the LOO splits.
108-1	25629-25630	A	_
108-2	25631-25639	matching	_
108-3	25640-25649	procedure	_
108-4	25650-25655	based	_
108-5	25656-25658	on	_
108-6	25659-25670	correlation	_
108-7	25671-25675	with	_
108-8	25676-25679	the	_
108-9	25680-25688	template	_
108-10	25689-25691	of	_
108-11	25692-25699	spatial	_
108-12	25700-25710	components	_
108-13	25711-25714	was	_
108-14	25715-25719	used	_
108-15	25720-25722	to	_
108-16	25723-25732	establish	_
108-17	25733-25742	component	_
108-18	25743-25757	correspondence	_
108-19	25758-25765	between	_
108-20	25766-25769	the	_
108-21	25770-25773	LOO	_
108-22	25774-25780	splits	_
108-23	25780-25781	.	_

#Text=Then, a voxel‐wise two‐sample t test between the two groups for the training data was conducted to order the voxel in terms of their t‐test value/significance to obtain maximally discriminative features.
109-1	25782-25786	Then	_
109-2	25786-25787	,	_
109-3	25788-25789	a	_
109-4	25790-25800	voxel‐wise	_
109-5	25801-25811	two‐sample	_
109-6	25812-25813	t	_
109-7	25814-25818	test	_
109-8	25819-25826	between	_
109-9	25827-25830	the	_
109-10	25831-25834	two	_
109-11	25835-25841	groups	_
109-12	25842-25845	for	_
109-13	25846-25849	the	_
109-14	25850-25858	training	_
109-15	25859-25863	data	_
109-16	25864-25867	was	_
109-17	25868-25877	conducted	_
109-18	25878-25880	to	_
109-19	25881-25886	order	_
109-20	25887-25890	the	_
109-21	25891-25896	voxel	_
109-22	25897-25899	in	_
109-23	25900-25905	terms	_
109-24	25906-25908	of	_
109-25	25909-25914	their	_
109-26	25915-25921	t‐test	_
109-27	25922-25927	value	_
109-28	25927-25928	/	_
109-29	25928-25940	significance	_
109-30	25941-25943	to	_
109-31	25944-25950	obtain	_
109-32	25951-25960	maximally	_
109-33	25961-25975	discriminative	_
109-34	25976-25984	features	_
109-35	25984-25985	.	_

#Text=Only voxels with t values larger than a threshold t 0 proceeded to the next step.
110-1	25986-25990	Only	_
110-2	25991-25997	voxels	_
110-3	25998-26002	with	_
110-4	26003-26004	t	_
110-5	26005-26011	values	_
110-6	26012-26018	larger	_
110-7	26019-26023	than	_
110-8	26024-26025	a	_
110-9	26026-26035	threshold	_
110-10	26036-26037	t	_
110-11	26038-26039	0	_
110-12	26040-26049	proceeded	_
110-13	26050-26052	to	_
110-14	26053-26056	the	_
110-15	26057-26061	next	_
110-16	26062-26066	step	_
110-17	26066-26067	.	_

#Text=The threshold t 0 was determined such that the class separation in the final FLD step was maximal within the training data set.
111-1	26068-26071	The	_
111-2	26072-26081	threshold	_
111-3	26082-26083	t	_
111-4	26084-26085	0	_
111-5	26086-26089	was	_
111-6	26090-26100	determined	_
111-7	26101-26105	such	_
111-8	26106-26110	that	_
111-9	26111-26114	the	_
111-10	26115-26120	class	_
111-11	26121-26131	separation	_
111-12	26132-26134	in	_
111-13	26135-26138	the	_
111-14	26139-26144	final	_
111-15	26145-26148	FLD	_
111-16	26149-26153	step	_
111-17	26154-26157	was	_
111-18	26158-26165	maximal	_
111-19	26166-26172	within	_
111-20	26173-26176	the	_
111-21	26177-26185	training	_
111-22	26186-26190	data	_
111-23	26191-26194	set	_
111-24	26194-26195	.	_

#Text=When the final threshold value (t 0) was determined, the threshold was applied to the test data.
112-1	26196-26200	When	_
112-2	26201-26204	the	_
112-3	26205-26210	final	_
112-4	26211-26220	threshold	_
112-5	26221-26226	value	_
112-6	26227-26228	(	_
112-7	26228-26229	t	_
112-8	26230-26231	0	_
112-9	26231-26232	)	_
112-10	26233-26236	was	_
112-11	26237-26247	determined	_
112-12	26247-26248	,	_
112-13	26249-26252	the	_
112-14	26253-26262	threshold	_
112-15	26263-26266	was	_
112-16	26267-26274	applied	_
112-17	26275-26277	to	_
112-18	26278-26281	the	_
112-19	26282-26286	test	_
112-20	26287-26291	data	_
112-21	26291-26292	.	_

#Text=Subsequently, the spatial components for the test and training data were decomposed by kernel PCA.
113-1	26293-26305	Subsequently	_
113-2	26305-26306	,	_
113-3	26307-26310	the	_
113-4	26311-26318	spatial	_
113-5	26319-26329	components	_
113-6	26330-26333	for	_
113-7	26334-26337	the	_
113-8	26338-26342	test	_
113-9	26343-26346	and	_
113-10	26347-26355	training	_
113-11	26356-26360	data	_
113-12	26361-26365	were	_
113-13	26366-26376	decomposed	_
113-14	26377-26379	by	_
113-15	26380-26386	kernel	_
113-16	26387-26390	PCA	_
113-17	26390-26391	.	_

#Text=Finally, the test and training data were projected to one dimension by Fisher's linear discriminant analysis (LDA) to make a final prediction of the test label.
114-1	26392-26399	Finally	_
114-2	26399-26400	,	_
114-3	26401-26404	the	_
114-4	26405-26409	test	_
114-5	26410-26413	and	_
114-6	26414-26422	training	_
114-7	26423-26427	data	_
114-8	26428-26432	were	_
114-9	26433-26442	projected	_
114-10	26443-26445	to	_
114-11	26446-26449	one	_
114-12	26450-26459	dimension	_
114-13	26460-26462	by	_
114-14	26463-26471	Fisher's	_
114-15	26472-26478	linear	_
114-16	26479-26491	discriminant	_
114-17	26492-26500	analysis	_
114-18	26501-26502	(	_
114-19	26502-26505	LDA	_
114-20	26505-26506	)	_
114-21	26507-26509	to	_
114-22	26510-26514	make	_
114-23	26515-26516	a	_
114-24	26517-26522	final	_
114-25	26523-26533	prediction	_
114-26	26534-26536	of	_
114-27	26537-26540	the	_
114-28	26541-26545	test	_
114-29	26546-26551	label	_
114-30	26551-26552	.	_

#Text=After feature extraction and selection, classification was done for each of the 16 components independently and then combined by majority voting to make a final decision on the classification of each test sample.
115-1	26553-26558	After	_
115-2	26559-26566	feature	_
115-3	26567-26577	extraction	_
115-4	26578-26581	and	_
115-5	26582-26591	selection	_
115-6	26591-26592	,	_
115-7	26593-26607	classification	_
115-8	26608-26611	was	_
115-9	26612-26616	done	_
115-10	26617-26620	for	_
115-11	26621-26625	each	_
115-12	26626-26628	of	_
115-13	26629-26632	the	_
115-14	26633-26635	16	_
115-15	26636-26646	components	_
115-16	26647-26660	independently	_
115-17	26661-26664	and	_
115-18	26665-26669	then	_
115-19	26670-26678	combined	_
115-20	26679-26681	by	_
115-21	26682-26690	majority	_
115-22	26691-26697	voting	_
115-23	26698-26700	to	_
115-24	26701-26705	make	_
115-25	26706-26707	a	_
115-26	26708-26713	final	_
115-27	26714-26722	decision	_
115-28	26723-26725	on	_
115-29	26726-26729	the	_
115-30	26730-26744	classification	_
115-31	26745-26747	of	_
115-32	26748-26752	each	_
115-33	26753-26757	test	_
115-34	26758-26764	sample	_
115-35	26764-26765	.	_

#Text=The classification procedure in Du et al.'
116-1	26766-26769	The	_
116-2	26770-26784	classification	_
116-3	26785-26794	procedure	_
116-4	26795-26797	in	_
116-5	26798-26800	Du	_
116-6	26801-26803	et	_
116-7	26804-26806	al	_
116-8	26806-26807	.	_
116-9	26807-26808	'	_

#Text=s (2012) study also reported the classification rates for combinations of components that achieved a high accuracy.
117-1	26808-26809	s	_
117-2	26810-26811	(	_
117-3	26811-26815	2012	_
117-4	26815-26816	)	_
117-5	26817-26822	study	_
117-6	26823-26827	also	_
117-7	26828-26836	reported	_
117-8	26837-26840	the	_
117-9	26841-26855	classification	_
117-10	26856-26861	rates	_
117-11	26862-26865	for	_
117-12	26866-26878	combinations	_
117-13	26879-26881	of	_
117-14	26882-26892	components	_
117-15	26893-26897	that	_
117-16	26898-26906	achieved	_
117-17	26907-26908	a	_
117-18	26909-26913	high	_
117-19	26914-26922	accuracy	_
117-20	26922-26923	.	_

#Text=However, as this selection procedure might lead to biased classification rates, we only considered classification results based on majority voting across all selected components in the present study.
118-1	26924-26931	However	_
118-2	26931-26932	,	_
118-3	26933-26935	as	_
118-4	26936-26940	this	_
118-5	26941-26950	selection	_
118-6	26951-26960	procedure	_
118-7	26961-26966	might	_
118-8	26967-26971	lead	_
118-9	26972-26974	to	_
118-10	26975-26981	biased	_
118-11	26982-26996	classification	_
118-12	26997-27002	rates	_
118-13	27002-27003	,	_
118-14	27004-27006	we	_
118-15	27007-27011	only	_
118-16	27012-27022	considered	_
118-17	27023-27037	classification	_
118-18	27038-27045	results	_
118-19	27046-27051	based	_
118-20	27052-27054	on	_
118-21	27055-27063	majority	_
118-22	27064-27070	voting	_
118-23	27071-27077	across	_
118-24	27078-27081	all	_
118-25	27082-27090	selected	_
118-26	27091-27101	components	_
118-27	27102-27104	in	_
118-28	27105-27108	the	_
118-29	27109-27116	present	_
118-30	27117-27122	study	_
118-31	27122-27123	.	_

#Text=Assessing between‐site generalizability
#Text=To assess between‐site generalizability by external validation, the template of spatial components which was used to select features in assessing within‐site generalizability was applied to the validated set of rsfMRI data.
119-1	27124-27133	Assessing	_
119-2	27134-27146	between‐site	_
119-3	27147-27163	generalizability	_
119-4	27164-27166	To	_
119-5	27167-27173	assess	_
119-6	27174-27186	between‐site	_
119-7	27187-27203	generalizability	_
119-8	27204-27206	by	_
119-9	27207-27215	external	_
119-10	27216-27226	validation	_
119-11	27226-27227	,	_
119-12	27228-27231	the	_
119-13	27232-27240	template	_
119-14	27241-27243	of	_
119-15	27244-27251	spatial	_
119-16	27252-27262	components	_
119-17	27263-27268	which	_
119-18	27269-27272	was	_
119-19	27273-27277	used	_
119-20	27278-27280	to	_
119-21	27281-27287	select	_
119-22	27288-27296	features	_
119-23	27297-27299	in	_
119-24	27300-27309	assessing	_
119-25	27310-27321	within‐site	_
119-26	27322-27338	generalizability	_
119-27	27339-27342	was	_
119-28	27343-27350	applied	_
119-29	27351-27353	to	_
119-30	27354-27357	the	_
119-31	27358-27367	validated	_
119-32	27368-27371	set	_
119-33	27372-27374	of	_
119-34	27375-27381	rsfMRI	_
119-35	27382-27386	data	_
119-36	27386-27387	.	_

#Text=The spatial components for each participant in the validated data set were obtained through spatial–temporal reconstruction based on the template which was built from the main data set.
120-1	27388-27391	The	_
120-2	27392-27399	spatial	_
120-3	27400-27410	components	_
120-4	27411-27414	for	_
120-5	27415-27419	each	_
120-6	27420-27431	participant	_
120-7	27432-27434	in	_
120-8	27435-27438	the	_
120-9	27439-27448	validated	_
120-10	27449-27453	data	_
120-11	27454-27457	set	_
120-12	27458-27462	were	_
120-13	27463-27471	obtained	_
120-14	27472-27479	through	_
120-15	27480-27496	spatial–temporal	_
120-16	27497-27511	reconstruction	_
120-17	27512-27517	based	_
120-18	27518-27520	on	_
120-19	27521-27524	the	_
120-20	27525-27533	template	_
120-21	27534-27539	which	_
120-22	27540-27543	was	_
120-23	27544-27549	built	_
120-24	27550-27554	from	_
120-25	27555-27558	the	_
120-26	27559-27563	main	_
120-27	27564-27568	data	_
120-28	27569-27572	set	_
120-29	27572-27573	.	_

#Text=In this setting, determination of the threshold t 0, kernel PCA and training of the LDA classifier considered only the main data set (training set), and hence the identified classification model was directly applied to the validated data set without any adaptation.
121-1	27574-27576	In	_
121-2	27577-27581	this	_
121-3	27582-27589	setting	_
121-4	27589-27590	,	_
121-5	27591-27604	determination	_
121-6	27605-27607	of	_
121-7	27608-27611	the	_
121-8	27612-27621	threshold	_
121-9	27622-27623	t	_
121-10	27624-27625	0	_
121-11	27625-27626	,	_
121-12	27627-27633	kernel	_
121-13	27634-27637	PCA	_
121-14	27638-27641	and	_
121-15	27642-27650	training	_
121-16	27651-27653	of	_
121-17	27654-27657	the	_
121-18	27658-27661	LDA	_
121-19	27662-27672	classifier	_
121-20	27673-27683	considered	_
121-21	27684-27688	only	_
121-22	27689-27692	the	_
121-23	27693-27697	main	_
121-24	27698-27702	data	_
121-25	27703-27706	set	_
121-26	27707-27708	(	_
121-27	27708-27716	training	_
121-28	27717-27720	set	_
121-29	27720-27721	)	_
121-30	27721-27722	,	_
121-31	27723-27726	and	_
121-32	27727-27732	hence	_
121-33	27733-27736	the	_
121-34	27737-27747	identified	_
121-35	27748-27762	classification	_
121-36	27763-27768	model	_
121-37	27769-27772	was	_
121-38	27773-27781	directly	_
121-39	27782-27789	applied	_
121-40	27790-27792	to	_
121-41	27793-27796	the	_
121-42	27797-27806	validated	_
121-43	27807-27811	data	_
121-44	27812-27815	set	_
121-45	27816-27823	without	_
121-46	27824-27827	any	_
121-47	27828-27838	adaptation	_
121-48	27838-27839	.	_

#Text=Apart from changing the LOO cross‐validation to cross‐sample validation, all classification parameters and procedures remained identical.
122-1	27840-27845	Apart	_
122-2	27846-27850	from	_
122-3	27851-27859	changing	_
122-4	27860-27863	the	_
122-5	27864-27867	LOO	_
122-6	27868-27884	cross‐validation	_
122-7	27885-27887	to	_
122-8	27888-27900	cross‐sample	_
122-9	27901-27911	validation	_
122-10	27911-27912	,	_
122-11	27913-27916	all	_
122-12	27917-27931	classification	_
122-13	27932-27942	parameters	_
122-14	27943-27946	and	_
122-15	27947-27957	procedures	_
122-16	27958-27966	remained	_
122-17	27967-27976	identical	_
122-18	27976-27977	.	_

#Text=To further explore factors influencing between‐site generalizability, we updated the ICA step to consider data from both sites.
123-1	27978-27980	To	_
123-2	27981-27988	further	_
123-3	27989-27996	explore	_
123-4	27997-28004	factors	_
123-5	28005-28016	influencing	_
123-6	28017-28029	between‐site	_
123-7	28030-28046	generalizability	_
123-8	28046-28047	,	_
123-9	28048-28050	we	_
123-10	28051-28058	updated	_
123-11	28059-28062	the	_
123-12	28063-28066	ICA	_
123-13	28067-28071	step	_
123-14	28072-28074	to	_
123-15	28075-28083	consider	_
123-16	28084-28088	data	_
123-17	28089-28093	from	_
123-18	28094-28098	both	_
123-19	28099-28104	sites	_
123-20	28104-28105	.	_

#Text=To achieve this, we identified 30 spatially independent components across both data sets using group ICA and established correspondence to the template components from the within‐site generalization procedure using spatial correlation.
124-1	28106-28108	To	_
124-2	28109-28116	achieve	_
124-3	28117-28121	this	_
124-4	28121-28122	,	_
124-5	28123-28125	we	_
124-6	28126-28136	identified	_
124-7	28137-28139	30	_
124-8	28140-28149	spatially	_
124-9	28150-28161	independent	_
124-10	28162-28172	components	_
124-11	28173-28179	across	_
124-12	28180-28184	both	_
124-13	28185-28189	data	_
124-14	28190-28194	sets	_
124-15	28195-28200	using	_
124-16	28201-28206	group	_
124-17	28207-28210	ICA	_
124-18	28211-28214	and	_
124-19	28215-28226	established	_
124-20	28227-28241	correspondence	_
124-21	28242-28244	to	_
124-22	28245-28248	the	_
124-23	28249-28257	template	_
124-24	28258-28268	components	_
124-25	28269-28273	from	_
124-26	28274-28277	the	_
124-27	28278-28289	within‐site	_
124-28	28290-28304	generalization	_
124-29	28305-28314	procedure	_
124-30	28315-28320	using	_
124-31	28321-28328	spatial	_
124-32	28329-28340	correlation	_
124-33	28340-28341	.	_

#Text=The matching procedure involved calculating the pairwise spatial correlation between all 30 estimated components and the 16 template components.
125-1	28342-28345	The	_
125-2	28346-28354	matching	_
125-3	28355-28364	procedure	_
125-4	28365-28373	involved	_
125-5	28374-28385	calculating	_
125-6	28386-28389	the	_
125-7	28390-28398	pairwise	_
125-8	28399-28406	spatial	_
125-9	28407-28418	correlation	_
125-10	28419-28426	between	_
125-11	28427-28430	all	_
125-12	28431-28433	30	_
125-13	28434-28443	estimated	_
125-14	28444-28454	components	_
125-15	28455-28458	and	_
125-16	28459-28462	the	_
125-17	28463-28465	16	_
125-18	28466-28474	template	_
125-19	28475-28485	components	_
125-20	28485-28486	.	_

#Text=Then, pairs of components that exhibited the highest absolute correlation were sequentially matched to identify all 16 components in the joint data set.
126-1	28487-28491	Then	_
126-2	28491-28492	,	_
126-3	28493-28498	pairs	_
126-4	28499-28501	of	_
126-5	28502-28512	components	_
126-6	28513-28517	that	_
126-7	28518-28527	exhibited	_
126-8	28528-28531	the	_
126-9	28532-28539	highest	_
126-10	28540-28548	absolute	_
126-11	28549-28560	correlation	_
126-12	28561-28565	were	_
126-13	28566-28578	sequentially	_
126-14	28579-28586	matched	_
126-15	28587-28589	to	_
126-16	28590-28598	identify	_
126-17	28599-28602	all	_
126-18	28603-28605	16	_
126-19	28606-28616	components	_
126-20	28617-28619	in	_
126-21	28620-28623	the	_
126-22	28624-28629	joint	_
126-23	28630-28634	data	_
126-24	28635-28638	set	_
126-25	28638-28639	.	_

#Text=After this matching procedure, the components were visually inspected to confirm that they represented the same brain regions as the template.
127-1	28640-28645	After	_
127-2	28646-28650	this	_
127-3	28651-28659	matching	_
127-4	28660-28669	procedure	_
127-5	28669-28670	,	_
127-6	28671-28674	the	_
127-7	28675-28685	components	_
127-8	28686-28690	were	_
127-9	28691-28699	visually	_
127-10	28700-28709	inspected	_
127-11	28710-28712	to	_
127-12	28713-28720	confirm	_
127-13	28721-28725	that	_
127-14	28726-28730	they	_
127-15	28731-28742	represented	_
127-16	28743-28746	the	_
127-17	28747-28751	same	_
127-18	28752-28757	brain	_
127-19	28758-28765	regions	_
127-20	28766-28768	as	_
127-21	28769-28772	the	_
127-22	28773-28781	template	_
127-23	28781-28782	.	_

#Text=Importantly, in this setting, the validated data set was only considered in the training of the group ICA model and hence no label information from the validated data set was used in feature extraction or fitting of the classification model.
128-1	28783-28794	Importantly	_
128-2	28794-28795	,	_
128-3	28796-28798	in	_
128-4	28799-28803	this	_
128-5	28804-28811	setting	_
128-6	28811-28812	,	_
128-7	28813-28816	the	_
128-8	28817-28826	validated	_
128-9	28827-28831	data	_
128-10	28832-28835	set	_
128-11	28836-28839	was	_
128-12	28840-28844	only	_
128-13	28845-28855	considered	_
128-14	28856-28858	in	_
128-15	28859-28862	the	_
128-16	28863-28871	training	_
128-17	28872-28874	of	_
128-18	28875-28878	the	_
128-19	28879-28884	group	_
128-20	28885-28888	ICA	_
128-21	28889-28894	model	_
128-22	28895-28898	and	_
128-23	28899-28904	hence	_
128-24	28905-28907	no	_
128-25	28908-28913	label	_
128-26	28914-28925	information	_
128-27	28926-28930	from	_
128-28	28931-28934	the	_
128-29	28935-28944	validated	_
128-30	28945-28949	data	_
128-31	28950-28953	set	_
128-32	28954-28957	was	_
128-33	28958-28962	used	_
128-34	28963-28965	in	_
128-35	28966-28973	feature	_
128-36	28974-28984	extraction	_
128-37	28985-28987	or	_
128-38	28988-28995	fitting	_
128-39	28996-28998	of	_
128-40	28999-29002	the	_
128-41	29003-29017	classification	_
128-42	29018-29023	model	_
128-43	29023-29024	.	_

#Text=Apart from the different templates of spatial components, the classification procedure was identical to the within‐site generalization setting.
129-1	29025-29030	Apart	_
129-2	29031-29035	from	_
129-3	29036-29039	the	_
129-4	29040-29049	different	_
129-5	29050-29059	templates	_
129-6	29060-29062	of	_
129-7	29063-29070	spatial	_
129-8	29071-29081	components	_
129-9	29081-29082	,	_
129-10	29083-29086	the	_
129-11	29087-29101	classification	_
129-12	29102-29111	procedure	_
129-13	29112-29115	was	_
129-14	29116-29125	identical	_
129-15	29126-29128	to	_
129-16	29129-29132	the	_
129-17	29133-29144	within‐site	_
129-18	29145-29159	generalization	_
129-19	29160-29167	setting	_
129-20	29167-29168	.	_

#Text=The significance of the classification performance was assessed using a random permutation test in all settings where an empirical null distribution was obtained by applying an identical classification procedure to the data with permutated class labels.
130-1	29169-29172	The	_
130-2	29173-29185	significance	_
130-3	29186-29188	of	_
130-4	29189-29192	the	_
130-5	29193-29207	classification	_
130-6	29208-29219	performance	_
130-7	29220-29223	was	_
130-8	29224-29232	assessed	_
130-9	29233-29238	using	_
130-10	29239-29240	a	_
130-11	29241-29247	random	_
130-12	29248-29259	permutation	_
130-13	29260-29264	test	_
130-14	29265-29267	in	_
130-15	29268-29271	all	_
130-16	29272-29280	settings	_
130-17	29281-29286	where	_
130-18	29287-29289	an	_
130-19	29290-29299	empirical	_
130-20	29300-29304	null	_
130-21	29305-29317	distribution	_
130-22	29318-29321	was	_
130-23	29322-29330	obtained	_
130-24	29331-29333	by	_
130-25	29334-29342	applying	_
130-26	29343-29345	an	_
130-27	29346-29355	identical	_
130-28	29356-29370	classification	_
130-29	29371-29380	procedure	_
130-30	29381-29383	to	_
130-31	29384-29387	the	_
130-32	29388-29392	data	_
130-33	29393-29397	with	_
130-34	29398-29408	permutated	_
130-35	29409-29414	class	_
130-36	29415-29421	labels	_
130-37	29421-29422	.	_

#Text=RESULTS
#Text=Group ICA on the main rsfMRI data set
#Text=Based on the aforementioned criteria, 16 components were selected to classify patients with schizophrenia from healthy controls in the analysis.
131-1	29423-29430	RESULTS	_
131-2	29431-29436	Group	_
131-3	29437-29440	ICA	_
131-4	29441-29443	on	_
131-5	29444-29447	the	_
131-6	29448-29452	main	_
131-7	29453-29459	rsfMRI	_
131-8	29460-29464	data	_
131-9	29465-29468	set	_
131-10	29469-29474	Based	_
131-11	29475-29477	on	_
131-12	29478-29481	the	_
131-13	29482-29496	aforementioned	_
131-14	29497-29505	criteria	_
131-15	29505-29506	,	_
131-16	29507-29509	16	_
131-17	29510-29520	components	_
131-18	29521-29525	were	_
131-19	29526-29534	selected	_
131-20	29535-29537	to	_
131-21	29538-29546	classify	_
131-22	29547-29555	patients	_
131-23	29556-29560	with	_
131-24	29561-29574	schizophrenia	_
131-25	29575-29579	from	_
131-26	29580-29587	healthy	_
131-27	29588-29596	controls	_
131-28	29597-29599	in	_
131-29	29600-29603	the	_
131-30	29604-29612	analysis	_
131-31	29612-29613	.	_

#Text=The selected components are shown in Figure 2.
132-1	29614-29617	The	_
132-2	29618-29626	selected	_
132-3	29627-29637	components	_
132-4	29638-29641	are	_
132-5	29642-29647	shown	_
132-6	29648-29650	in	_
132-7	29651-29657	Figure	_
132-8	29658-29659	2	_
132-9	29659-29660	.	_

#Text=The name, spatial location, peak MNI region, and peak MNI coordinates for each component are shown in Table 5.
133-1	29661-29664	The	_
133-2	29665-29669	name	_
133-3	29669-29670	,	_
133-4	29671-29678	spatial	_
133-5	29679-29687	location	_
133-6	29687-29688	,	_
133-7	29689-29693	peak	_
133-8	29694-29697	MNI	_
133-9	29698-29704	region	_
133-10	29704-29705	,	_
133-11	29706-29709	and	_
133-12	29710-29714	peak	_
133-13	29715-29718	MNI	_
133-14	29719-29730	coordinates	_
133-15	29731-29734	for	_
133-16	29735-29739	each	_
133-17	29740-29749	component	_
133-18	29750-29753	are	_
133-19	29754-29759	shown	_
133-20	29760-29762	in	_
133-21	29763-29768	Table	_
133-22	29769-29770	5	_
133-23	29770-29771	.	_

#Text=Three orthogonal slices from selected components are shown in the figure.
134-1	29772-29777	Three	_
134-2	29778-29788	orthogonal	_
134-3	29789-29795	slices	_
134-4	29796-29800	from	_
134-5	29801-29809	selected	_
134-6	29810-29820	components	_
134-7	29821-29824	are	_
134-8	29825-29830	shown	_
134-9	29831-29833	in	_
134-10	29834-29837	the	_
134-11	29838-29844	figure	_
134-12	29844-29845	.	_

#Text=The mean components were calculated across all participants and converted into Z‐scores.
135-1	29846-29849	The	_
135-2	29850-29854	mean	_
135-3	29855-29865	components	_
135-4	29866-29870	were	_
135-5	29871-29881	calculated	_
135-6	29882-29888	across	_
135-7	29889-29892	all	_
135-8	29893-29905	participants	_
135-9	29906-29909	and	_
135-10	29910-29919	converted	_
135-11	29920-29924	into	_
135-12	29925-29933	Z‐scores	_
135-13	29933-29934	.	_

#Text=Orthogonal projects are reproduced according to neurological convention
#Text=
#Text=Classification performance for each component
#Text=Ind\tArea\tValidation type\tAcc\tSens\tSpec\tInd\tArea\tValidation type\tAcc\tSens\tSpec\t \t(1)\tOccipital lateral cortex\tInternal\t0.686\t0.588\t0.784\t(9)\tPosterior DMN\tInternal\t0.441\t0.392\t0.490\t \t\t\tExternal1\t0.417\t0.485\t0.333\t\t\tExternal1\t0.450\t0.424\t0.481\t \t\t\tExternal2\t0.450\t0.333\t0.593\t\t\tExternal2\t0.583\t0.485\t0.704\t \t(2)\tOccipital medial cortex\tInternal\t0.578\t0.510\t0.647\t(10)\tMiddle cingulate\tInternal\t0.686\t0.510\t0.863\t \t\t\tExternal1\t0.533\t0.455\t0.630\t\t\tExternal1\t0.433\t0.152\t0.778\t \t\t\tExternal2\t0.583\t0.515\t0.667\t\t\tExternal2\t0.617\t0.636\t0.593\t \t(3)\tCerebellum\tInternal\t0.598\t0.392\t0.804\t(11)\tOccipital medial cortex\tInternal\t0.588\t0.353\t0.824\t \t\t\tExternal1\t0.417\t0.333\t0.519\t\t\tExternal1\t0.550\t0.333\t0.815\t \t\t\tExternal2\t0.517\t0.333\t0.741\t\t\tExternal2\t0.550\t0.697\t0.370\t \t(4)\tFusiform\tInternal\t0.657\t0.490\t0.824\t(12)\tFrontal superior cortex\tInternal\t0.529\t0.627\t0.431\t \t\t\tExternal1\t0.567\t0.364\t0.815\t\t\tExternal1\t0.550\t0.727\t0.333\t \t\t\tExternal2\t0.467\t0.242\t0.741\t\t\tExternal2\t0.533\t0.576\t0.481\t \t(5)\tBasal ganglia\tInternal\t0.706\t0.627\t0.784\t(13)\tDMN\tInternal\t0.647\t0.490\t0.804\t \t\t\tExternal1\t0.500\t0.242\t0.815\t\t\tExternal1\t0.483\t0.303\t0.704\t \t\t\tExternal2\t0.667\t0.606\t0.741\t\t\tExternal2\t0.617\t0.576\t0.667\t \t(6)\tPrecentral gyrus\tInternal\t0.578\t0.686\t0.471\t(14)\tCentral gyrus\tInternal\t0.627\t0.431\t0.824\t \t\t\tExternal1\t0.500\t0.576\t0.407\t\t\tExternal1\t0.617\t0.485\t0.778\t \t\t\tExternal2\t0.633\t0.576\t0.704\t\t\tExternal2\t0.483\t0.242\t0.778\t \t(7)\tAnterior DMN\tInternal\t0.618\t0.510\t0.725\t(15)\tDMN\tInternal\t0.431\t0.353\t0.510\t \t\t\tExternal1\t0.600\t0.545\t0.667\t\t\tExternal1\t0.583\t0.606\t0.556\t \t\t\tExternal2\t0.550\t0.788\t0.259\t\t\tExternal2\t0.650\t0.606\t0.704\t \t(8)\tTemporal lobe\tInternal\t0.657\t0.667\t0.647\t(16)\tPrecuneus\tInternal\t0.676\t0.647\t0.706\t \t\t\tExternal1\t0.550\t0.333\t0.815\t\t\tExternal1\t0.550\t0.455\t0.667\t \t\t\tExternal2\t0.667\t0.788\t0.519\t\t\tExternal2\t0.583\t0.333\t0.889\t \t
#Text=
#Text=Note.
136-1	29935-29945	Orthogonal	_
136-2	29946-29954	projects	_
136-3	29955-29958	are	_
136-4	29959-29969	reproduced	_
136-5	29970-29979	according	_
136-6	29980-29982	to	_
136-7	29983-29995	neurological	_
136-8	29996-30006	convention	_
136-9	30008-30022	Classification	_
136-10	30023-30034	performance	_
136-11	30035-30038	for	_
136-12	30039-30043	each	_
136-13	30044-30053	component	_
136-14	30054-30057	Ind	_
136-15	30058-30062	Area	_
136-16	30063-30073	Validation	_
136-17	30074-30078	type	_
136-18	30079-30082	Acc	_
136-19	30083-30087	Sens	_
136-20	30088-30092	Spec	_
136-21	30093-30096	Ind	_
136-22	30097-30101	Area	_
136-23	30102-30112	Validation	_
136-24	30113-30117	type	_
136-25	30118-30121	Acc	_
136-26	30122-30126	Sens	_
136-27	30127-30131	Spec	_
136-28	30134-30135	(	_
136-29	30135-30136	1	_
136-30	30136-30137	)	_
136-31	30138-30147	Occipital	_
136-32	30148-30155	lateral	_
136-33	30156-30162	cortex	_
136-34	30163-30171	Internal	_
136-35	30172-30177	0.686	_
136-36	30178-30183	0.588	_
136-37	30184-30189	0.784	_
136-38	30190-30191	(	_
136-39	30191-30192	9	_
136-40	30192-30193	)	_
136-41	30194-30203	Posterior	_
136-42	30204-30207	DMN	_
136-43	30208-30216	Internal	_
136-44	30217-30222	0.441	_
136-45	30223-30228	0.392	_
136-46	30229-30234	0.490	_
136-47	30239-30248	External1	_
136-48	30249-30254	0.417	_
136-49	30255-30260	0.485	_
136-50	30261-30266	0.333	_
136-51	30269-30278	External1	_
136-52	30279-30284	0.450	_
136-53	30285-30290	0.424	_
136-54	30291-30296	0.481	_
136-55	30301-30310	External2	_
136-56	30311-30316	0.450	_
136-57	30317-30322	0.333	_
136-58	30323-30328	0.593	_
136-59	30331-30340	External2	_
136-60	30341-30346	0.583	_
136-61	30347-30352	0.485	_
136-62	30353-30358	0.704	_
136-63	30361-30362	(	_
136-64	30362-30363	2	_
136-65	30363-30364	)	_
136-66	30365-30374	Occipital	_
136-67	30375-30381	medial	_
136-68	30382-30388	cortex	_
136-69	30389-30397	Internal	_
136-70	30398-30403	0.578	_
136-71	30404-30409	0.510	_
136-72	30410-30415	0.647	_
136-73	30416-30417	(	_
136-74	30417-30419	10	_
136-75	30419-30420	)	_
136-76	30421-30427	Middle	_
136-77	30428-30437	cingulate	_
136-78	30438-30446	Internal	_
136-79	30447-30452	0.686	_
136-80	30453-30458	0.510	_
136-81	30459-30464	0.863	_
136-82	30469-30478	External1	_
136-83	30479-30484	0.533	_
136-84	30485-30490	0.455	_
136-85	30491-30496	0.630	_
136-86	30499-30508	External1	_
136-87	30509-30514	0.433	_
136-88	30515-30520	0.152	_
136-89	30521-30526	0.778	_
136-90	30531-30540	External2	_
136-91	30541-30546	0.583	_
136-92	30547-30552	0.515	_
136-93	30553-30558	0.667	_
136-94	30561-30570	External2	_
136-95	30571-30576	0.617	_
136-96	30577-30582	0.636	_
136-97	30583-30588	0.593	_
136-98	30591-30592	(	_
136-99	30592-30593	3	_
136-100	30593-30594	)	_
136-101	30595-30605	Cerebellum	_
136-102	30606-30614	Internal	_
136-103	30615-30620	0.598	_
136-104	30621-30626	0.392	_
136-105	30627-30632	0.804	_
136-106	30633-30634	(	_
136-107	30634-30636	11	_
136-108	30636-30637	)	_
136-109	30638-30647	Occipital	_
136-110	30648-30654	medial	_
136-111	30655-30661	cortex	_
136-112	30662-30670	Internal	_
136-113	30671-30676	0.588	_
136-114	30677-30682	0.353	_
136-115	30683-30688	0.824	_
136-116	30693-30702	External1	_
136-117	30703-30708	0.417	_
136-118	30709-30714	0.333	_
136-119	30715-30720	0.519	_
136-120	30723-30732	External1	_
136-121	30733-30738	0.550	_
136-122	30739-30744	0.333	_
136-123	30745-30750	0.815	_
136-124	30755-30764	External2	_
136-125	30765-30770	0.517	_
136-126	30771-30776	0.333	_
136-127	30777-30782	0.741	_
136-128	30785-30794	External2	_
136-129	30795-30800	0.550	_
136-130	30801-30806	0.697	_
136-131	30807-30812	0.370	_
136-132	30815-30816	(	_
136-133	30816-30817	4	_
136-134	30817-30818	)	_
136-135	30819-30827	Fusiform	_
136-136	30828-30836	Internal	_
136-137	30837-30842	0.657	_
136-138	30843-30848	0.490	_
136-139	30849-30854	0.824	_
136-140	30855-30856	(	_
136-141	30856-30858	12	_
136-142	30858-30859	)	_
136-143	30860-30867	Frontal	_
136-144	30868-30876	superior	_
136-145	30877-30883	cortex	_
136-146	30884-30892	Internal	_
136-147	30893-30898	0.529	_
136-148	30899-30904	0.627	_
136-149	30905-30910	0.431	_
136-150	30915-30924	External1	_
136-151	30925-30930	0.567	_
136-152	30931-30936	0.364	_
136-153	30937-30942	0.815	_
136-154	30945-30954	External1	_
136-155	30955-30960	0.550	_
136-156	30961-30966	0.727	_
136-157	30967-30972	0.333	_
136-158	30977-30986	External2	_
136-159	30987-30992	0.467	_
136-160	30993-30998	0.242	_
136-161	30999-31004	0.741	_
136-162	31007-31016	External2	_
136-163	31017-31022	0.533	_
136-164	31023-31028	0.576	_
136-165	31029-31034	0.481	_
136-166	31037-31038	(	_
136-167	31038-31039	5	_
136-168	31039-31040	)	_
136-169	31041-31046	Basal	_
136-170	31047-31054	ganglia	_
136-171	31055-31063	Internal	_
136-172	31064-31069	0.706	_
136-173	31070-31075	0.627	_
136-174	31076-31081	0.784	_
136-175	31082-31083	(	_
136-176	31083-31085	13	_
136-177	31085-31086	)	_
136-178	31087-31090	DMN	_
136-179	31091-31099	Internal	_
136-180	31100-31105	0.647	_
136-181	31106-31111	0.490	_
136-182	31112-31117	0.804	_
136-183	31122-31131	External1	_
136-184	31132-31137	0.500	_
136-185	31138-31143	0.242	_
136-186	31144-31149	0.815	_
136-187	31152-31161	External1	_
136-188	31162-31167	0.483	_
136-189	31168-31173	0.303	_
136-190	31174-31179	0.704	_
136-191	31184-31193	External2	_
136-192	31194-31199	0.667	_
136-193	31200-31205	0.606	_
136-194	31206-31211	0.741	_
136-195	31214-31223	External2	_
136-196	31224-31229	0.617	_
136-197	31230-31235	0.576	_
136-198	31236-31241	0.667	_
136-199	31244-31245	(	_
136-200	31245-31246	6	_
136-201	31246-31247	)	_
136-202	31248-31258	Precentral	_
136-203	31259-31264	gyrus	_
136-204	31265-31273	Internal	_
136-205	31274-31279	0.578	_
136-206	31280-31285	0.686	_
136-207	31286-31291	0.471	_
136-208	31292-31293	(	_
136-209	31293-31295	14	_
136-210	31295-31296	)	_
136-211	31297-31304	Central	_
136-212	31305-31310	gyrus	_
136-213	31311-31319	Internal	_
136-214	31320-31325	0.627	_
136-215	31326-31331	0.431	_
136-216	31332-31337	0.824	_
136-217	31342-31351	External1	_
136-218	31352-31357	0.500	_
136-219	31358-31363	0.576	_
136-220	31364-31369	0.407	_
136-221	31372-31381	External1	_
136-222	31382-31387	0.617	_
136-223	31388-31393	0.485	_
136-224	31394-31399	0.778	_
136-225	31404-31413	External2	_
136-226	31414-31419	0.633	_
136-227	31420-31425	0.576	_
136-228	31426-31431	0.704	_
136-229	31434-31443	External2	_
136-230	31444-31449	0.483	_
136-231	31450-31455	0.242	_
136-232	31456-31461	0.778	_
136-233	31464-31465	(	_
136-234	31465-31466	7	_
136-235	31466-31467	)	_
136-236	31468-31476	Anterior	_
136-237	31477-31480	DMN	_
136-238	31481-31489	Internal	_
136-239	31490-31495	0.618	_
136-240	31496-31501	0.510	_
136-241	31502-31507	0.725	_
136-242	31508-31509	(	_
136-243	31509-31511	15	_
136-244	31511-31512	)	_
136-245	31513-31516	DMN	_
136-246	31517-31525	Internal	_
136-247	31526-31531	0.431	_
136-248	31532-31537	0.353	_
136-249	31538-31543	0.510	_
136-250	31548-31557	External1	_
136-251	31558-31563	0.600	_
136-252	31564-31569	0.545	_
136-253	31570-31575	0.667	_
136-254	31578-31587	External1	_
136-255	31588-31593	0.583	_
136-256	31594-31599	0.606	_
136-257	31600-31605	0.556	_
136-258	31610-31619	External2	_
136-259	31620-31625	0.550	_
136-260	31626-31631	0.788	_
136-261	31632-31637	0.259	_
136-262	31640-31649	External2	_
136-263	31650-31655	0.650	_
136-264	31656-31661	0.606	_
136-265	31662-31667	0.704	_
136-266	31670-31671	(	_
136-267	31671-31672	8	_
136-268	31672-31673	)	_
136-269	31674-31682	Temporal	_
136-270	31683-31687	lobe	_
136-271	31688-31696	Internal	_
136-272	31697-31702	0.657	_
136-273	31703-31708	0.667	_
136-274	31709-31714	0.647	_
136-275	31715-31716	(	_
136-276	31716-31718	16	_
136-277	31718-31719	)	_
136-278	31720-31729	Precuneus	_
136-279	31730-31738	Internal	_
136-280	31739-31744	0.676	_
136-281	31745-31750	0.647	_
136-282	31751-31756	0.706	_
136-283	31761-31770	External1	_
136-284	31771-31776	0.550	_
136-285	31777-31782	0.333	_
136-286	31783-31788	0.815	_
136-287	31791-31800	External1	_
136-288	31801-31806	0.550	_
136-289	31807-31812	0.455	_
136-290	31813-31818	0.667	_
136-291	31823-31832	External2	_
136-292	31833-31838	0.667	_
136-293	31839-31844	0.788	_
136-294	31845-31850	0.519	_
136-295	31853-31862	External2	_
136-296	31863-31868	0.583	_
136-297	31869-31874	0.333	_
136-298	31875-31880	0.889	_
136-299	31885-31889	Note	_
136-300	31889-31890	.	_

#Text=Ind, index; Acc, accuracy; Sens, sensitivity; Spec, specificity; Internal, internal validation within the main data set; External1, external validation generalizing to the validated data set from the main data set by the template based on the main data set; External2, external validation generalizing to the validated data set from the main data set by the template based on both data set.
137-1	31891-31894	Ind	_
137-2	31894-31895	,	_
137-3	31896-31901	index	_
137-4	31901-31902	;	_
137-5	31903-31906	Acc	_
137-6	31906-31907	,	_
137-7	31908-31916	accuracy	_
137-8	31916-31917	;	_
137-9	31918-31922	Sens	_
137-10	31922-31923	,	_
137-11	31924-31935	sensitivity	_
137-12	31935-31936	;	_
137-13	31937-31941	Spec	_
137-14	31941-31942	,	_
137-15	31943-31954	specificity	_
137-16	31954-31955	;	_
137-17	31956-31964	Internal	_
137-18	31964-31965	,	_
137-19	31966-31974	internal	_
137-20	31975-31985	validation	_
137-21	31986-31992	within	_
137-22	31993-31996	the	_
137-23	31997-32001	main	_
137-24	32002-32006	data	_
137-25	32007-32010	set	_
137-26	32010-32011	;	_
137-27	32012-32021	External1	_
137-28	32021-32022	,	_
137-29	32023-32031	external	_
137-30	32032-32042	validation	_
137-31	32043-32055	generalizing	_
137-32	32056-32058	to	_
137-33	32059-32062	the	_
137-34	32063-32072	validated	_
137-35	32073-32077	data	_
137-36	32078-32081	set	_
137-37	32082-32086	from	_
137-38	32087-32090	the	_
137-39	32091-32095	main	_
137-40	32096-32100	data	_
137-41	32101-32104	set	_
137-42	32105-32107	by	_
137-43	32108-32111	the	_
137-44	32112-32120	template	_
137-45	32121-32126	based	_
137-46	32127-32129	on	_
137-47	32130-32133	the	_
137-48	32134-32138	main	_
137-49	32139-32143	data	_
137-50	32144-32147	set	_
137-51	32147-32148	;	_
137-52	32149-32158	External2	_
137-53	32158-32159	,	_
137-54	32160-32168	external	_
137-55	32169-32179	validation	_
137-56	32180-32192	generalizing	_
137-57	32193-32195	to	_
137-58	32196-32199	the	_
137-59	32200-32209	validated	_
137-60	32210-32214	data	_
137-61	32215-32218	set	_
137-62	32219-32223	from	_
137-63	32224-32227	the	_
137-64	32228-32232	main	_
137-65	32233-32237	data	_
137-66	32238-32241	set	_
137-67	32242-32244	by	_
137-68	32245-32248	the	_
137-69	32249-32257	template	_
137-70	32258-32263	based	_
137-71	32264-32266	on	_
137-72	32267-32271	both	_
137-73	32272-32276	data	_
137-74	32277-32280	set	_
137-75	32280-32281	.	_

#Text=Within‐site classification performance
#Text=For classification based on individual features, the performances including accuracy, sensitivity, and specificity of each component are shown in Table 5.
138-1	32282-32293	Within‐site	_
138-2	32294-32308	classification	_
138-3	32309-32320	performance	_
138-4	32321-32324	For	_
138-5	32325-32339	classification	_
138-6	32340-32345	based	_
138-7	32346-32348	on	_
138-8	32349-32359	individual	_
138-9	32360-32368	features	_
138-10	32368-32369	,	_
138-11	32370-32373	the	_
138-12	32374-32386	performances	_
138-13	32387-32396	including	_
138-14	32397-32405	accuracy	_
138-15	32405-32406	,	_
138-16	32407-32418	sensitivity	_
138-17	32418-32419	,	_
138-18	32420-32423	and	_
138-19	32424-32435	specificity	_
138-20	32436-32438	of	_
138-21	32439-32443	each	_
138-22	32444-32453	component	_
138-23	32454-32457	are	_
138-24	32458-32463	shown	_
138-25	32464-32466	in	_
138-26	32467-32472	Table	_
138-27	32473-32474	5	_
138-28	32474-32475	.	_

#Text=We found that the basal ganglia (the fifth feature) achieved the highest accuracy (0.706).
139-1	32476-32478	We	_
139-2	32479-32484	found	_
139-3	32485-32489	that	_
139-4	32490-32493	the	_
139-5	32494-32499	basal	_
139-6	32500-32507	ganglia	_
139-7	32508-32509	(	_
139-8	32509-32512	the	_
139-9	32513-32518	fifth	_
139-10	32519-32526	feature	_
139-11	32526-32527	)	_
139-12	32528-32536	achieved	_
139-13	32537-32540	the	_
139-14	32541-32548	highest	_
139-15	32549-32557	accuracy	_
139-16	32558-32559	(	_
139-17	32559-32564	0.706	_
139-18	32564-32565	)	_
139-19	32565-32566	.	_

#Text=The occipital lateral cortex (the first feature), the fusiform gyrus (the fourth feature), the temporal lobe (the eighth feature), the middle cingulate gyrus (the 10th feature), and the precuneus (the 16th feature) achieved a similar accuracy.
140-1	32567-32570	The	_
140-2	32571-32580	occipital	_
140-3	32581-32588	lateral	_
140-4	32589-32595	cortex	_
140-5	32596-32597	(	_
140-6	32597-32600	the	_
140-7	32601-32606	first	_
140-8	32607-32614	feature	_
140-9	32614-32615	)	_
140-10	32615-32616	,	_
140-11	32617-32620	the	_
140-12	32621-32629	fusiform	_
140-13	32630-32635	gyrus	_
140-14	32636-32637	(	_
140-15	32637-32640	the	_
140-16	32641-32647	fourth	_
140-17	32648-32655	feature	_
140-18	32655-32656	)	_
140-19	32656-32657	,	_
140-20	32658-32661	the	_
140-21	32662-32670	temporal	_
140-22	32671-32675	lobe	_
140-23	32676-32677	(	_
140-24	32677-32680	the	_
140-25	32681-32687	eighth	_
140-26	32688-32695	feature	_
140-27	32695-32696	)	_
140-28	32696-32697	,	_
140-29	32698-32701	the	_
140-30	32702-32708	middle	_
140-31	32709-32718	cingulate	_
140-32	32719-32724	gyrus	_
140-33	32725-32726	(	_
140-34	32726-32729	the	_
140-35	32730-32734	10th	_
140-36	32735-32742	feature	_
140-37	32742-32743	)	_
140-38	32743-32744	,	_
140-39	32745-32748	and	_
140-40	32749-32752	the	_
140-41	32753-32762	precuneus	_
140-42	32763-32764	(	_
140-43	32764-32767	the	_
140-44	32768-32772	16th	_
140-45	32773-32780	feature	_
140-46	32780-32781	)	_
140-47	32782-32790	achieved	_
140-48	32791-32792	a	_
140-49	32793-32800	similar	_
140-50	32801-32809	accuracy	_
140-51	32809-32810	.	_

#Text=However, the accuracy of the posterior DMN (the ninth feature) and the DMN (the 15th feature) was lower than random chance.
141-1	32811-32818	However	_
141-2	32818-32819	,	_
141-3	32820-32823	the	_
141-4	32824-32832	accuracy	_
141-5	32833-32835	of	_
141-6	32836-32839	the	_
141-7	32840-32849	posterior	_
141-8	32850-32853	DMN	_
141-9	32854-32855	(	_
141-10	32855-32858	the	_
141-11	32859-32864	ninth	_
141-12	32865-32872	feature	_
141-13	32872-32873	)	_
141-14	32874-32877	and	_
141-15	32878-32881	the	_
141-16	32882-32885	DMN	_
141-17	32886-32887	(	_
141-18	32887-32890	the	_
141-19	32891-32895	15th	_
141-20	32896-32903	feature	_
141-21	32903-32904	)	_
141-22	32905-32908	was	_
141-23	32909-32914	lower	_
141-24	32915-32919	than	_
141-25	32920-32926	random	_
141-26	32927-32933	chance	_
141-27	32933-32934	.	_

#Text=The sensitivity across all features was close to or lower than 0.5, while the specificity across all features was close to or higher than 0.5.
142-1	32935-32938	The	_
142-2	32939-32950	sensitivity	_
142-3	32951-32957	across	_
142-4	32958-32961	all	_
142-5	32962-32970	features	_
142-6	32971-32974	was	_
142-7	32975-32980	close	_
142-8	32981-32983	to	_
142-9	32984-32986	or	_
142-10	32987-32992	lower	_
142-11	32993-32997	than	_
142-12	32998-33001	0.5	_
142-13	33001-33002	,	_
142-14	33003-33008	while	_
142-15	33009-33012	the	_
142-16	33013-33024	specificity	_
142-17	33025-33031	across	_
142-18	33032-33035	all	_
142-19	33036-33044	features	_
142-20	33045-33048	was	_
142-21	33049-33054	close	_
142-22	33055-33057	to	_
142-23	33058-33060	or	_
142-24	33061-33067	higher	_
142-25	33068-33072	than	_
142-26	33073-33076	0.5	_
142-27	33076-33077	.	_

#Text=When combining all 16 features, majority voting achieved a classification accuracy of 0.725, a sensitivity of 0.569, and a specificity of 0.882.
143-1	33078-33082	When	_
143-2	33083-33092	combining	_
143-3	33093-33096	all	_
143-4	33097-33099	16	_
143-5	33100-33108	features	_
143-6	33108-33109	,	_
143-7	33110-33118	majority	_
143-8	33119-33125	voting	_
143-9	33126-33134	achieved	_
143-10	33135-33136	a	_
143-11	33137-33151	classification	_
143-12	33152-33160	accuracy	_
143-13	33161-33163	of	_
143-14	33164-33169	0.725	_
143-15	33169-33170	,	_
143-16	33171-33172	a	_
143-17	33173-33184	sensitivity	_
143-18	33185-33187	of	_
143-19	33188-33193	0.569	_
143-20	33193-33194	,	_
143-21	33195-33198	and	_
143-22	33199-33200	a	_
143-23	33201-33212	specificity	_
143-24	33213-33215	of	_
143-25	33216-33221	0.882	_
143-26	33221-33222	.	_

#Text=Between‐site classification performance
#Text=Between‐site generalizability was assessed using the template of spatial components from the main data set.
144-1	33223-33235	Between‐site	_
144-2	33236-33250	classification	_
144-3	33251-33262	performance	_
144-4	33263-33275	Between‐site	_
144-5	33276-33292	generalizability	_
144-6	33293-33296	was	_
144-7	33297-33305	assessed	_
144-8	33306-33311	using	_
144-9	33312-33315	the	_
144-10	33316-33324	template	_
144-11	33325-33327	of	_
144-12	33328-33335	spatial	_
144-13	33336-33346	components	_
144-14	33347-33351	from	_
144-15	33352-33355	the	_
144-16	33356-33360	main	_
144-17	33361-33365	data	_
144-18	33366-33369	set	_
144-19	33369-33370	.	_

#Text=We found that accuracy in general decreased to the random level for classification from each selected component (see Table 4 and Figure 3).
145-1	33371-33373	We	_
145-2	33374-33379	found	_
145-3	33380-33384	that	_
145-4	33385-33393	accuracy	_
145-5	33394-33396	in	_
145-6	33397-33404	general	_
145-7	33405-33414	decreased	_
145-8	33415-33417	to	_
145-9	33418-33421	the	_
145-10	33422-33428	random	_
145-11	33429-33434	level	_
145-12	33435-33438	for	_
145-13	33439-33453	classification	_
145-14	33454-33458	from	_
145-15	33459-33463	each	_
145-16	33464-33472	selected	_
145-17	33473-33482	component	_
145-18	33483-33484	(	_
145-19	33484-33487	see	_
145-20	33488-33493	Table	_
145-21	33494-33495	4	_
145-22	33496-33499	and	_
145-23	33500-33506	Figure	_
145-24	33507-33508	3	_
145-25	33508-33509	)	_
145-26	33509-33510	.	_

#Text=When all 16 features were combined by majority voting, the performance was worse compared to the within‐site performance evaluated by internal validation, with an accuracy of 0.550, a sensitivity of 0.394 and a specificity of 0.741.
146-1	33511-33515	When	_
146-2	33516-33519	all	_
146-3	33520-33522	16	_
146-4	33523-33531	features	_
146-5	33532-33536	were	_
146-6	33537-33545	combined	_
146-7	33546-33548	by	_
146-8	33549-33557	majority	_
146-9	33558-33564	voting	_
146-10	33564-33565	,	_
146-11	33566-33569	the	_
146-12	33570-33581	performance	_
146-13	33582-33585	was	_
146-14	33586-33591	worse	_
146-15	33592-33600	compared	_
146-16	33601-33603	to	_
146-17	33604-33607	the	_
146-18	33608-33619	within‐site	_
146-19	33620-33631	performance	_
146-20	33632-33641	evaluated	_
146-21	33642-33644	by	_
146-22	33645-33653	internal	_
146-23	33654-33664	validation	_
146-24	33664-33665	,	_
146-25	33666-33670	with	_
146-26	33671-33673	an	_
146-27	33674-33682	accuracy	_
146-28	33683-33685	of	_
146-29	33686-33691	0.550	_
146-30	33691-33692	,	_
146-31	33693-33694	a	_
146-32	33695-33706	sensitivity	_
146-33	33707-33709	of	_
146-34	33710-33715	0.394	_
146-35	33716-33719	and	_
146-36	33720-33721	a	_
146-37	33722-33733	specificity	_
146-38	33734-33736	of	_
146-39	33737-33742	0.741	_
146-40	33742-33743	.	_

#Text=Random permutation test showed that the accuracy failed to reach statistical significance, with a p value of .183.
147-1	33744-33750	Random	_
147-2	33751-33762	permutation	_
147-3	33763-33767	test	_
147-4	33768-33774	showed	_
147-5	33775-33779	that	_
147-6	33780-33783	the	_
147-7	33784-33792	accuracy	_
147-8	33793-33799	failed	_
147-9	33800-33802	to	_
147-10	33803-33808	reach	_
147-11	33809-33820	statistical	_
147-12	33821-33833	significance	_
147-13	33833-33834	,	_
147-14	33835-33839	with	_
147-15	33840-33841	a	_
147-16	33842-33843	p	_
147-17	33844-33849	value	_
147-18	33850-33852	of	_
147-19	33853-33857	.183	_
147-20	33857-33858	.	_

#Text=Accuracy, sensitivity, and specificity based on individual features.
148-1	33859-33867	Accuracy	_
148-2	33867-33868	,	_
148-3	33869-33880	sensitivity	_
148-4	33880-33881	,	_
148-5	33882-33885	and	_
148-6	33886-33897	specificity	_
148-7	33898-33903	based	_
148-8	33904-33906	on	_
148-9	33907-33917	individual	_
148-10	33918-33926	features	_
148-11	33926-33927	.	_

#Text=Internal validation was conducted within the main data set, external validation1 was conducted by directly applying the classification procedure from the main data set to the validated data set, and external validation2 was conducted using an updated group ICA across both data sets but with all other steps being identical
#Text=For the between‐site generalizability by external validation using ICA across both data sets, we found that the performance was similar to the within‐site classification performance for each selected component (see Table 5 and Figure 3).
149-1	33928-33936	Internal	_
149-2	33937-33947	validation	_
149-3	33948-33951	was	_
149-4	33952-33961	conducted	_
149-5	33962-33968	within	_
149-6	33969-33972	the	_
149-7	33973-33977	main	_
149-8	33978-33982	data	_
149-9	33983-33986	set	_
149-10	33986-33987	,	_
149-11	33988-33996	external	_
149-12	33997-34008	validation1	_
149-13	34009-34012	was	_
149-14	34013-34022	conducted	_
149-15	34023-34025	by	_
149-16	34026-34034	directly	_
149-17	34035-34043	applying	_
149-18	34044-34047	the	_
149-19	34048-34062	classification	_
149-20	34063-34072	procedure	_
149-21	34073-34077	from	_
149-22	34078-34081	the	_
149-23	34082-34086	main	_
149-24	34087-34091	data	_
149-25	34092-34095	set	_
149-26	34096-34098	to	_
149-27	34099-34102	the	_
149-28	34103-34112	validated	_
149-29	34113-34117	data	_
149-30	34118-34121	set	_
149-31	34121-34122	,	_
149-32	34123-34126	and	_
149-33	34127-34135	external	_
149-34	34136-34147	validation2	_
149-35	34148-34151	was	_
149-36	34152-34161	conducted	_
149-37	34162-34167	using	_
149-38	34168-34170	an	_
149-39	34171-34178	updated	_
149-40	34179-34184	group	_
149-41	34185-34188	ICA	_
149-42	34189-34195	across	_
149-43	34196-34200	both	_
149-44	34201-34205	data	_
149-45	34206-34210	sets	_
149-46	34211-34214	but	_
149-47	34215-34219	with	_
149-48	34220-34223	all	_
149-49	34224-34229	other	_
149-50	34230-34235	steps	_
149-51	34236-34241	being	_
149-52	34242-34251	identical	_
149-53	34252-34255	For	_
149-54	34256-34259	the	_
149-55	34260-34272	between‐site	_
149-56	34273-34289	generalizability	_
149-57	34290-34292	by	_
149-58	34293-34301	external	_
149-59	34302-34312	validation	_
149-60	34313-34318	using	_
149-61	34319-34322	ICA	_
149-62	34323-34329	across	_
149-63	34330-34334	both	_
149-64	34335-34339	data	_
149-65	34340-34344	sets	_
149-66	34344-34345	,	_
149-67	34346-34348	we	_
149-68	34349-34354	found	_
149-69	34355-34359	that	_
149-70	34360-34363	the	_
149-71	34364-34375	performance	_
149-72	34376-34379	was	_
149-73	34380-34387	similar	_
149-74	34388-34390	to	_
149-75	34391-34394	the	_
149-76	34395-34406	within‐site	_
149-77	34407-34421	classification	_
149-78	34422-34433	performance	_
149-79	34434-34437	for	_
149-80	34438-34442	each	_
149-81	34443-34451	selected	_
149-82	34452-34461	component	_
149-83	34462-34463	(	_
149-84	34463-34466	see	_
149-85	34467-34472	Table	_
149-86	34473-34474	5	_
149-87	34475-34478	and	_
149-88	34479-34485	Figure	_
149-89	34486-34487	3	_
149-90	34487-34488	)	_
149-91	34488-34489	.	_

#Text=When all 16 features were combined by majority voting, the performance remained similar to the first classification, with an accuracy of 0.700, a sensitivity of 0.636 and a specificity of 0.778.
150-1	34490-34494	When	_
150-2	34495-34498	all	_
150-3	34499-34501	16	_
150-4	34502-34510	features	_
150-5	34511-34515	were	_
150-6	34516-34524	combined	_
150-7	34525-34527	by	_
150-8	34528-34536	majority	_
150-9	34537-34543	voting	_
150-10	34543-34544	,	_
150-11	34545-34548	the	_
150-12	34549-34560	performance	_
150-13	34561-34569	remained	_
150-14	34570-34577	similar	_
150-15	34578-34580	to	_
150-16	34581-34584	the	_
150-17	34585-34590	first	_
150-18	34591-34605	classification	_
150-19	34605-34606	,	_
150-20	34607-34611	with	_
150-21	34612-34614	an	_
150-22	34615-34623	accuracy	_
150-23	34624-34626	of	_
150-24	34627-34632	0.700	_
150-25	34632-34633	,	_
150-26	34634-34635	a	_
150-27	34636-34647	sensitivity	_
150-28	34648-34650	of	_
150-29	34651-34656	0.636	_
150-30	34657-34660	and	_
150-31	34661-34662	a	_
150-32	34663-34674	specificity	_
150-33	34675-34677	of	_
150-34	34678-34683	0.778	_
150-35	34683-34684	.	_

#Text=Random permutation test revealed that the accuracy was statistically significant, with a p value of .0005.
151-1	34685-34691	Random	_
151-2	34692-34703	permutation	_
151-3	34704-34708	test	_
151-4	34709-34717	revealed	_
151-5	34718-34722	that	_
151-6	34723-34726	the	_
151-7	34727-34735	accuracy	_
151-8	34736-34739	was	_
151-9	34740-34753	statistically	_
151-10	34754-34765	significant	_
151-11	34765-34766	,	_
151-12	34767-34771	with	_
151-13	34772-34773	a	_
151-14	34774-34775	p	_
151-15	34776-34781	value	_
151-16	34782-34784	of	_
151-17	34785-34790	.0005	_
151-18	34790-34791	.	_

#Text=DISCUSSION
#Text=Classification performance compared with the previous study through LOO
#Text=In this study, we first followed a machine learning procedure developed by Du et al. (2012) using rsfMRI data from a sample of schizophrenia patients and healthy controls to assess the within‐site generalizability and the reproducibility of the machine learning procedure.
152-1	34792-34802	DISCUSSION	_
152-2	34803-34817	Classification	_
152-3	34818-34829	performance	_
152-4	34830-34838	compared	_
152-5	34839-34843	with	_
152-6	34844-34847	the	_
152-7	34848-34856	previous	_
152-8	34857-34862	study	_
152-9	34863-34870	through	_
152-10	34871-34874	LOO	_
152-11	34875-34877	In	_
152-12	34878-34882	this	_
152-13	34883-34888	study	_
152-14	34888-34889	,	_
152-15	34890-34892	we	_
152-16	34893-34898	first	_
152-17	34899-34907	followed	_
152-18	34908-34909	a	_
152-19	34910-34917	machine	_
152-20	34918-34926	learning	_
152-21	34927-34936	procedure	_
152-22	34937-34946	developed	_
152-23	34947-34949	by	_
152-24	34950-34952	Du	_
152-25	34953-34955	et	_
152-26	34956-34958	al	_
152-27	34958-34959	.	_
152-28	34960-34961	(	_
152-29	34961-34965	2012	_
152-30	34965-34966	)	_
152-31	34967-34972	using	_
152-32	34973-34979	rsfMRI	_
152-33	34980-34984	data	_
152-34	34985-34989	from	_
152-35	34990-34991	a	_
152-36	34992-34998	sample	_
152-37	34999-35001	of	_
152-38	35002-35015	schizophrenia	_
152-39	35016-35024	patients	_
152-40	35025-35028	and	_
152-41	35029-35036	healthy	_
152-42	35037-35045	controls	_
152-43	35046-35048	to	_
152-44	35049-35055	assess	_
152-45	35056-35059	the	_
152-46	35060-35071	within‐site	_
152-47	35072-35088	generalizability	_
152-48	35089-35092	and	_
152-49	35093-35096	the	_
152-50	35097-35112	reproducibility	_
152-51	35113-35115	of	_
152-52	35116-35119	the	_
152-53	35120-35127	machine	_
152-54	35128-35136	learning	_
152-55	35137-35146	procedure	_
152-56	35146-35147	.	_

#Text=The classification followed the same feature extraction, feature selection, and LOO validation steps as Du et al. (2012).
153-1	35148-35151	The	_
153-2	35152-35166	classification	_
153-3	35167-35175	followed	_
153-4	35176-35179	the	_
153-5	35180-35184	same	_
153-6	35185-35192	feature	_
153-7	35193-35203	extraction	_
153-8	35203-35204	,	_
153-9	35205-35212	feature	_
153-10	35213-35222	selection	_
153-11	35222-35223	,	_
153-12	35224-35227	and	_
153-13	35228-35231	LOO	_
153-14	35232-35242	validation	_
153-15	35243-35248	steps	_
153-16	35249-35251	as	_
153-17	35252-35254	Du	_
153-18	35255-35257	et	_
153-19	35258-35260	al	_
153-20	35260-35261	.	_
153-21	35262-35263	(	_
153-22	35263-35267	2012	_
153-23	35267-35268	)	_
153-24	35268-35269	.	_

#Text=We found that based on individual features, the highest classification accuracy was 0.706, while the classification accuracy was 0.725 when all selected components were combined.
154-1	35270-35272	We	_
154-2	35273-35278	found	_
154-3	35279-35283	that	_
154-4	35284-35289	based	_
154-5	35290-35292	on	_
154-6	35293-35303	individual	_
154-7	35304-35312	features	_
154-8	35312-35313	,	_
154-9	35314-35317	the	_
154-10	35318-35325	highest	_
154-11	35326-35340	classification	_
154-12	35341-35349	accuracy	_
154-13	35350-35353	was	_
154-14	35354-35359	0.706	_
154-15	35359-35360	,	_
154-16	35361-35366	while	_
154-17	35367-35370	the	_
154-18	35371-35385	classification	_
154-19	35386-35394	accuracy	_
154-20	35395-35398	was	_
154-21	35399-35404	0.725	_
154-22	35405-35409	when	_
154-23	35410-35413	all	_
154-24	35414-35422	selected	_
154-25	35423-35433	components	_
154-26	35434-35438	were	_
154-27	35439-35447	combined	_
154-28	35447-35448	.	_

#Text=To establish correspondence with Du et al.'
155-1	35449-35451	To	_
155-2	35452-35461	establish	_
155-3	35462-35476	correspondence	_
155-4	35477-35481	with	_
155-5	35482-35484	Du	_
155-6	35485-35487	et	_
155-7	35488-35490	al	_
155-8	35490-35491	.	_
155-9	35491-35492	'	_

#Text=s (2012) study, the performance of individual components can be found in Table 5.
156-1	35492-35493	s	_
156-2	35494-35495	(	_
156-3	35495-35499	2012	_
156-4	35499-35500	)	_
156-5	35501-35506	study	_
156-6	35506-35507	,	_
156-7	35508-35511	the	_
156-8	35512-35523	performance	_
156-9	35524-35526	of	_
156-10	35527-35537	individual	_
156-11	35538-35548	components	_
156-12	35549-35552	can	_
156-13	35553-35555	be	_
156-14	35556-35561	found	_
156-15	35562-35564	in	_
156-16	35565-35570	Table	_
156-17	35571-35572	5	_
156-18	35572-35573	.	_

#Text=Since testing individual components or combinations of those would result in multiple comparisons and the classification results using individual components were less stable than the result from majority voting, we focused on the results obtained from majority voting across all 16 components to avoid overinterpretation.
157-1	35574-35579	Since	_
157-2	35580-35587	testing	_
157-3	35588-35598	individual	_
157-4	35599-35609	components	_
157-5	35610-35612	or	_
157-6	35613-35625	combinations	_
157-7	35626-35628	of	_
157-8	35629-35634	those	_
157-9	35635-35640	would	_
157-10	35641-35647	result	_
157-11	35648-35650	in	_
157-12	35651-35659	multiple	_
157-13	35660-35671	comparisons	_
157-14	35672-35675	and	_
157-15	35676-35679	the	_
157-16	35680-35694	classification	_
157-17	35695-35702	results	_
157-18	35703-35708	using	_
157-19	35709-35719	individual	_
157-20	35720-35730	components	_
157-21	35731-35735	were	_
157-22	35736-35740	less	_
157-23	35741-35747	stable	_
157-24	35748-35752	than	_
157-25	35753-35756	the	_
157-26	35757-35763	result	_
157-27	35764-35768	from	_
157-28	35769-35777	majority	_
157-29	35778-35784	voting	_
157-30	35784-35785	,	_
157-31	35786-35788	we	_
157-32	35789-35796	focused	_
157-33	35797-35799	on	_
157-34	35800-35803	the	_
157-35	35804-35811	results	_
157-36	35812-35820	obtained	_
157-37	35821-35825	from	_
157-38	35826-35834	majority	_
157-39	35835-35841	voting	_
157-40	35842-35848	across	_
157-41	35849-35852	all	_
157-42	35853-35855	16	_
157-43	35856-35866	components	_
157-44	35867-35869	to	_
157-45	35870-35875	avoid	_
157-46	35876-35894	overinterpretation	_
157-47	35894-35895	.	_

#Text=Although the accuracy in the present study is not as high as the results from Du et al. (2012), compared with the overall reported accuracy of 65–95% in the field (Anderson & Cohen, 2013; Bassett et al., 2012; Fan et al., 2011; Su et al., 2013; Venkataraman et al., 2012), our results support the reproducibility of the machine learning procedure which can successfully discriminate patients with schizophrenia from healthy controls.
158-1	35896-35904	Although	_
158-2	35905-35908	the	_
158-3	35909-35917	accuracy	_
158-4	35918-35920	in	_
158-5	35921-35924	the	_
158-6	35925-35932	present	_
158-7	35933-35938	study	_
158-8	35939-35941	is	_
158-9	35942-35945	not	_
158-10	35946-35948	as	_
158-11	35949-35953	high	_
158-12	35954-35956	as	_
158-13	35957-35960	the	_
158-14	35961-35968	results	_
158-15	35969-35973	from	_
158-16	35974-35976	Du	_
158-17	35977-35979	et	_
158-18	35980-35982	al	_
158-19	35982-35983	.	_
158-20	35984-35985	(	_
158-21	35985-35989	2012	_
158-22	35989-35990	)	_
158-23	35990-35991	,	_
158-24	35992-36000	compared	_
158-25	36001-36005	with	_
158-26	36006-36009	the	_
158-27	36010-36017	overall	_
158-28	36018-36026	reported	_
158-29	36027-36035	accuracy	_
158-30	36036-36038	of	_
158-31	36039-36041	65	_
158-32	36041-36042	–	_
158-33	36042-36045	95%	_
158-34	36046-36048	in	_
158-35	36049-36052	the	_
158-36	36053-36058	field	_
158-37	36059-36060	(	_
158-38	36060-36068	Anderson	_
158-39	36069-36070	&	_
158-40	36071-36076	Cohen	_
158-41	36076-36077	,	_
158-42	36078-36082	2013	_
158-43	36082-36083	;	_
158-44	36084-36091	Bassett	_
158-45	36092-36094	et	_
158-46	36095-36097	al	_
158-47	36097-36098	.	_
158-48	36098-36099	,	_
158-49	36100-36104	2012	_
158-50	36104-36105	;	_
158-51	36106-36109	Fan	_
158-52	36110-36112	et	_
158-53	36113-36115	al	_
158-54	36115-36116	.	_
158-55	36116-36117	,	_
158-56	36118-36122	2011	_
158-57	36122-36123	;	_
158-58	36124-36126	Su	_
158-59	36127-36129	et	_
158-60	36130-36132	al	_
158-61	36132-36133	.	_
158-62	36133-36134	,	_
158-63	36135-36139	2013	_
158-64	36139-36140	;	_
158-65	36141-36153	Venkataraman	_
158-66	36154-36156	et	_
158-67	36157-36159	al	_
158-68	36159-36160	.	_
158-69	36160-36161	,	_
158-70	36162-36166	2012	_
158-71	36166-36167	)	_
158-72	36167-36168	,	_
158-73	36169-36172	our	_
158-74	36173-36180	results	_
158-75	36181-36188	support	_
158-76	36189-36192	the	_
158-77	36193-36208	reproducibility	_
158-78	36209-36211	of	_
158-79	36212-36215	the	_
158-80	36216-36223	machine	_
158-81	36224-36232	learning	_
158-82	36233-36242	procedure	_
158-83	36243-36248	which	_
158-84	36249-36252	can	_
158-85	36253-36265	successfully	_
158-86	36266-36278	discriminate	_
158-87	36279-36287	patients	_
158-88	36288-36292	with	_
158-89	36293-36306	schizophrenia	_
158-90	36307-36311	from	_
158-91	36312-36319	healthy	_
158-92	36320-36328	controls	_
158-93	36328-36329	.	_

#Text=Several factors may explain the reduced within‐site generalizability we found.
159-1	36330-36337	Several	_
159-2	36338-36345	factors	_
159-3	36346-36349	may	_
159-4	36350-36357	explain	_
159-5	36358-36361	the	_
159-6	36362-36369	reduced	_
159-7	36370-36381	within‐site	_
159-8	36382-36398	generalizability	_
159-9	36399-36401	we	_
159-10	36402-36407	found	_
159-11	36407-36408	.	_

#Text=First, 51 pairs of participants were recruited for LOO validation in our study, but Du et al.'
160-1	36409-36414	First	_
160-2	36414-36415	,	_
160-3	36416-36418	51	_
160-4	36419-36424	pairs	_
160-5	36425-36427	of	_
160-6	36428-36440	participants	_
160-7	36441-36445	were	_
160-8	36446-36455	recruited	_
160-9	36456-36459	for	_
160-10	36460-36463	LOO	_
160-11	36464-36474	validation	_
160-12	36475-36477	in	_
160-13	36478-36481	our	_
160-14	36482-36487	study	_
160-15	36487-36488	,	_
160-16	36489-36492	but	_
160-17	36493-36495	Du	_
160-18	36496-36498	et	_
160-19	36499-36501	al	_
160-20	36501-36502	.	_
160-21	36502-36503	'	_

#Text=s study only had 28 pairs.
161-1	36503-36504	s	_
161-2	36505-36510	study	_
161-3	36511-36515	only	_
161-4	36516-36519	had	_
161-5	36520-36522	28	_
161-6	36523-36528	pairs	_
161-7	36528-36529	.	_

#Text=The smaller sample size in Du et al.'
162-1	36530-36533	The	_
162-2	36534-36541	smaller	_
162-3	36542-36548	sample	_
162-4	36549-36553	size	_
162-5	36554-36556	in	_
162-6	36557-36559	Du	_
162-7	36560-36562	et	_
162-8	36563-36565	al	_
162-9	36565-36566	.	_
162-10	36566-36567	'	_

#Text=s study in the context of analyzing high‐dimensional imaging data could easily lead to overfitting of the predictive model to their data set (Mwangi, Tian, & Soares, 2014).
163-1	36567-36568	s	_
163-2	36569-36574	study	_
163-3	36575-36577	in	_
163-4	36578-36581	the	_
163-5	36582-36589	context	_
163-6	36590-36592	of	_
163-7	36593-36602	analyzing	_
163-8	36603-36619	high‐dimensional	_
163-9	36620-36627	imaging	_
163-10	36628-36632	data	_
163-11	36633-36638	could	_
163-12	36639-36645	easily	_
163-13	36646-36650	lead	_
163-14	36651-36653	to	_
163-15	36654-36665	overfitting	_
163-16	36666-36668	of	_
163-17	36669-36672	the	_
163-18	36673-36683	predictive	_
163-19	36684-36689	model	_
163-20	36690-36692	to	_
163-21	36693-36698	their	_
163-22	36699-36703	data	_
163-23	36704-36707	set	_
163-24	36708-36709	(	_
163-25	36709-36715	Mwangi	_
163-26	36715-36716	,	_
163-27	36717-36721	Tian	_
163-28	36721-36722	,	_
163-29	36723-36724	&	_
163-30	36725-36731	Soares	_
163-31	36731-36732	,	_
163-32	36733-36737	2014	_
163-33	36737-36738	)	_
163-34	36738-36739	.	_

#Text=Second, the longer illness duration and lower symptom severity of our patients might have introduced more heterogeneity into the profile of participants (an der Heiden & Hafner, 2000; Irani, Kalkstein, Moberg, & Moberg, 2011), making it more difficult to identify patterns that are directly related to the disorder in question.
164-1	36740-36746	Second	_
164-2	36746-36747	,	_
164-3	36748-36751	the	_
164-4	36752-36758	longer	_
164-5	36759-36766	illness	_
164-6	36767-36775	duration	_
164-7	36776-36779	and	_
164-8	36780-36785	lower	_
164-9	36786-36793	symptom	_
164-10	36794-36802	severity	_
164-11	36803-36805	of	_
164-12	36806-36809	our	_
164-13	36810-36818	patients	_
164-14	36819-36824	might	_
164-15	36825-36829	have	_
164-16	36830-36840	introduced	_
164-17	36841-36845	more	_
164-18	36846-36859	heterogeneity	_
164-19	36860-36864	into	_
164-20	36865-36868	the	_
164-21	36869-36876	profile	_
164-22	36877-36879	of	_
164-23	36880-36892	participants	_
164-24	36893-36894	(	_
164-25	36894-36896	an	_
164-26	36897-36900	der	_
164-27	36901-36907	Heiden	_
164-28	36908-36909	&	_
164-29	36910-36916	Hafner	_
164-30	36916-36917	,	_
164-31	36918-36922	2000	_
164-32	36922-36923	;	_
164-33	36924-36929	Irani	_
164-34	36929-36930	,	_
164-35	36931-36940	Kalkstein	_
164-36	36940-36941	,	_
164-37	36942-36948	Moberg	_
164-38	36948-36949	,	_
164-39	36950-36951	&	_
164-40	36952-36958	Moberg	_
164-41	36958-36959	,	_
164-42	36960-36964	2011	_
164-43	36964-36965	)	_
164-44	36965-36966	,	_
164-45	36967-36973	making	_
164-46	36974-36976	it	_
164-47	36977-36981	more	_
164-48	36982-36991	difficult	_
164-49	36992-36994	to	_
164-50	36995-37003	identify	_
164-51	37004-37012	patterns	_
164-52	37013-37017	that	_
164-53	37018-37021	are	_
164-54	37022-37030	directly	_
164-55	37031-37038	related	_
164-56	37039-37041	to	_
164-57	37042-37045	the	_
164-58	37046-37054	disorder	_
164-59	37055-37057	in	_
164-60	37058-37066	question	_
164-61	37066-37067	.	_

#Text=Finally, although comprehensive preprocessing was performed to reduce noise and limit the effect of artifacts on the analysis (Churchill et al., 2011), these confounding factors could still persist and could affect the classification performance.
165-1	37068-37075	Finally	_
165-2	37075-37076	,	_
165-3	37077-37085	although	_
165-4	37086-37099	comprehensive	_
165-5	37100-37113	preprocessing	_
165-6	37114-37117	was	_
165-7	37118-37127	performed	_
165-8	37128-37130	to	_
165-9	37131-37137	reduce	_
165-10	37138-37143	noise	_
165-11	37144-37147	and	_
165-12	37148-37153	limit	_
165-13	37154-37157	the	_
165-14	37158-37164	effect	_
165-15	37165-37167	of	_
165-16	37168-37177	artifacts	_
165-17	37178-37180	on	_
165-18	37181-37184	the	_
165-19	37185-37193	analysis	_
165-20	37194-37195	(	_
165-21	37195-37204	Churchill	_
165-22	37205-37207	et	_
165-23	37208-37210	al	_
165-24	37210-37211	.	_
165-25	37211-37212	,	_
165-26	37213-37217	2011	_
165-27	37217-37218	)	_
165-28	37218-37219	,	_
165-29	37220-37225	these	_
165-30	37226-37237	confounding	_
165-31	37238-37245	factors	_
165-32	37246-37251	could	_
165-33	37252-37257	still	_
165-34	37258-37265	persist	_
165-35	37266-37269	and	_
165-36	37270-37275	could	_
165-37	37276-37282	affect	_
165-38	37283-37286	the	_
165-39	37287-37301	classification	_
165-40	37302-37313	performance	_
165-41	37313-37314	.	_

#Text=Implication of between‐site generalizability
#Text=When assessing between‐site generalizability in two completely independent data sets from two sites, we obtained a nonsignificant accuracy of 0.550 and a significant accuracy of 0.700 based on all selected features when applying a template of spatial components built based on only the main data set and both data sets, respectively.
166-1	37315-37326	Implication	_
166-2	37327-37329	of	_
166-3	37330-37342	between‐site	_
166-4	37343-37359	generalizability	_
166-5	37360-37364	When	_
166-6	37365-37374	assessing	_
166-7	37375-37387	between‐site	_
166-8	37388-37404	generalizability	_
166-9	37405-37407	in	_
166-10	37408-37411	two	_
166-11	37412-37422	completely	_
166-12	37423-37434	independent	_
166-13	37435-37439	data	_
166-14	37440-37444	sets	_
166-15	37445-37449	from	_
166-16	37450-37453	two	_
166-17	37454-37459	sites	_
166-18	37459-37460	,	_
166-19	37461-37463	we	_
166-20	37464-37472	obtained	_
166-21	37473-37474	a	_
166-22	37475-37489	nonsignificant	_
166-23	37490-37498	accuracy	_
166-24	37499-37501	of	_
166-25	37502-37507	0.550	_
166-26	37508-37511	and	_
166-27	37512-37513	a	_
166-28	37514-37525	significant	_
166-29	37526-37534	accuracy	_
166-30	37535-37537	of	_
166-31	37538-37543	0.700	_
166-32	37544-37549	based	_
166-33	37550-37552	on	_
166-34	37553-37556	all	_
166-35	37557-37565	selected	_
166-36	37566-37574	features	_
166-37	37575-37579	when	_
166-38	37580-37588	applying	_
166-39	37589-37590	a	_
166-40	37591-37599	template	_
166-41	37600-37602	of	_
166-42	37603-37610	spatial	_
166-43	37611-37621	components	_
166-44	37622-37627	built	_
166-45	37628-37633	based	_
166-46	37634-37636	on	_
166-47	37637-37641	only	_
166-48	37642-37645	the	_
166-49	37646-37650	main	_
166-50	37651-37655	data	_
166-51	37656-37659	set	_
166-52	37660-37663	and	_
166-53	37664-37668	both	_
166-54	37669-37673	data	_
166-55	37674-37678	sets	_
166-56	37678-37679	,	_
166-57	37680-37692	respectively	_
166-58	37692-37693	.	_

#Text=It is important to note that although the validated data set was utilized with the main data set for generating a new template of spatial components through spatial group ICA, the labels of the validated data set were still kept unseen when training the model to ensure that the training and testing data sets were independent.
167-1	37694-37696	It	_
167-2	37697-37699	is	_
167-3	37700-37709	important	_
167-4	37710-37712	to	_
167-5	37713-37717	note	_
167-6	37718-37722	that	_
167-7	37723-37731	although	_
167-8	37732-37735	the	_
167-9	37736-37745	validated	_
167-10	37746-37750	data	_
167-11	37751-37754	set	_
167-12	37755-37758	was	_
167-13	37759-37767	utilized	_
167-14	37768-37772	with	_
167-15	37773-37776	the	_
167-16	37777-37781	main	_
167-17	37782-37786	data	_
167-18	37787-37790	set	_
167-19	37791-37794	for	_
167-20	37795-37805	generating	_
167-21	37806-37807	a	_
167-22	37808-37811	new	_
167-23	37812-37820	template	_
167-24	37821-37823	of	_
167-25	37824-37831	spatial	_
167-26	37832-37842	components	_
167-27	37843-37850	through	_
167-28	37851-37858	spatial	_
167-29	37859-37864	group	_
167-30	37865-37868	ICA	_
167-31	37868-37869	,	_
167-32	37870-37873	the	_
167-33	37874-37880	labels	_
167-34	37881-37883	of	_
167-35	37884-37887	the	_
167-36	37888-37897	validated	_
167-37	37898-37902	data	_
167-38	37903-37906	set	_
167-39	37907-37911	were	_
167-40	37912-37917	still	_
167-41	37918-37922	kept	_
167-42	37923-37929	unseen	_
167-43	37930-37934	when	_
167-44	37935-37943	training	_
167-45	37944-37947	the	_
167-46	37948-37953	model	_
167-47	37954-37956	to	_
167-48	37957-37963	ensure	_
167-49	37964-37968	that	_
167-50	37969-37972	the	_
167-51	37973-37981	training	_
167-52	37982-37985	and	_
167-53	37986-37993	testing	_
167-54	37994-37998	data	_
167-55	37999-38003	sets	_
167-56	38004-38008	were	_
167-57	38009-38020	independent	_
167-58	38020-38021	.	_

#Text=More importantly, the findings that the predictive model did not successfully generalize to the novel data set when applying the template only based on the training data set but successfully generalized to the independent testing data set when applying the template based on both data sets substantially extends our understanding of the generalizability of machine learning using rsfMRI data.
168-1	38022-38026	More	_
168-2	38027-38038	importantly	_
168-3	38038-38039	,	_
168-4	38040-38043	the	_
168-5	38044-38052	findings	_
168-6	38053-38057	that	_
168-7	38058-38061	the	_
168-8	38062-38072	predictive	_
168-9	38073-38078	model	_
168-10	38079-38082	did	_
168-11	38083-38086	not	_
168-12	38087-38099	successfully	_
168-13	38100-38110	generalize	_
168-14	38111-38113	to	_
168-15	38114-38117	the	_
168-16	38118-38123	novel	_
168-17	38124-38128	data	_
168-18	38129-38132	set	_
168-19	38133-38137	when	_
168-20	38138-38146	applying	_
168-21	38147-38150	the	_
168-22	38151-38159	template	_
168-23	38160-38164	only	_
168-24	38165-38170	based	_
168-25	38171-38173	on	_
168-26	38174-38177	the	_
168-27	38178-38186	training	_
168-28	38187-38191	data	_
168-29	38192-38195	set	_
168-30	38196-38199	but	_
168-31	38200-38212	successfully	_
168-32	38213-38224	generalized	_
168-33	38225-38227	to	_
168-34	38228-38231	the	_
168-35	38232-38243	independent	_
168-36	38244-38251	testing	_
168-37	38252-38256	data	_
168-38	38257-38260	set	_
168-39	38261-38265	when	_
168-40	38266-38274	applying	_
168-41	38275-38278	the	_
168-42	38279-38287	template	_
168-43	38288-38293	based	_
168-44	38294-38296	on	_
168-45	38297-38301	both	_
168-46	38302-38306	data	_
168-47	38307-38311	sets	_
168-48	38312-38325	substantially	_
168-49	38326-38333	extends	_
168-50	38334-38337	our	_
168-51	38338-38351	understanding	_
168-52	38352-38354	of	_
168-53	38355-38358	the	_
168-54	38359-38375	generalizability	_
168-55	38376-38378	of	_
168-56	38379-38386	machine	_
168-57	38387-38395	learning	_
168-58	38396-38401	using	_
168-59	38402-38408	rsfMRI	_
168-60	38409-38413	data	_
168-61	38413-38414	.	_

#Text=Failure to generalize does not necessarily mean that a model is invalid, since multiple factors are different between independent data sets (Scheinost et al., 2019).
169-1	38415-38422	Failure	_
169-2	38423-38425	to	_
169-3	38426-38436	generalize	_
169-4	38437-38441	does	_
169-5	38442-38445	not	_
169-6	38446-38457	necessarily	_
169-7	38458-38462	mean	_
169-8	38463-38467	that	_
169-9	38468-38469	a	_
169-10	38470-38475	model	_
169-11	38476-38478	is	_
169-12	38479-38486	invalid	_
169-13	38486-38487	,	_
169-14	38488-38493	since	_
169-15	38494-38502	multiple	_
169-16	38503-38510	factors	_
169-17	38511-38514	are	_
169-18	38515-38524	different	_
169-19	38525-38532	between	_
169-20	38533-38544	independent	_
169-21	38545-38549	data	_
169-22	38550-38554	sets	_
169-23	38555-38556	(	_
169-24	38556-38565	Scheinost	_
169-25	38566-38568	et	_
169-26	38569-38571	al	_
169-27	38571-38572	.	_
169-28	38572-38573	,	_
169-29	38574-38578	2019	_
169-30	38578-38579	)	_
169-31	38579-38580	.	_

#Text=As indicated in Table 3, the schizophrenia patients in the main data set were significantly older, had significantly higher estimated IQ, longer illness duration and higher PANSS positive subscale score, but significantly lower PANSS total, negative and general subscale scores compared with patients in the validated data set.
170-1	38581-38583	As	_
170-2	38584-38593	indicated	_
170-3	38594-38596	in	_
170-4	38597-38602	Table	_
170-5	38603-38604	3	_
170-6	38604-38605	,	_
170-7	38606-38609	the	_
170-8	38610-38623	schizophrenia	_
170-9	38624-38632	patients	_
170-10	38633-38635	in	_
170-11	38636-38639	the	_
170-12	38640-38644	main	_
170-13	38645-38649	data	_
170-14	38650-38653	set	_
170-15	38654-38658	were	_
170-16	38659-38672	significantly	_
170-17	38673-38678	older	_
170-18	38678-38679	,	_
170-19	38680-38683	had	_
170-20	38684-38697	significantly	_
170-21	38698-38704	higher	_
170-22	38705-38714	estimated	_
170-23	38715-38717	IQ	_
170-24	38717-38718	,	_
170-25	38719-38725	longer	_
170-26	38726-38733	illness	_
170-27	38734-38742	duration	_
170-28	38743-38746	and	_
170-29	38747-38753	higher	_
170-30	38754-38759	PANSS	_
170-31	38760-38768	positive	_
170-32	38769-38777	subscale	_
170-33	38778-38783	score	_
170-34	38783-38784	,	_
170-35	38785-38788	but	_
170-36	38789-38802	significantly	_
170-37	38803-38808	lower	_
170-38	38809-38814	PANSS	_
170-39	38815-38820	total	_
170-40	38820-38821	,	_
170-41	38822-38830	negative	_
170-42	38831-38834	and	_
170-43	38835-38842	general	_
170-44	38843-38851	subscale	_
170-45	38852-38858	scores	_
170-46	38859-38867	compared	_
170-47	38868-38872	with	_
170-48	38873-38881	patients	_
170-49	38882-38884	in	_
170-50	38885-38888	the	_
170-51	38889-38898	validated	_
170-52	38899-38903	data	_
170-53	38904-38907	set	_
170-54	38907-38908	.	_

#Text=In addition, the healthy controls in the main data set had significantly higher estimated IQ than the healthy controls in the validated data set.
171-1	38909-38911	In	_
171-2	38912-38920	addition	_
171-3	38920-38921	,	_
171-4	38922-38925	the	_
171-5	38926-38933	healthy	_
171-6	38934-38942	controls	_
171-7	38943-38945	in	_
171-8	38946-38949	the	_
171-9	38950-38954	main	_
171-10	38955-38959	data	_
171-11	38960-38963	set	_
171-12	38964-38967	had	_
171-13	38968-38981	significantly	_
171-14	38982-38988	higher	_
171-15	38989-38998	estimated	_
171-16	38999-39001	IQ	_
171-17	39002-39006	than	_
171-18	39007-39010	the	_
171-19	39011-39018	healthy	_
171-20	39019-39027	controls	_
171-21	39028-39030	in	_
171-22	39031-39034	the	_
171-23	39035-39044	validated	_
171-24	39045-39049	data	_
171-25	39050-39053	set	_
171-26	39053-39054	.	_

#Text=Such heterogeneity between the two data sets may be one potential factor contributing to the failure in direct generalization.
172-1	39055-39059	Such	_
172-2	39060-39073	heterogeneity	_
172-3	39074-39081	between	_
172-4	39082-39085	the	_
172-5	39086-39089	two	_
172-6	39090-39094	data	_
172-7	39095-39099	sets	_
172-8	39100-39103	may	_
172-9	39104-39106	be	_
172-10	39107-39110	one	_
172-11	39111-39120	potential	_
172-12	39121-39127	factor	_
172-13	39128-39140	contributing	_
172-14	39141-39143	to	_
172-15	39144-39147	the	_
172-16	39148-39155	failure	_
172-17	39156-39158	in	_
172-18	39159-39165	direct	_
172-19	39166-39180	generalization	_
172-20	39180-39181	.	_

#Text=In addition, the two data sets were acquired independently from different scanners with different acquisition parameters, which could further compromise generalizability.
173-1	39182-39184	In	_
173-2	39185-39193	addition	_
173-3	39193-39194	,	_
173-4	39195-39198	the	_
173-5	39199-39202	two	_
173-6	39203-39207	data	_
173-7	39208-39212	sets	_
173-8	39213-39217	were	_
173-9	39218-39226	acquired	_
173-10	39227-39240	independently	_
173-11	39241-39245	from	_
173-12	39246-39255	different	_
173-13	39256-39264	scanners	_
173-14	39265-39269	with	_
173-15	39270-39279	different	_
173-16	39280-39291	acquisition	_
173-17	39292-39302	parameters	_
173-18	39302-39303	,	_
173-19	39304-39309	which	_
173-20	39310-39315	could	_
173-21	39316-39323	further	_
173-22	39324-39334	compromise	_
173-23	39335-39351	generalizability	_
173-24	39351-39352	.	_

#Text=The differences in classification performance highlights the importance of considering differences in the new data when constructing classification models and demonstrates the usefulness of unsupervised transfer learning in this setting.
174-1	39353-39356	The	_
174-2	39357-39368	differences	_
174-3	39369-39371	in	_
174-4	39372-39386	classification	_
174-5	39387-39398	performance	_
174-6	39399-39409	highlights	_
174-7	39410-39413	the	_
174-8	39414-39424	importance	_
174-9	39425-39427	of	_
174-10	39428-39439	considering	_
174-11	39440-39451	differences	_
174-12	39452-39454	in	_
174-13	39455-39458	the	_
174-14	39459-39462	new	_
174-15	39463-39467	data	_
174-16	39468-39472	when	_
174-17	39473-39485	constructing	_
174-18	39486-39500	classification	_
174-19	39501-39507	models	_
174-20	39508-39511	and	_
174-21	39512-39524	demonstrates	_
174-22	39525-39528	the	_
174-23	39529-39539	usefulness	_
174-24	39540-39542	of	_
174-25	39543-39555	unsupervised	_
174-26	39556-39564	transfer	_
174-27	39565-39573	learning	_
174-28	39574-39576	in	_
174-29	39577-39581	this	_
174-30	39582-39589	setting	_
174-31	39589-39590	.	_

#Text=Moreover, meta‐analytic studies of machine learning in schizophrenia have demonstrated that age, medication exposure, illness stage, and gender are all significant moderators of classification performance (Kambeitz et al., 2015; Neuhaus & Popescu, 2018).
175-1	39591-39599	Moreover	_
175-2	39599-39600	,	_
175-3	39601-39614	meta‐analytic	_
175-4	39615-39622	studies	_
175-5	39623-39625	of	_
175-6	39626-39633	machine	_
175-7	39634-39642	learning	_
175-8	39643-39645	in	_
175-9	39646-39659	schizophrenia	_
175-10	39660-39664	have	_
175-11	39665-39677	demonstrated	_
175-12	39678-39682	that	_
175-13	39683-39686	age	_
175-14	39686-39687	,	_
175-15	39688-39698	medication	_
175-16	39699-39707	exposure	_
175-17	39707-39708	,	_
175-18	39709-39716	illness	_
175-19	39717-39722	stage	_
175-20	39722-39723	,	_
175-21	39724-39727	and	_
175-22	39728-39734	gender	_
175-23	39735-39738	are	_
175-24	39739-39742	all	_
175-25	39743-39754	significant	_
175-26	39755-39765	moderators	_
175-27	39766-39768	of	_
175-28	39769-39783	classification	_
175-29	39784-39795	performance	_
175-30	39796-39797	(	_
175-31	39797-39805	Kambeitz	_
175-32	39806-39808	et	_
175-33	39809-39811	al	_
175-34	39811-39812	.	_
175-35	39812-39813	,	_
175-36	39814-39818	2015	_
175-37	39818-39819	;	_
175-38	39820-39827	Neuhaus	_
175-39	39828-39829	&	_
175-40	39830-39837	Popescu	_
175-41	39837-39838	,	_
175-42	39839-39843	2018	_
175-43	39843-39844	)	_
175-44	39844-39845	.	_

#Text=Cui, Liu, Song, et al. (2018) and Cui, Liu, Wang, et al. (2018) evaluated the classification performance of their machine learning algorithm within the same data set and across different data sets and also found that the classification accuracy across different data sets was lower than within the same data set.
176-1	39846-39849	Cui	_
176-2	39849-39850	,	_
176-3	39851-39854	Liu	_
176-4	39854-39855	,	_
176-5	39856-39860	Song	_
176-6	39860-39861	,	_
176-7	39862-39864	et	_
176-8	39865-39867	al	_
176-9	39867-39868	.	_
176-10	39869-39870	(	_
176-11	39870-39874	2018	_
176-12	39874-39875	)	_
176-13	39876-39879	and	_
176-14	39880-39883	Cui	_
176-15	39883-39884	,	_
176-16	39885-39888	Liu	_
176-17	39888-39889	,	_
176-18	39890-39894	Wang	_
176-19	39894-39895	,	_
176-20	39896-39898	et	_
176-21	39899-39901	al	_
176-22	39901-39902	.	_
176-23	39903-39904	(	_
176-24	39904-39908	2018	_
176-25	39908-39909	)	_
176-26	39910-39919	evaluated	_
176-27	39920-39923	the	_
176-28	39924-39938	classification	_
176-29	39939-39950	performance	_
176-30	39951-39953	of	_
176-31	39954-39959	their	_
176-32	39960-39967	machine	_
176-33	39968-39976	learning	_
176-34	39977-39986	algorithm	_
176-35	39987-39993	within	_
176-36	39994-39997	the	_
176-37	39998-40002	same	_
176-38	40003-40007	data	_
176-39	40008-40011	set	_
176-40	40012-40015	and	_
176-41	40016-40022	across	_
176-42	40023-40032	different	_
176-43	40033-40037	data	_
176-44	40038-40042	sets	_
176-45	40043-40046	and	_
176-46	40047-40051	also	_
176-47	40052-40057	found	_
176-48	40058-40062	that	_
176-49	40063-40066	the	_
176-50	40067-40081	classification	_
176-51	40082-40090	accuracy	_
176-52	40091-40097	across	_
176-53	40098-40107	different	_
176-54	40108-40112	data	_
176-55	40113-40117	sets	_
176-56	40118-40121	was	_
176-57	40122-40127	lower	_
176-58	40128-40132	than	_
176-59	40133-40139	within	_
176-60	40140-40143	the	_
176-61	40144-40148	same	_
176-62	40149-40153	data	_
176-63	40154-40157	set	_
176-64	40157-40158	.	_

#Text=However, the extent of difference in accuracy was not large in their study compared with ours.
177-1	40159-40166	However	_
177-2	40166-40167	,	_
177-3	40168-40171	the	_
177-4	40172-40178	extent	_
177-5	40179-40181	of	_
177-6	40182-40192	difference	_
177-7	40193-40195	in	_
177-8	40196-40204	accuracy	_
177-9	40205-40208	was	_
177-10	40209-40212	not	_
177-11	40213-40218	large	_
177-12	40219-40221	in	_
177-13	40222-40227	their	_
177-14	40228-40233	study	_
177-15	40234-40242	compared	_
177-16	40243-40247	with	_
177-17	40248-40252	ours	_
177-18	40252-40253	.	_

#Text=This could be due to differences in participant characteristics.
178-1	40254-40258	This	_
178-2	40259-40264	could	_
178-3	40265-40267	be	_
178-4	40268-40271	due	_
178-5	40272-40274	to	_
178-6	40275-40286	differences	_
178-7	40287-40289	in	_
178-8	40290-40301	participant	_
178-9	40302-40317	characteristics	_
178-10	40317-40318	.	_

#Text=In their study, patients with untreated first‐episode schizophrenia were recruited and the demographics were very similar between the two samples; whereas in our study, we recruited patients with chronic schizophrenia and the demographics were different between the two samples.
179-1	40319-40321	In	_
179-2	40322-40327	their	_
179-3	40328-40333	study	_
179-4	40333-40334	,	_
179-5	40335-40343	patients	_
179-6	40344-40348	with	_
179-7	40349-40358	untreated	_
179-8	40359-40372	first‐episode	_
179-9	40373-40386	schizophrenia	_
179-10	40387-40391	were	_
179-11	40392-40401	recruited	_
179-12	40402-40405	and	_
179-13	40406-40409	the	_
179-14	40410-40422	demographics	_
179-15	40423-40427	were	_
179-16	40428-40432	very	_
179-17	40433-40440	similar	_
179-18	40441-40448	between	_
179-19	40449-40452	the	_
179-20	40453-40456	two	_
179-21	40457-40464	samples	_
179-22	40464-40465	;	_
179-23	40466-40473	whereas	_
179-24	40474-40476	in	_
179-25	40477-40480	our	_
179-26	40481-40486	study	_
179-27	40486-40487	,	_
179-28	40488-40490	we	_
179-29	40491-40500	recruited	_
179-30	40501-40509	patients	_
179-31	40510-40514	with	_
179-32	40515-40522	chronic	_
179-33	40523-40536	schizophrenia	_
179-34	40537-40540	and	_
179-35	40541-40544	the	_
179-36	40545-40557	demographics	_
179-37	40558-40562	were	_
179-38	40563-40572	different	_
179-39	40573-40580	between	_
179-40	40581-40584	the	_
179-41	40585-40588	two	_
179-42	40589-40596	samples	_
179-43	40596-40597	.	_

#Text=Taken together, these findings suggest that future research to construct machine learning models should take into account illness heterogeneity.
180-1	40598-40603	Taken	_
180-2	40604-40612	together	_
180-3	40612-40613	,	_
180-4	40614-40619	these	_
180-5	40620-40628	findings	_
180-6	40629-40636	suggest	_
180-7	40637-40641	that	_
180-8	40642-40648	future	_
180-9	40649-40657	research	_
180-10	40658-40660	to	_
180-11	40661-40670	construct	_
180-12	40671-40678	machine	_
180-13	40679-40687	learning	_
180-14	40688-40694	models	_
180-15	40695-40701	should	_
180-16	40702-40706	take	_
180-17	40707-40711	into	_
180-18	40712-40719	account	_
180-19	40720-40727	illness	_
180-20	40728-40741	heterogeneity	_
180-21	40741-40742	.	_

#Text=Implication for schizophrenia research
#Text=The classification performance based on individual features in this study revealed that the striatum yielded the highest accuracy.
181-1	40743-40754	Implication	_
181-2	40755-40758	for	_
181-3	40759-40772	schizophrenia	_
181-4	40773-40781	research	_
181-5	40782-40785	The	_
181-6	40786-40800	classification	_
181-7	40801-40812	performance	_
181-8	40813-40818	based	_
181-9	40819-40821	on	_
181-10	40822-40832	individual	_
181-11	40833-40841	features	_
181-12	40842-40844	in	_
181-13	40845-40849	this	_
181-14	40850-40855	study	_
181-15	40856-40864	revealed	_
181-16	40865-40869	that	_
181-17	40870-40873	the	_
181-18	40874-40882	striatum	_
181-19	40883-40890	yielded	_
181-20	40891-40894	the	_
181-21	40895-40902	highest	_
181-22	40903-40911	accuracy	_
181-23	40911-40912	.	_

#Text=Spatial components including the lateral occipital cortex, the fusiform gyrus, the temporal lobe, the middle cingulate gyrus, the DMN, and the precuneus could also distinguish patients with schizophrenia from healthy controls with acceptable accuracy.
182-1	40913-40920	Spatial	_
182-2	40921-40931	components	_
182-3	40932-40941	including	_
182-4	40942-40945	the	_
182-5	40946-40953	lateral	_
182-6	40954-40963	occipital	_
182-7	40964-40970	cortex	_
182-8	40970-40971	,	_
182-9	40972-40975	the	_
182-10	40976-40984	fusiform	_
182-11	40985-40990	gyrus	_
182-12	40990-40991	,	_
182-13	40992-40995	the	_
182-14	40996-41004	temporal	_
182-15	41005-41009	lobe	_
182-16	41009-41010	,	_
182-17	41011-41014	the	_
182-18	41015-41021	middle	_
182-19	41022-41031	cingulate	_
182-20	41032-41037	gyrus	_
182-21	41037-41038	,	_
182-22	41039-41042	the	_
182-23	41043-41046	DMN	_
182-24	41046-41047	,	_
182-25	41048-41051	and	_
182-26	41052-41055	the	_
182-27	41056-41065	precuneus	_
182-28	41066-41071	could	_
182-29	41072-41076	also	_
182-30	41077-41088	distinguish	_
182-31	41089-41097	patients	_
182-32	41098-41102	with	_
182-33	41103-41116	schizophrenia	_
182-34	41117-41121	from	_
182-35	41122-41129	healthy	_
182-36	41130-41138	controls	_
182-37	41139-41143	with	_
182-38	41144-41154	acceptable	_
182-39	41155-41163	accuracy	_
182-40	41163-41164	.	_

#Text=These findings are supported by previous studies using machine learning methods in schizophrenia (Du et al., 2012; Fan et al., 2011; Savio & Grana, 2015; Tang et al., 2012; Yu et al., 2013).
183-1	41165-41170	These	_
183-2	41171-41179	findings	_
183-3	41180-41183	are	_
183-4	41184-41193	supported	_
183-5	41194-41196	by	_
183-6	41197-41205	previous	_
183-7	41206-41213	studies	_
183-8	41214-41219	using	_
183-9	41220-41227	machine	_
183-10	41228-41236	learning	_
183-11	41237-41244	methods	_
183-12	41245-41247	in	_
183-13	41248-41261	schizophrenia	_
183-14	41262-41263	(	_
183-15	41263-41265	Du	_
183-16	41266-41268	et	_
183-17	41269-41271	al	_
183-18	41271-41272	.	_
183-19	41272-41273	,	_
183-20	41274-41278	2012	_
183-21	41278-41279	;	_
183-22	41280-41283	Fan	_
183-23	41284-41286	et	_
183-24	41287-41289	al	_
183-25	41289-41290	.	_
183-26	41290-41291	,	_
183-27	41292-41296	2011	_
183-28	41296-41297	;	_
183-29	41298-41303	Savio	_
183-30	41304-41305	&	_
183-31	41306-41311	Grana	_
183-32	41311-41312	,	_
183-33	41313-41317	2015	_
183-34	41317-41318	;	_
183-35	41319-41323	Tang	_
183-36	41324-41326	et	_
183-37	41327-41329	al	_
183-38	41329-41330	.	_
183-39	41330-41331	,	_
183-40	41332-41336	2012	_
183-41	41336-41337	;	_
183-42	41338-41340	Yu	_
183-43	41341-41343	et	_
183-44	41344-41346	al	_
183-45	41346-41347	.	_
183-46	41347-41348	,	_
183-47	41349-41353	2013	_
183-48	41353-41354	)	_
183-49	41354-41355	.	_

#Text=Our findings suggest that the striatum may play a key role in schizophrenia.
184-1	41356-41359	Our	_
184-2	41360-41368	findings	_
184-3	41369-41376	suggest	_
184-4	41377-41381	that	_
184-5	41382-41385	the	_
184-6	41386-41394	striatum	_
184-7	41395-41398	may	_
184-8	41399-41403	play	_
184-9	41404-41405	a	_
184-10	41406-41409	key	_
184-11	41410-41414	role	_
184-12	41415-41417	in	_
184-13	41418-41431	schizophrenia	_
184-14	41431-41432	.	_

#Text=This is consistent with results from previous studies which demonstrated alteration in striatal volume (Chakravarty et al., 2015) and white matter connectivity (James et al., 2016).
185-1	41433-41437	This	_
185-2	41438-41440	is	_
185-3	41441-41451	consistent	_
185-4	41452-41456	with	_
185-5	41457-41464	results	_
185-6	41465-41469	from	_
185-7	41470-41478	previous	_
185-8	41479-41486	studies	_
185-9	41487-41492	which	_
185-10	41493-41505	demonstrated	_
185-11	41506-41516	alteration	_
185-12	41517-41519	in	_
185-13	41520-41528	striatal	_
185-14	41529-41535	volume	_
185-15	41536-41537	(	_
185-16	41537-41548	Chakravarty	_
185-17	41549-41551	et	_
185-18	41552-41554	al	_
185-19	41554-41555	.	_
185-20	41555-41556	,	_
185-21	41557-41561	2015	_
185-22	41561-41562	)	_
185-23	41563-41566	and	_
185-24	41567-41572	white	_
185-25	41573-41579	matter	_
185-26	41580-41592	connectivity	_
185-27	41593-41594	(	_
185-28	41594-41599	James	_
185-29	41600-41602	et	_
185-30	41603-41605	al	_
185-31	41605-41606	.	_
185-32	41606-41607	,	_
185-33	41608-41612	2016	_
185-34	41612-41613	)	_
185-35	41613-41614	.	_

#Text=For the DMN, studies by Fan et al. (2011) and Du et al. (2012) also suggest that it is one of the most informative brain regions for the diagnosis of schizophrenia.
186-1	41615-41618	For	_
186-2	41619-41622	the	_
186-3	41623-41626	DMN	_
186-4	41626-41627	,	_
186-5	41628-41635	studies	_
186-6	41636-41638	by	_
186-7	41639-41642	Fan	_
186-8	41643-41645	et	_
186-9	41646-41648	al	_
186-10	41648-41649	.	_
186-11	41650-41651	(	_
186-12	41651-41655	2011	_
186-13	41655-41656	)	_
186-14	41657-41660	and	_
186-15	41661-41663	Du	_
186-16	41664-41666	et	_
186-17	41667-41669	al	_
186-18	41669-41670	.	_
186-19	41671-41672	(	_
186-20	41672-41676	2012	_
186-21	41676-41677	)	_
186-22	41678-41682	also	_
186-23	41683-41690	suggest	_
186-24	41691-41695	that	_
186-25	41696-41698	it	_
186-26	41699-41701	is	_
186-27	41702-41705	one	_
186-28	41706-41708	of	_
186-29	41709-41712	the	_
186-30	41713-41717	most	_
186-31	41718-41729	informative	_
186-32	41730-41735	brain	_
186-33	41736-41743	regions	_
186-34	41744-41747	for	_
186-35	41748-41751	the	_
186-36	41752-41761	diagnosis	_
186-37	41762-41764	of	_
186-38	41765-41778	schizophrenia	_
186-39	41778-41779	.	_

#Text=Moreover, a recent study found that the DMN interacted with the central executive network and the salience network in smoking schizophrenia patients, indicating the potential role of the DMN in the symptomatology of the disorder (Liao et al., 2018).
187-1	41780-41788	Moreover	_
187-2	41788-41789	,	_
187-3	41790-41791	a	_
187-4	41792-41798	recent	_
187-5	41799-41804	study	_
187-6	41805-41810	found	_
187-7	41811-41815	that	_
187-8	41816-41819	the	_
187-9	41820-41823	DMN	_
187-10	41824-41834	interacted	_
187-11	41835-41839	with	_
187-12	41840-41843	the	_
187-13	41844-41851	central	_
187-14	41852-41861	executive	_
187-15	41862-41869	network	_
187-16	41870-41873	and	_
187-17	41874-41877	the	_
187-18	41878-41886	salience	_
187-19	41887-41894	network	_
187-20	41895-41897	in	_
187-21	41898-41905	smoking	_
187-22	41906-41919	schizophrenia	_
187-23	41920-41928	patients	_
187-24	41928-41929	,	_
187-25	41930-41940	indicating	_
187-26	41941-41944	the	_
187-27	41945-41954	potential	_
187-28	41955-41959	role	_
187-29	41960-41962	of	_
187-30	41963-41966	the	_
187-31	41967-41970	DMN	_
187-32	41971-41973	in	_
187-33	41974-41977	the	_
187-34	41978-41992	symptomatology	_
187-35	41993-41995	of	_
187-36	41996-41999	the	_
187-37	42000-42008	disorder	_
187-38	42009-42010	(	_
187-39	42010-42014	Liao	_
187-40	42015-42017	et	_
187-41	42018-42020	al	_
187-42	42020-42021	.	_
187-43	42021-42022	,	_
187-44	42023-42027	2018	_
187-45	42027-42028	)	_
187-46	42028-42029	.	_

#Text=At the same time, the structural and functional alterations in the DMN in schizophrenia patients have been shown to be related to impairment in working memory and attention (Garrity et al., 2007; Hu et al., 2017; Pomarol‐Clotet et al., 2008; Salgado‐Pineda et al., 2011; Whitfield‐Gabrieli & Ford, 2012).
188-1	42030-42032	At	_
188-2	42033-42036	the	_
188-3	42037-42041	same	_
188-4	42042-42046	time	_
188-5	42046-42047	,	_
188-6	42048-42051	the	_
188-7	42052-42062	structural	_
188-8	42063-42066	and	_
188-9	42067-42077	functional	_
188-10	42078-42089	alterations	_
188-11	42090-42092	in	_
188-12	42093-42096	the	_
188-13	42097-42100	DMN	_
188-14	42101-42103	in	_
188-15	42104-42117	schizophrenia	_
188-16	42118-42126	patients	_
188-17	42127-42131	have	_
188-18	42132-42136	been	_
188-19	42137-42142	shown	_
188-20	42143-42145	to	_
188-21	42146-42148	be	_
188-22	42149-42156	related	_
188-23	42157-42159	to	_
188-24	42160-42170	impairment	_
188-25	42171-42173	in	_
188-26	42174-42181	working	_
188-27	42182-42188	memory	_
188-28	42189-42192	and	_
188-29	42193-42202	attention	_
188-30	42203-42204	(	_
188-31	42204-42211	Garrity	_
188-32	42212-42214	et	_
188-33	42215-42217	al	_
188-34	42217-42218	.	_
188-35	42218-42219	,	_
188-36	42220-42224	2007	_
188-37	42224-42225	;	_
188-38	42226-42228	Hu	_
188-39	42229-42231	et	_
188-40	42232-42234	al	_
188-41	42234-42235	.	_
188-42	42235-42236	,	_
188-43	42237-42241	2017	_
188-44	42241-42242	;	_
188-45	42243-42257	Pomarol‐Clotet	_
188-46	42258-42260	et	_
188-47	42261-42263	al	_
188-48	42263-42264	.	_
188-49	42264-42265	,	_
188-50	42266-42270	2008	_
188-51	42270-42271	;	_
188-52	42272-42286	Salgado‐Pineda	_
188-53	42287-42289	et	_
188-54	42290-42292	al	_
188-55	42292-42293	.	_
188-56	42293-42294	,	_
188-57	42295-42299	2011	_
188-58	42299-42300	;	_
188-59	42301-42319	Whitfield‐Gabrieli	_
188-60	42320-42321	&	_
188-61	42322-42326	Ford	_
188-62	42326-42327	,	_
188-63	42328-42332	2012	_
188-64	42332-42333	)	_
188-65	42333-42334	.	_

#Text=Previous studies have also suggested that the fusiform gyrus and the temporal lobe may be discriminative features for classification (Savio & Grana, 2015; Tang et al., 2012).
189-1	42335-42343	Previous	_
189-2	42344-42351	studies	_
189-3	42352-42356	have	_
189-4	42357-42361	also	_
189-5	42362-42371	suggested	_
189-6	42372-42376	that	_
189-7	42377-42380	the	_
189-8	42381-42389	fusiform	_
189-9	42390-42395	gyrus	_
189-10	42396-42399	and	_
189-11	42400-42403	the	_
189-12	42404-42412	temporal	_
189-13	42413-42417	lobe	_
189-14	42418-42421	may	_
189-15	42422-42424	be	_
189-16	42425-42439	discriminative	_
189-17	42440-42448	features	_
189-18	42449-42452	for	_
189-19	42453-42467	classification	_
189-20	42468-42469	(	_
189-21	42469-42474	Savio	_
189-22	42475-42476	&	_
189-23	42477-42482	Grana	_
189-24	42482-42483	,	_
189-25	42484-42488	2015	_
189-26	42488-42489	;	_
189-27	42490-42494	Tang	_
189-28	42495-42497	et	_
189-29	42498-42500	al	_
189-30	42500-42501	.	_
189-31	42501-42502	,	_
189-32	42503-42507	2012	_
189-33	42507-42508	)	_
189-34	42508-42509	.	_

#Text=In anatomical studies, reduced gray matter volume at the superior temporal gyrus has been reported in schizophrenia patients (Ohi et al., 2016; Sun, Maller, Guo, & Fitzgerald, 2009), which may also be related to hallucinations (Cui, Liu, Song, et al., 2018; Cui, Liu, Wang, et al., 2018).
190-1	42510-42512	In	_
190-2	42513-42523	anatomical	_
190-3	42524-42531	studies	_
190-4	42531-42532	,	_
190-5	42533-42540	reduced	_
190-6	42541-42545	gray	_
190-7	42546-42552	matter	_
190-8	42553-42559	volume	_
190-9	42560-42562	at	_
190-10	42563-42566	the	_
190-11	42567-42575	superior	_
190-12	42576-42584	temporal	_
190-13	42585-42590	gyrus	_
190-14	42591-42594	has	_
190-15	42595-42599	been	_
190-16	42600-42608	reported	_
190-17	42609-42611	in	_
190-18	42612-42625	schizophrenia	_
190-19	42626-42634	patients	_
190-20	42635-42636	(	_
190-21	42636-42639	Ohi	_
190-22	42640-42642	et	_
190-23	42643-42645	al	_
190-24	42645-42646	.	_
190-25	42646-42647	,	_
190-26	42648-42652	2016	_
190-27	42652-42653	;	_
190-28	42654-42657	Sun	_
190-29	42657-42658	,	_
190-30	42659-42665	Maller	_
190-31	42665-42666	,	_
190-32	42667-42670	Guo	_
190-33	42670-42671	,	_
190-34	42672-42673	&	_
190-35	42674-42684	Fitzgerald	_
190-36	42684-42685	,	_
190-37	42686-42690	2009	_
190-38	42690-42691	)	_
190-39	42691-42692	,	_
190-40	42693-42698	which	_
190-41	42699-42702	may	_
190-42	42703-42707	also	_
190-43	42708-42710	be	_
190-44	42711-42718	related	_
190-45	42719-42721	to	_
190-46	42722-42736	hallucinations	_
190-47	42737-42738	(	_
190-48	42738-42741	Cui	_
190-49	42741-42742	,	_
190-50	42743-42746	Liu	_
190-51	42746-42747	,	_
190-52	42748-42752	Song	_
190-53	42752-42753	,	_
190-54	42754-42756	et	_
190-55	42757-42759	al	_
190-56	42759-42760	.	_
190-57	42760-42761	,	_
190-58	42762-42766	2018	_
190-59	42766-42767	;	_
190-60	42768-42771	Cui	_
190-61	42771-42772	,	_
190-62	42773-42776	Liu	_
190-63	42776-42777	,	_
190-64	42778-42782	Wang	_
190-65	42782-42783	,	_
190-66	42784-42786	et	_
190-67	42787-42789	al	_
190-68	42789-42790	.	_
190-69	42790-42791	,	_
190-70	42792-42796	2018	_
190-71	42796-42797	)	_
190-72	42797-42798	.	_

#Text=Limitation
#Text=This study has several limitations.
191-1	42799-42809	Limitation	_
191-2	42810-42814	This	_
191-3	42815-42820	study	_
191-4	42821-42824	has	_
191-5	42825-42832	several	_
191-6	42833-42844	limitations	_
191-7	42844-42845	.	_

#Text=First, the sample size in the present study was small.
192-1	42846-42851	First	_
192-2	42851-42852	,	_
192-3	42853-42856	the	_
192-4	42857-42863	sample	_
192-5	42864-42868	size	_
192-6	42869-42871	in	_
192-7	42872-42875	the	_
192-8	42876-42883	present	_
192-9	42884-42889	study	_
192-10	42890-42893	was	_
192-11	42894-42899	small	_
192-12	42899-42900	.	_

#Text=Bigger data sets are needed to avoid overfitting and to build a classifier with better generalizability.
193-1	42901-42907	Bigger	_
193-2	42908-42912	data	_
193-3	42913-42917	sets	_
193-4	42918-42921	are	_
193-5	42922-42928	needed	_
193-6	42929-42931	to	_
193-7	42932-42937	avoid	_
193-8	42938-42949	overfitting	_
193-9	42950-42953	and	_
193-10	42954-42956	to	_
193-11	42957-42962	build	_
193-12	42963-42964	a	_
193-13	42965-42975	classifier	_
193-14	42976-42980	with	_
193-15	42981-42987	better	_
193-16	42988-43004	generalizability	_
193-17	43004-43005	.	_

#Text=Second, only one modality of data (rsfMRI) was utilized, even though both functional and structural brain information may be important for high‐accuracy classification using machine learning (Mikolas et al., 2017; Orban et al., 2018; Ota et al., 2012).
194-1	43006-43012	Second	_
194-2	43012-43013	,	_
194-3	43014-43018	only	_
194-4	43019-43022	one	_
194-5	43023-43031	modality	_
194-6	43032-43034	of	_
194-7	43035-43039	data	_
194-8	43040-43041	(	_
194-9	43041-43047	rsfMRI	_
194-10	43047-43048	)	_
194-11	43049-43052	was	_
194-12	43053-43061	utilized	_
194-13	43061-43062	,	_
194-14	43063-43067	even	_
194-15	43068-43074	though	_
194-16	43075-43079	both	_
194-17	43080-43090	functional	_
194-18	43091-43094	and	_
194-19	43095-43105	structural	_
194-20	43106-43111	brain	_
194-21	43112-43123	information	_
194-22	43124-43127	may	_
194-23	43128-43130	be	_
194-24	43131-43140	important	_
194-25	43141-43144	for	_
194-26	43145-43158	high‐accuracy	_
194-27	43159-43173	classification	_
194-28	43174-43179	using	_
194-29	43180-43187	machine	_
194-30	43188-43196	learning	_
194-31	43197-43198	(	_
194-32	43198-43205	Mikolas	_
194-33	43206-43208	et	_
194-34	43209-43211	al	_
194-35	43211-43212	.	_
194-36	43212-43213	,	_
194-37	43214-43218	2017	_
194-38	43218-43219	;	_
194-39	43220-43225	Orban	_
194-40	43226-43228	et	_
194-41	43229-43231	al	_
194-42	43231-43232	.	_
194-43	43232-43233	,	_
194-44	43234-43238	2018	_
194-45	43238-43239	;	_
194-46	43240-43243	Ota	_
194-47	43244-43246	et	_
194-48	43247-43249	al	_
194-49	43249-43250	.	_
194-50	43250-43251	,	_
194-51	43252-43256	2012	_
194-52	43256-43257	)	_
194-53	43257-43258	.	_

#Text=Third, we did not collect the smoking status of our participants in this study.
195-1	43259-43264	Third	_
195-2	43264-43265	,	_
195-3	43266-43268	we	_
195-4	43269-43272	did	_
195-5	43273-43276	not	_
195-6	43277-43284	collect	_
195-7	43285-43288	the	_
195-8	43289-43296	smoking	_
195-9	43297-43303	status	_
195-10	43304-43306	of	_
195-11	43307-43310	our	_
195-12	43311-43323	participants	_
195-13	43324-43326	in	_
195-14	43327-43331	this	_
195-15	43332-43337	study	_
195-16	43337-43338	.	_

#Text=Considering the high rate of smoking in schizophrenia patients (Liao et al., 2018), which may influence brain activity (Potvin et al., 2016; Tanabe, Tregellas, Martin, & Freedman, 2006), smoking status may be a confounding factor that affects classification performance.
196-1	43339-43350	Considering	_
196-2	43351-43354	the	_
196-3	43355-43359	high	_
196-4	43360-43364	rate	_
196-5	43365-43367	of	_
196-6	43368-43375	smoking	_
196-7	43376-43378	in	_
196-8	43379-43392	schizophrenia	_
196-9	43393-43401	patients	_
196-10	43402-43403	(	_
196-11	43403-43407	Liao	_
196-12	43408-43410	et	_
196-13	43411-43413	al	_
196-14	43413-43414	.	_
196-15	43414-43415	,	_
196-16	43416-43420	2018	_
196-17	43420-43421	)	_
196-18	43421-43422	,	_
196-19	43423-43428	which	_
196-20	43429-43432	may	_
196-21	43433-43442	influence	_
196-22	43443-43448	brain	_
196-23	43449-43457	activity	_
196-24	43458-43459	(	_
196-25	43459-43465	Potvin	_
196-26	43466-43468	et	_
196-27	43469-43471	al	_
196-28	43471-43472	.	_
196-29	43472-43473	,	_
196-30	43474-43478	2016	_
196-31	43478-43479	;	_
196-32	43480-43486	Tanabe	_
196-33	43486-43487	,	_
196-34	43488-43497	Tregellas	_
196-35	43497-43498	,	_
196-36	43499-43505	Martin	_
196-37	43505-43506	,	_
196-38	43507-43508	&	_
196-39	43509-43517	Freedman	_
196-40	43517-43518	,	_
196-41	43519-43523	2006	_
196-42	43523-43524	)	_
196-43	43524-43525	,	_
196-44	43526-43533	smoking	_
196-45	43534-43540	status	_
196-46	43541-43544	may	_
196-47	43545-43547	be	_
196-48	43548-43549	a	_
196-49	43550-43561	confounding	_
196-50	43562-43568	factor	_
196-51	43569-43573	that	_
196-52	43574-43581	affects	_
196-53	43582-43596	classification	_
196-54	43597-43608	performance	_
196-55	43608-43609	.	_

#Text=Fourth, since our findings suggest the importance to take scanning setting and characteristics of participants into account when collecting data from different sites, future studies should examine how these two sets of factors affect between‐site generalizability.
197-1	43610-43616	Fourth	_
197-2	43616-43617	,	_
197-3	43618-43623	since	_
197-4	43624-43627	our	_
197-5	43628-43636	findings	_
197-6	43637-43644	suggest	_
197-7	43645-43648	the	_
197-8	43649-43659	importance	_
197-9	43660-43662	to	_
197-10	43663-43667	take	_
197-11	43668-43676	scanning	_
197-12	43677-43684	setting	_
197-13	43685-43688	and	_
197-14	43689-43704	characteristics	_
197-15	43705-43707	of	_
197-16	43708-43720	participants	_
197-17	43721-43725	into	_
197-18	43726-43733	account	_
197-19	43734-43738	when	_
197-20	43739-43749	collecting	_
197-21	43750-43754	data	_
197-22	43755-43759	from	_
197-23	43760-43769	different	_
197-24	43770-43775	sites	_
197-25	43775-43776	,	_
197-26	43777-43783	future	_
197-27	43784-43791	studies	_
197-28	43792-43798	should	_
197-29	43799-43806	examine	_
197-30	43807-43810	how	_
197-31	43811-43816	these	_
197-32	43817-43820	two	_
197-33	43821-43825	sets	_
197-34	43826-43828	of	_
197-35	43829-43836	factors	_
197-36	43837-43843	affect	_
197-37	43844-43856	between‐site	_
197-38	43857-43873	generalizability	_
197-39	43873-43874	.	_

#Text=CONCLUSION
#Text=In this study, we found that the machine learning procedure developed by Du et al. (2012) could successfully classify patients with schizophrenia from healthy controls based on rsfMRI data in internal validation but not external validation.
198-1	43875-43885	CONCLUSION	_
198-2	43886-43888	In	_
198-3	43889-43893	this	_
198-4	43894-43899	study	_
198-5	43899-43900	,	_
198-6	43901-43903	we	_
198-7	43904-43909	found	_
198-8	43910-43914	that	_
198-9	43915-43918	the	_
198-10	43919-43926	machine	_
198-11	43927-43935	learning	_
198-12	43936-43945	procedure	_
198-13	43946-43955	developed	_
198-14	43956-43958	by	_
198-15	43959-43961	Du	_
198-16	43962-43964	et	_
198-17	43965-43967	al	_
198-18	43967-43968	.	_
198-19	43969-43970	(	_
198-20	43970-43974	2012	_
198-21	43974-43975	)	_
198-22	43976-43981	could	_
198-23	43982-43994	successfully	_
198-24	43995-44003	classify	_
198-25	44004-44012	patients	_
198-26	44013-44017	with	_
198-27	44018-44031	schizophrenia	_
198-28	44032-44036	from	_
198-29	44037-44044	healthy	_
198-30	44045-44053	controls	_
198-31	44054-44059	based	_
198-32	44060-44062	on	_
198-33	44063-44069	rsfMRI	_
198-34	44070-44074	data	_
198-35	44075-44077	in	_
198-36	44078-44086	internal	_
198-37	44087-44097	validation	_
198-38	44098-44101	but	_
198-39	44102-44105	not	_
198-40	44106-44114	external	_
198-41	44115-44125	validation	_
198-42	44125-44126	.	_

#Text=Moreover, we found that a transfer learning procedure based on unsupervised learning was able to improve between‐site generalizability and may eventually contribute to the incorporation of machine learning approaches into clinical practice.
199-1	44127-44135	Moreover	_
199-2	44135-44136	,	_
199-3	44137-44139	we	_
199-4	44140-44145	found	_
199-5	44146-44150	that	_
199-6	44151-44152	a	_
199-7	44153-44161	transfer	_
199-8	44162-44170	learning	_
199-9	44171-44180	procedure	_
199-10	44181-44186	based	_
199-11	44187-44189	on	_
199-12	44190-44202	unsupervised	_
199-13	44203-44211	learning	_
199-14	44212-44215	was	_
199-15	44216-44220	able	_
199-16	44221-44223	to	_
199-17	44224-44231	improve	_
199-18	44232-44244	between‐site	_
199-19	44245-44261	generalizability	_
199-20	44262-44265	and	_
199-21	44266-44269	may	_
199-22	44270-44280	eventually	_
199-23	44281-44291	contribute	_
199-24	44292-44294	to	_
199-25	44295-44298	the	_
199-26	44299-44312	incorporation	_
199-27	44313-44315	of	_
199-28	44316-44323	machine	_
199-29	44324-44332	learning	_
199-30	44333-44343	approaches	_
199-31	44344-44348	into	_
199-32	44349-44357	clinical	_
199-33	44358-44366	practice	_
199-34	44366-44367	.	_

#Text=CONFLICT OF INTEREST
#Text=The authors declare no potential conflict of interest.
200-1	44368-44376	CONFLICT	_
200-2	44377-44379	OF	_
200-3	44380-44388	INTEREST	_
200-4	44389-44392	The	_
200-5	44393-44400	authors	_
200-6	44401-44408	declare	_
200-7	44409-44411	no	_
200-8	44412-44421	potential	_
200-9	44422-44430	conflict	_
200-10	44431-44433	of	_
200-11	44434-44442	interest	_
200-12	44442-44443	.	_

#Text=DATA AVAILABILITY STATEMENT
#Text=The data of the present study are available from the corresponding author upon request.
201-1	44444-44448	DATA	_
201-2	44449-44461	AVAILABILITY	_
201-3	44462-44471	STATEMENT	_
201-4	44472-44475	The	_
201-5	44476-44480	data	_
201-6	44481-44483	of	_
201-7	44484-44487	the	_
201-8	44488-44495	present	_
201-9	44496-44501	study	_
201-10	44502-44505	are	_
201-11	44506-44515	available	_
201-12	44516-44520	from	_
201-13	44521-44524	the	_
201-14	44525-44538	corresponding	_
201-15	44539-44545	author	_
201-16	44546-44550	upon	_
201-17	44551-44558	request	_
201-18	44558-44559	.	_

#Text=REFERENCES
#Text=The epidemiology of onset and course of schizophrenia
#Text=Decreased small‐world functional network connectivity and clustering across resting state networks in schizophrenia: An fMRI classification tutorial
#Text=Measuring pathology using the PANSS across diagnoses: Inconsistency of the positive symptom domain across schizophrenia, schizoaffective, and bipolar disorder
#Text=
#Text=Single subject prediction of brain disorders in neuroimaging: Promises and pitfalls
#Text=Classification of schizophrenia patients based on resting‐state functional network connectivity
#Text=Computational anatomy with the SPM software
#Text=Altered resting state complexity in schizophrenia
#Text=An information‐maximization approach to blind separation and blind deconvolution
#Text=Treatment response prediction and individualized identification of first‐episode drug‐naïve schizophrenia using brain functional connectivity
#Text=Striatal shape abnormalities as novel neurodevelopmental endophenotypes in schizophrenia: A longitudinal study
#Text=The burden of mental, neurological, and substance use disorders in China and India: A systematic analysis of community representative epidemiological studies
#Text=Nodal centrality of functional network in the differentiation of schizophrenia
#Text=Voxel‐based, brain‐wide association study of aberrant functional connectivity in schizophrenia implicates thalamocortical circuitry
#Text=Optimizing preprocessing and analysis pipelines for single‐subject fMRI.
202-1	44560-44570	REFERENCES	_
202-2	44571-44574	The	_
202-3	44575-44587	epidemiology	_
202-4	44588-44590	of	_
202-5	44591-44596	onset	_
202-6	44597-44600	and	_
202-7	44601-44607	course	_
202-8	44608-44610	of	_
202-9	44611-44624	schizophrenia	_
202-10	44625-44634	Decreased	_
202-11	44635-44646	small‐world	_
202-12	44647-44657	functional	_
202-13	44658-44665	network	_
202-14	44666-44678	connectivity	_
202-15	44679-44682	and	_
202-16	44683-44693	clustering	_
202-17	44694-44700	across	_
202-18	44701-44708	resting	_
202-19	44709-44714	state	_
202-20	44715-44723	networks	_
202-21	44724-44726	in	_
202-22	44727-44740	schizophrenia	_
202-23	44740-44741	:	_
202-24	44742-44744	An	_
202-25	44745-44749	fMRI	_
202-26	44750-44764	classification	_
202-27	44765-44773	tutorial	_
202-28	44774-44783	Measuring	_
202-29	44784-44793	pathology	_
202-30	44794-44799	using	_
202-31	44800-44803	the	_
202-32	44804-44809	PANSS	_
202-33	44810-44816	across	_
202-34	44817-44826	diagnoses	_
202-35	44826-44827	:	_
202-36	44828-44841	Inconsistency	_
202-37	44842-44844	of	_
202-38	44845-44848	the	_
202-39	44849-44857	positive	_
202-40	44858-44865	symptom	_
202-41	44866-44872	domain	_
202-42	44873-44879	across	_
202-43	44880-44893	schizophrenia	_
202-44	44893-44894	,	_
202-45	44895-44910	schizoaffective	_
202-46	44910-44911	,	_
202-47	44912-44915	and	_
202-48	44916-44923	bipolar	_
202-49	44924-44932	disorder	_
202-50	44934-44940	Single	_
202-51	44941-44948	subject	_
202-52	44949-44959	prediction	_
202-53	44960-44962	of	_
202-54	44963-44968	brain	_
202-55	44969-44978	disorders	_
202-56	44979-44981	in	_
202-57	44982-44994	neuroimaging	_
202-58	44994-44995	:	_
202-59	44996-45004	Promises	_
202-60	45005-45008	and	_
202-61	45009-45017	pitfalls	_
202-62	45018-45032	Classification	_
202-63	45033-45035	of	_
202-64	45036-45049	schizophrenia	_
202-65	45050-45058	patients	_
202-66	45059-45064	based	_
202-67	45065-45067	on	_
202-68	45068-45081	resting‐state	_
202-69	45082-45092	functional	_
202-70	45093-45100	network	_
202-71	45101-45113	connectivity	_
202-72	45114-45127	Computational	_
202-73	45128-45135	anatomy	_
202-74	45136-45140	with	_
202-75	45141-45144	the	_
202-76	45145-45148	SPM	_
202-77	45149-45157	software	_
202-78	45158-45165	Altered	_
202-79	45166-45173	resting	_
202-80	45174-45179	state	_
202-81	45180-45190	complexity	_
202-82	45191-45193	in	_
202-83	45194-45207	schizophrenia	_
202-84	45208-45210	An	_
202-85	45211-45235	information‐maximization	_
202-86	45236-45244	approach	_
202-87	45245-45247	to	_
202-88	45248-45253	blind	_
202-89	45254-45264	separation	_
202-90	45265-45268	and	_
202-91	45269-45274	blind	_
202-92	45275-45288	deconvolution	_
202-93	45289-45298	Treatment	_
202-94	45299-45307	response	_
202-95	45308-45318	prediction	_
202-96	45319-45322	and	_
202-97	45323-45337	individualized	_
202-98	45338-45352	identification	_
202-99	45353-45355	of	_
202-100	45356-45369	first‐episode	_
202-101	45370-45380	drug‐naïve	_
202-102	45381-45394	schizophrenia	_
202-103	45395-45400	using	_
202-104	45401-45406	brain	_
202-105	45407-45417	functional	_
202-106	45418-45430	connectivity	_
202-107	45431-45439	Striatal	_
202-108	45440-45445	shape	_
202-109	45446-45459	abnormalities	_
202-110	45460-45462	as	_
202-111	45463-45468	novel	_
202-112	45469-45487	neurodevelopmental	_
202-113	45488-45502	endophenotypes	_
202-114	45503-45505	in	_
202-115	45506-45519	schizophrenia	_
202-116	45519-45520	:	_
202-117	45521-45522	A	_
202-118	45523-45535	longitudinal	_
202-119	45536-45541	study	_
202-120	45542-45545	The	_
202-121	45546-45552	burden	_
202-122	45553-45555	of	_
202-123	45556-45562	mental	_
202-124	45562-45563	,	_
202-125	45564-45576	neurological	_
202-126	45576-45577	,	_
202-127	45578-45581	and	_
202-128	45582-45591	substance	_
202-129	45592-45595	use	_
202-130	45596-45605	disorders	_
202-131	45606-45608	in	_
202-132	45609-45614	China	_
202-133	45615-45618	and	_
202-134	45619-45624	India	_
202-135	45624-45625	:	_
202-136	45626-45627	A	_
202-137	45628-45638	systematic	_
202-138	45639-45647	analysis	_
202-139	45648-45650	of	_
202-140	45651-45660	community	_
202-141	45661-45675	representative	_
202-142	45676-45691	epidemiological	_
202-143	45692-45699	studies	_
202-144	45700-45705	Nodal	_
202-145	45706-45716	centrality	_
202-146	45717-45719	of	_
202-147	45720-45730	functional	_
202-148	45731-45738	network	_
202-149	45739-45741	in	_
202-150	45742-45745	the	_
202-151	45746-45761	differentiation	_
202-152	45762-45764	of	_
202-153	45765-45778	schizophrenia	_
202-154	45779-45790	Voxel‐based	_
202-155	45790-45791	,	_
202-156	45792-45802	brain‐wide	_
202-157	45803-45814	association	_
202-158	45815-45820	study	_
202-159	45821-45823	of	_
202-160	45824-45832	aberrant	_
202-161	45833-45843	functional	_
202-162	45844-45856	connectivity	_
202-163	45857-45859	in	_
202-164	45860-45873	schizophrenia	_
202-165	45874-45884	implicates	_
202-166	45885-45900	thalamocortical	_
202-167	45901-45910	circuitry	_
202-168	45911-45921	Optimizing	_
202-169	45922-45935	preprocessing	_
202-170	45936-45939	and	_
202-171	45940-45948	analysis	_
202-172	45949-45958	pipelines	_
202-173	45959-45962	for	_
202-174	45963-45977	single‐subject	_
202-175	45978-45982	fMRI	_
202-176	45982-45983	.	_

#Text=I.
203-1	45984-45985	I	_
203-2	45985-45986	.	_

#Text=Standard temporal motion and physiological noise correction methods
#Text=Computer aided diagnosis of schizophrenia on resting state fMRI data by ensembles of ELM
#Text=Disease definition for schizophrenia by functional connectivity using radiomics strategy
#Text=Auditory verbal hallucinations are related to cortical thinning in the left middle temporal gyrus of patients with schizophrenia
#Text=Statistical power and prediction accuracy in multisite resting‐state fMRI connectivity
#Text=Why voxel‐based morphometric analysis should be used with great caution when characterizing group differences
#Text=High classification accuracy for schizophrenia with rest and task FMRI data
#Text=Meta‐analysis of diffusion tensor imaging studies in schizophrenia
#Text=Discriminant analysis of functional connectivity patterns on Grassmann manifold
#Text=Combining classification with fMRI‐derived complex network measures for potential neurodiagnostics
#Text=Diagnostic and statistical manual of mental disorders: DSM‐IV: American Psychiatric Association
#Text=Movement‐related effects in fMRI time‐series
#Text=Aberrant "default mode" functional connectivity in schizophrenia
#Text=
#Text=Brain volumes in schizophrenia: A meta‐analysis in over 18 000 subjects
#Text=A review of the functional and anatomical default mode network in schizophrenia
#Text=Neuropsychological performance in older patients with schizophrenia: A meta‐analysis of cross‐sectional and longitudinal studies
#Text=Abnormal frontostriatal connectivity in adolescent‐onset schizophrenia and its relationship to cognitive functioning
#Text=Detecting neuroimaging biomarkers for schizophrenia: A meta‐analysis of multivariate pattern recognition studies
#Text=Disintegration of sensorimotor brain networks in schizophrenia
#Text=The positive and negative syndrome scale (PANSS) for schizophrenia
#Text=Deep neural network with weight sparsity control and pre‐training extracts hierarchical features and enhances classification performance: Evidence from whole‐brain resting‐state functional connectivity patterns of schizophrenia
#Text=The hierarchical taxonomy of psychopathology (HiTOP): A dimensional alternative to traditional nosologies
#Text=The NIMH research domain criteria initiative: Background, issues, and pragmatics
#Text=Preservation effect: Cigarette smoking acts on the dynamic of influences among unifying neuropsychiatric LiaTriple networks in schizophrenia
#Text=Five factor model of schizophrenia: Replication across samples
#Text=Perspectives on machine learning for classification of schizotypy using fMRI data
#Text=Classification of first‐episode schizophrenia spectrum disorders and controls from whole brain white matter fractional anisotropy using machine learning
#Text=A review of feature reduction techniques in neuroimaging
#Text=Impact of sample size and matching on single‐subject classification of schizophrenia: A meta‐analysis
#Text=Using dual regression to investigate network shape and amplitude in functional connectivity analyses
#Text=Structural alterations of the superior temporal gyrus in schizophrenia: Detailed subregional differences
#Text=Multisite generalizability of schizophrenia diagnosis classification based on functional brain connectivity
#Text=Discrimination of female schizophrenia patients from healthy women using multiple structural brain measures obtained with voxel‐based morphometry
#Text=New approaches to psychiatric diagnostic classification
#Text=A wavelet method for modeling and despiking motion artifacts from resting‐state fMRI time series
#Text=Failure to deactivate in the prefrontal cortex in schizophrenia: Dysfunction of the default mode network?
204-1	45987-45995	Standard	_
204-2	45996-46004	temporal	_
204-3	46005-46011	motion	_
204-4	46012-46015	and	_
204-5	46016-46029	physiological	_
204-6	46030-46035	noise	_
204-7	46036-46046	correction	_
204-8	46047-46054	methods	_
204-9	46055-46063	Computer	_
204-10	46064-46069	aided	_
204-11	46070-46079	diagnosis	_
204-12	46080-46082	of	_
204-13	46083-46096	schizophrenia	_
204-14	46097-46099	on	_
204-15	46100-46107	resting	_
204-16	46108-46113	state	_
204-17	46114-46118	fMRI	_
204-18	46119-46123	data	_
204-19	46124-46126	by	_
204-20	46127-46136	ensembles	_
204-21	46137-46139	of	_
204-22	46140-46143	ELM	_
204-23	46144-46151	Disease	_
204-24	46152-46162	definition	_
204-25	46163-46166	for	_
204-26	46167-46180	schizophrenia	_
204-27	46181-46183	by	_
204-28	46184-46194	functional	_
204-29	46195-46207	connectivity	_
204-30	46208-46213	using	_
204-31	46214-46223	radiomics	_
204-32	46224-46232	strategy	_
204-33	46233-46241	Auditory	_
204-34	46242-46248	verbal	_
204-35	46249-46263	hallucinations	_
204-36	46264-46267	are	_
204-37	46268-46275	related	_
204-38	46276-46278	to	_
204-39	46279-46287	cortical	_
204-40	46288-46296	thinning	_
204-41	46297-46299	in	_
204-42	46300-46303	the	_
204-43	46304-46308	left	_
204-44	46309-46315	middle	_
204-45	46316-46324	temporal	_
204-46	46325-46330	gyrus	_
204-47	46331-46333	of	_
204-48	46334-46342	patients	_
204-49	46343-46347	with	_
204-50	46348-46361	schizophrenia	_
204-51	46362-46373	Statistical	_
204-52	46374-46379	power	_
204-53	46380-46383	and	_
204-54	46384-46394	prediction	_
204-55	46395-46403	accuracy	_
204-56	46404-46406	in	_
204-57	46407-46416	multisite	_
204-58	46417-46430	resting‐state	_
204-59	46431-46435	fMRI	_
204-60	46436-46448	connectivity	_
204-61	46449-46452	Why	_
204-62	46453-46464	voxel‐based	_
204-63	46465-46477	morphometric	_
204-64	46478-46486	analysis	_
204-65	46487-46493	should	_
204-66	46494-46496	be	_
204-67	46497-46501	used	_
204-68	46502-46506	with	_
204-69	46507-46512	great	_
204-70	46513-46520	caution	_
204-71	46521-46525	when	_
204-72	46526-46540	characterizing	_
204-73	46541-46546	group	_
204-74	46547-46558	differences	_
204-75	46559-46563	High	_
204-76	46564-46578	classification	_
204-77	46579-46587	accuracy	_
204-78	46588-46591	for	_
204-79	46592-46605	schizophrenia	_
204-80	46606-46610	with	_
204-81	46611-46615	rest	_
204-82	46616-46619	and	_
204-83	46620-46624	task	_
204-84	46625-46629	FMRI	_
204-85	46630-46634	data	_
204-86	46635-46648	Meta‐analysis	_
204-87	46649-46651	of	_
204-88	46652-46661	diffusion	_
204-89	46662-46668	tensor	_
204-90	46669-46676	imaging	_
204-91	46677-46684	studies	_
204-92	46685-46687	in	_
204-93	46688-46701	schizophrenia	_
204-94	46702-46714	Discriminant	_
204-95	46715-46723	analysis	_
204-96	46724-46726	of	_
204-97	46727-46737	functional	_
204-98	46738-46750	connectivity	_
204-99	46751-46759	patterns	_
204-100	46760-46762	on	_
204-101	46763-46772	Grassmann	_
204-102	46773-46781	manifold	_
204-103	46782-46791	Combining	_
204-104	46792-46806	classification	_
204-105	46807-46811	with	_
204-106	46812-46824	fMRI‐derived	_
204-107	46825-46832	complex	_
204-108	46833-46840	network	_
204-109	46841-46849	measures	_
204-110	46850-46853	for	_
204-111	46854-46863	potential	_
204-112	46864-46880	neurodiagnostics	_
204-113	46881-46891	Diagnostic	_
204-114	46892-46895	and	_
204-115	46896-46907	statistical	_
204-116	46908-46914	manual	_
204-117	46915-46917	of	_
204-118	46918-46924	mental	_
204-119	46925-46934	disorders	_
204-120	46934-46935	:	_
204-121	46936-46942	DSM‐IV	_
204-122	46942-46943	:	_
204-123	46944-46952	American	_
204-124	46953-46964	Psychiatric	_
204-125	46965-46976	Association	_
204-126	46977-46993	Movement‐related	_
204-127	46994-47001	effects	_
204-128	47002-47004	in	_
204-129	47005-47009	fMRI	_
204-130	47010-47021	time‐series	_
204-131	47022-47030	Aberrant	_
204-132	47031-47032	"	_
204-133	47032-47039	default	_
204-134	47040-47044	mode	_
204-135	47044-47045	"	_
204-136	47046-47056	functional	_
204-137	47057-47069	connectivity	_
204-138	47070-47072	in	_
204-139	47073-47086	schizophrenia	_
204-140	47088-47093	Brain	_
204-141	47094-47101	volumes	_
204-142	47102-47104	in	_
204-143	47105-47118	schizophrenia	_
204-144	47118-47119	:	_
204-145	47120-47121	A	_
204-146	47122-47135	meta‐analysis	_
204-147	47136-47138	in	_
204-148	47139-47143	over	_
204-149	47144-47146	18	_
204-150	47147-47150	000	_
204-151	47151-47159	subjects	_
204-152	47160-47161	A	_
204-153	47162-47168	review	_
204-154	47169-47171	of	_
204-155	47172-47175	the	_
204-156	47176-47186	functional	_
204-157	47187-47190	and	_
204-158	47191-47201	anatomical	_
204-159	47202-47209	default	_
204-160	47210-47214	mode	_
204-161	47215-47222	network	_
204-162	47223-47225	in	_
204-163	47226-47239	schizophrenia	_
204-164	47240-47258	Neuropsychological	_
204-165	47259-47270	performance	_
204-166	47271-47273	in	_
204-167	47274-47279	older	_
204-168	47280-47288	patients	_
204-169	47289-47293	with	_
204-170	47294-47307	schizophrenia	_
204-171	47307-47308	:	_
204-172	47309-47310	A	_
204-173	47311-47324	meta‐analysis	_
204-174	47325-47327	of	_
204-175	47328-47343	cross‐sectional	_
204-176	47344-47347	and	_
204-177	47348-47360	longitudinal	_
204-178	47361-47368	studies	_
204-179	47369-47377	Abnormal	_
204-180	47378-47392	frontostriatal	_
204-181	47393-47405	connectivity	_
204-182	47406-47408	in	_
204-183	47409-47425	adolescent‐onset	_
204-184	47426-47439	schizophrenia	_
204-185	47440-47443	and	_
204-186	47444-47447	its	_
204-187	47448-47460	relationship	_
204-188	47461-47463	to	_
204-189	47464-47473	cognitive	_
204-190	47474-47485	functioning	_
204-191	47486-47495	Detecting	_
204-192	47496-47508	neuroimaging	_
204-193	47509-47519	biomarkers	_
204-194	47520-47523	for	_
204-195	47524-47537	schizophrenia	_
204-196	47537-47538	:	_
204-197	47539-47540	A	_
204-198	47541-47554	meta‐analysis	_
204-199	47555-47557	of	_
204-200	47558-47570	multivariate	_
204-201	47571-47578	pattern	_
204-202	47579-47590	recognition	_
204-203	47591-47598	studies	_
204-204	47599-47613	Disintegration	_
204-205	47614-47616	of	_
204-206	47617-47629	sensorimotor	_
204-207	47630-47635	brain	_
204-208	47636-47644	networks	_
204-209	47645-47647	in	_
204-210	47648-47661	schizophrenia	_
204-211	47662-47665	The	_
204-212	47666-47674	positive	_
204-213	47675-47678	and	_
204-214	47679-47687	negative	_
204-215	47688-47696	syndrome	_
204-216	47697-47702	scale	_
204-217	47703-47704	(	_
204-218	47704-47709	PANSS	_
204-219	47709-47710	)	_
204-220	47711-47714	for	_
204-221	47715-47728	schizophrenia	_
204-222	47729-47733	Deep	_
204-223	47734-47740	neural	_
204-224	47741-47748	network	_
204-225	47749-47753	with	_
204-226	47754-47760	weight	_
204-227	47761-47769	sparsity	_
204-228	47770-47777	control	_
204-229	47778-47781	and	_
204-230	47782-47794	pre‐training	_
204-231	47795-47803	extracts	_
204-232	47804-47816	hierarchical	_
204-233	47817-47825	features	_
204-234	47826-47829	and	_
204-235	47830-47838	enhances	_
204-236	47839-47853	classification	_
204-237	47854-47865	performance	_
204-238	47865-47866	:	_
204-239	47867-47875	Evidence	_
204-240	47876-47880	from	_
204-241	47881-47892	whole‐brain	_
204-242	47893-47906	resting‐state	_
204-243	47907-47917	functional	_
204-244	47918-47930	connectivity	_
204-245	47931-47939	patterns	_
204-246	47940-47942	of	_
204-247	47943-47956	schizophrenia	_
204-248	47957-47960	The	_
204-249	47961-47973	hierarchical	_
204-250	47974-47982	taxonomy	_
204-251	47983-47985	of	_
204-252	47986-48001	psychopathology	_
204-253	48002-48003	(	_
204-254	48003-48008	HiTOP	_
204-255	48008-48009	)	_
204-256	48009-48010	:	_
204-257	48011-48012	A	_
204-258	48013-48024	dimensional	_
204-259	48025-48036	alternative	_
204-260	48037-48039	to	_
204-261	48040-48051	traditional	_
204-262	48052-48062	nosologies	_
204-263	48063-48066	The	_
204-264	48067-48071	NIMH	_
204-265	48072-48080	research	_
204-266	48081-48087	domain	_
204-267	48088-48096	criteria	_
204-268	48097-48107	initiative	_
204-269	48107-48108	:	_
204-270	48109-48119	Background	_
204-271	48119-48120	,	_
204-272	48121-48127	issues	_
204-273	48127-48128	,	_
204-274	48129-48132	and	_
204-275	48133-48143	pragmatics	_
204-276	48144-48156	Preservation	_
204-277	48157-48163	effect	_
204-278	48163-48164	:	_
204-279	48165-48174	Cigarette	_
204-280	48175-48182	smoking	_
204-281	48183-48187	acts	_
204-282	48188-48190	on	_
204-283	48191-48194	the	_
204-284	48195-48202	dynamic	_
204-285	48203-48205	of	_
204-286	48206-48216	influences	_
204-287	48217-48222	among	_
204-288	48223-48231	unifying	_
204-289	48232-48248	neuropsychiatric	_
204-290	48249-48258	LiaTriple	_
204-291	48259-48267	networks	_
204-292	48268-48270	in	_
204-293	48271-48284	schizophrenia	_
204-294	48285-48289	Five	_
204-295	48290-48296	factor	_
204-296	48297-48302	model	_
204-297	48303-48305	of	_
204-298	48306-48319	schizophrenia	_
204-299	48319-48320	:	_
204-300	48321-48332	Replication	_
204-301	48333-48339	across	_
204-302	48340-48347	samples	_
204-303	48348-48360	Perspectives	_
204-304	48361-48363	on	_
204-305	48364-48371	machine	_
204-306	48372-48380	learning	_
204-307	48381-48384	for	_
204-308	48385-48399	classification	_
204-309	48400-48402	of	_
204-310	48403-48413	schizotypy	_
204-311	48414-48419	using	_
204-312	48420-48424	fMRI	_
204-313	48425-48429	data	_
204-314	48430-48444	Classification	_
204-315	48445-48447	of	_
204-316	48448-48461	first‐episode	_
204-317	48462-48475	schizophrenia	_
204-318	48476-48484	spectrum	_
204-319	48485-48494	disorders	_
204-320	48495-48498	and	_
204-321	48499-48507	controls	_
204-322	48508-48512	from	_
204-323	48513-48518	whole	_
204-324	48519-48524	brain	_
204-325	48525-48530	white	_
204-326	48531-48537	matter	_
204-327	48538-48548	fractional	_
204-328	48549-48559	anisotropy	_
204-329	48560-48565	using	_
204-330	48566-48573	machine	_
204-331	48574-48582	learning	_
204-332	48583-48584	A	_
204-333	48585-48591	review	_
204-334	48592-48594	of	_
204-335	48595-48602	feature	_
204-336	48603-48612	reduction	_
204-337	48613-48623	techniques	_
204-338	48624-48626	in	_
204-339	48627-48639	neuroimaging	_
204-340	48640-48646	Impact	_
204-341	48647-48649	of	_
204-342	48650-48656	sample	_
204-343	48657-48661	size	_
204-344	48662-48665	and	_
204-345	48666-48674	matching	_
204-346	48675-48677	on	_
204-347	48678-48692	single‐subject	_
204-348	48693-48707	classification	_
204-349	48708-48710	of	_
204-350	48711-48724	schizophrenia	_
204-351	48724-48725	:	_
204-352	48726-48727	A	_
204-353	48728-48741	meta‐analysis	_
204-354	48742-48747	Using	_
204-355	48748-48752	dual	_
204-356	48753-48763	regression	_
204-357	48764-48766	to	_
204-358	48767-48778	investigate	_
204-359	48779-48786	network	_
204-360	48787-48792	shape	_
204-361	48793-48796	and	_
204-362	48797-48806	amplitude	_
204-363	48807-48809	in	_
204-364	48810-48820	functional	_
204-365	48821-48833	connectivity	_
204-366	48834-48842	analyses	_
204-367	48843-48853	Structural	_
204-368	48854-48865	alterations	_
204-369	48866-48868	of	_
204-370	48869-48872	the	_
204-371	48873-48881	superior	_
204-372	48882-48890	temporal	_
204-373	48891-48896	gyrus	_
204-374	48897-48899	in	_
204-375	48900-48913	schizophrenia	_
204-376	48913-48914	:	_
204-377	48915-48923	Detailed	_
204-378	48924-48935	subregional	_
204-379	48936-48947	differences	_
204-380	48948-48957	Multisite	_
204-381	48958-48974	generalizability	_
204-382	48975-48977	of	_
204-383	48978-48991	schizophrenia	_
204-384	48992-49001	diagnosis	_
204-385	49002-49016	classification	_
204-386	49017-49022	based	_
204-387	49023-49025	on	_
204-388	49026-49036	functional	_
204-389	49037-49042	brain	_
204-390	49043-49055	connectivity	_
204-391	49056-49070	Discrimination	_
204-392	49071-49073	of	_
204-393	49074-49080	female	_
204-394	49081-49094	schizophrenia	_
204-395	49095-49103	patients	_
204-396	49104-49108	from	_
204-397	49109-49116	healthy	_
204-398	49117-49122	women	_
204-399	49123-49128	using	_
204-400	49129-49137	multiple	_
204-401	49138-49148	structural	_
204-402	49149-49154	brain	_
204-403	49155-49163	measures	_
204-404	49164-49172	obtained	_
204-405	49173-49177	with	_
204-406	49178-49189	voxel‐based	_
204-407	49190-49201	morphometry	_
204-408	49202-49205	New	_
204-409	49206-49216	approaches	_
204-410	49217-49219	to	_
204-411	49220-49231	psychiatric	_
204-412	49232-49242	diagnostic	_
204-413	49243-49257	classification	_
204-414	49258-49259	A	_
204-415	49260-49267	wavelet	_
204-416	49268-49274	method	_
204-417	49275-49278	for	_
204-418	49279-49287	modeling	_
204-419	49288-49291	and	_
204-420	49292-49301	despiking	_
204-421	49302-49308	motion	_
204-422	49309-49318	artifacts	_
204-423	49319-49323	from	_
204-424	49324-49337	resting‐state	_
204-425	49338-49342	fMRI	_
204-426	49343-49347	time	_
204-427	49348-49354	series	_
204-428	49355-49362	Failure	_
204-429	49363-49365	to	_
204-430	49366-49376	deactivate	_
204-431	49377-49379	in	_
204-432	49380-49383	the	_
204-433	49384-49394	prefrontal	_
204-434	49395-49401	cortex	_
204-435	49402-49404	in	_
204-436	49405-49418	schizophrenia	_
204-437	49418-49419	:	_
204-438	49420-49431	Dysfunction	_
204-439	49432-49434	of	_
204-440	49435-49438	the	_
204-441	49439-49446	default	_
204-442	49447-49451	mode	_
204-443	49452-49459	network	_
204-444	49459-49460	?	_

#Text=Increased ventro‐medial prefrontal activations in schizophrenia smokers during cigarette cravings
#Text=Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion
#Text=Correlated structural and functional brain abnormalities in the default mode network in schizophrenia patients
#Text=Some studies in machine learning using the game of checkers
#Text=Local activity features for computer aided diagnosis of schizophrenia on resting‐state fMRI
#Text=Ten simple rules for predictive modeling of individual differences in neuroimaging
#Text=Discriminative analysis of resting‐state functional connectivity patterns of schizophrenia using low dimensional embedding of fMRI
#Text=Consistent functional connectivity alterations in schizophrenia spectrum disorder: A multisite study
#Text=Discriminative analysis of non‐linear brain connectivity in schizophrenia: An fMRI study
#Text=Superior temporal gyrus volume change in schizophrenia: A review on region of interest volumetric studies
#Text=Effects of nicotine on hippocampal and cingulate activity during smooth pursuit eye movement in schizophrenia
#Text=Aberrant default mode functional connectivity in early onset schizophrenia
#Text=Identify schizophrenia using resting‐state functional connectivity: An exploratory research and analysis
#Text=Whole brain resting state functional connectivity abnormalities in schizophrenia
#Text=Disease prediction based on functional connectomes using a scalable and spatially‐informed support vector machine
#Text=Default mode network activity and connectivity in psychopathology
#Text=Building better biomarkers: Brain models in translational neuroimaging
#Text=Repeated ketamine administration alters N‐methyl‐D‐aspartic acid receptor subunit gene expression: Implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans
#Text=Functional connectivity‐based signatures of schizophrenia revealed by multiclass pattern analysis of resting‐state fMRI from schizophrenic patients and their healthy siblings
205-1	49461-49470	Increased	_
205-2	49471-49484	ventro‐medial	_
205-3	49485-49495	prefrontal	_
205-4	49496-49507	activations	_
205-5	49508-49510	in	_
205-6	49511-49524	schizophrenia	_
205-7	49525-49532	smokers	_
205-8	49533-49539	during	_
205-9	49540-49549	cigarette	_
205-10	49550-49558	cravings	_
205-11	49559-49567	Spurious	_
205-12	49568-49571	but	_
205-13	49572-49582	systematic	_
205-14	49583-49595	correlations	_
205-15	49596-49598	in	_
205-16	49599-49609	functional	_
205-17	49610-49622	connectivity	_
205-18	49623-49626	MRI	_
205-19	49627-49635	networks	_
205-20	49636-49641	arise	_
205-21	49642-49646	from	_
205-22	49647-49654	subject	_
205-23	49655-49661	motion	_
205-24	49662-49672	Correlated	_
205-25	49673-49683	structural	_
205-26	49684-49687	and	_
205-27	49688-49698	functional	_
205-28	49699-49704	brain	_
205-29	49705-49718	abnormalities	_
205-30	49719-49721	in	_
205-31	49722-49725	the	_
205-32	49726-49733	default	_
205-33	49734-49738	mode	_
205-34	49739-49746	network	_
205-35	49747-49749	in	_
205-36	49750-49763	schizophrenia	_
205-37	49764-49772	patients	_
205-38	49773-49777	Some	_
205-39	49778-49785	studies	_
205-40	49786-49788	in	_
205-41	49789-49796	machine	_
205-42	49797-49805	learning	_
205-43	49806-49811	using	_
205-44	49812-49815	the	_
205-45	49816-49820	game	_
205-46	49821-49823	of	_
205-47	49824-49832	checkers	_
205-48	49833-49838	Local	_
205-49	49839-49847	activity	_
205-50	49848-49856	features	_
205-51	49857-49860	for	_
205-52	49861-49869	computer	_
205-53	49870-49875	aided	_
205-54	49876-49885	diagnosis	_
205-55	49886-49888	of	_
205-56	49889-49902	schizophrenia	_
205-57	49903-49905	on	_
205-58	49906-49919	resting‐state	_
205-59	49920-49924	fMRI	_
205-60	49925-49928	Ten	_
205-61	49929-49935	simple	_
205-62	49936-49941	rules	_
205-63	49942-49945	for	_
205-64	49946-49956	predictive	_
205-65	49957-49965	modeling	_
205-66	49966-49968	of	_
205-67	49969-49979	individual	_
205-68	49980-49991	differences	_
205-69	49992-49994	in	_
205-70	49995-50007	neuroimaging	_
205-71	50008-50022	Discriminative	_
205-72	50023-50031	analysis	_
205-73	50032-50034	of	_
205-74	50035-50048	resting‐state	_
205-75	50049-50059	functional	_
205-76	50060-50072	connectivity	_
205-77	50073-50081	patterns	_
205-78	50082-50084	of	_
205-79	50085-50098	schizophrenia	_
205-80	50099-50104	using	_
205-81	50105-50108	low	_
205-82	50109-50120	dimensional	_
205-83	50121-50130	embedding	_
205-84	50131-50133	of	_
205-85	50134-50138	fMRI	_
205-86	50139-50149	Consistent	_
205-87	50150-50160	functional	_
205-88	50161-50173	connectivity	_
205-89	50174-50185	alterations	_
205-90	50186-50188	in	_
205-91	50189-50202	schizophrenia	_
205-92	50203-50211	spectrum	_
205-93	50212-50220	disorder	_
205-94	50220-50221	:	_
205-95	50222-50223	A	_
205-96	50224-50233	multisite	_
205-97	50234-50239	study	_
205-98	50240-50254	Discriminative	_
205-99	50255-50263	analysis	_
205-100	50264-50266	of	_
205-101	50267-50277	non‐linear	_
205-102	50278-50283	brain	_
205-103	50284-50296	connectivity	_
205-104	50297-50299	in	_
205-105	50300-50313	schizophrenia	_
205-106	50313-50314	:	_
205-107	50315-50317	An	_
205-108	50318-50322	fMRI	_
205-109	50323-50328	study	_
205-110	50329-50337	Superior	_
205-111	50338-50346	temporal	_
205-112	50347-50352	gyrus	_
205-113	50353-50359	volume	_
205-114	50360-50366	change	_
205-115	50367-50369	in	_
205-116	50370-50383	schizophrenia	_
205-117	50383-50384	:	_
205-118	50385-50386	A	_
205-119	50387-50393	review	_
205-120	50394-50396	on	_
205-121	50397-50403	region	_
205-122	50404-50406	of	_
205-123	50407-50415	interest	_
205-124	50416-50426	volumetric	_
205-125	50427-50434	studies	_
205-126	50435-50442	Effects	_
205-127	50443-50445	of	_
205-128	50446-50454	nicotine	_
205-129	50455-50457	on	_
205-130	50458-50469	hippocampal	_
205-131	50470-50473	and	_
205-132	50474-50483	cingulate	_
205-133	50484-50492	activity	_
205-134	50493-50499	during	_
205-135	50500-50506	smooth	_
205-136	50507-50514	pursuit	_
205-137	50515-50518	eye	_
205-138	50519-50527	movement	_
205-139	50528-50530	in	_
205-140	50531-50544	schizophrenia	_
205-141	50545-50553	Aberrant	_
205-142	50554-50561	default	_
205-143	50562-50566	mode	_
205-144	50567-50577	functional	_
205-145	50578-50590	connectivity	_
205-146	50591-50593	in	_
205-147	50594-50599	early	_
205-148	50600-50605	onset	_
205-149	50606-50619	schizophrenia	_
205-150	50620-50628	Identify	_
205-151	50629-50642	schizophrenia	_
205-152	50643-50648	using	_
205-153	50649-50662	resting‐state	_
205-154	50663-50673	functional	_
205-155	50674-50686	connectivity	_
205-156	50686-50687	:	_
205-157	50688-50690	An	_
205-158	50691-50702	exploratory	_
205-159	50703-50711	research	_
205-160	50712-50715	and	_
205-161	50716-50724	analysis	_
205-162	50725-50730	Whole	_
205-163	50731-50736	brain	_
205-164	50737-50744	resting	_
205-165	50745-50750	state	_
205-166	50751-50761	functional	_
205-167	50762-50774	connectivity	_
205-168	50775-50788	abnormalities	_
205-169	50789-50791	in	_
205-170	50792-50805	schizophrenia	_
205-171	50806-50813	Disease	_
205-172	50814-50824	prediction	_
205-173	50825-50830	based	_
205-174	50831-50833	on	_
205-175	50834-50844	functional	_
205-176	50845-50856	connectomes	_
205-177	50857-50862	using	_
205-178	50863-50864	a	_
205-179	50865-50873	scalable	_
205-180	50874-50877	and	_
205-181	50878-50896	spatially‐informed	_
205-182	50897-50904	support	_
205-183	50905-50911	vector	_
205-184	50912-50919	machine	_
205-185	50920-50927	Default	_
205-186	50928-50932	mode	_
205-187	50933-50940	network	_
205-188	50941-50949	activity	_
205-189	50950-50953	and	_
205-190	50954-50966	connectivity	_
205-191	50967-50969	in	_
205-192	50970-50985	psychopathology	_
205-193	50986-50994	Building	_
205-194	50995-51001	better	_
205-195	51002-51012	biomarkers	_
205-196	51012-51013	:	_
205-197	51014-51019	Brain	_
205-198	51020-51026	models	_
205-199	51027-51029	in	_
205-200	51030-51043	translational	_
205-201	51044-51056	neuroimaging	_
205-202	51057-51065	Repeated	_
205-203	51066-51074	ketamine	_
205-204	51075-51089	administration	_
205-205	51090-51096	alters	_
205-206	51097-51116	N‐methyl‐D‐aspartic	_
205-207	51117-51121	acid	_
205-208	51122-51130	receptor	_
205-209	51131-51138	subunit	_
205-210	51139-51143	gene	_
205-211	51144-51154	expression	_
205-212	51154-51155	:	_
205-213	51156-51167	Implication	_
205-214	51168-51170	of	_
205-215	51171-51178	genetic	_
205-216	51179-51192	vulnerability	_
205-217	51193-51196	for	_
205-218	51197-51205	ketamine	_
205-219	51206-51211	abuse	_
205-220	51212-51215	and	_
205-221	51216-51224	ketamine	_
205-222	51225-51234	psychosis	_
205-223	51235-51237	in	_
205-224	51238-51244	humans	_
205-225	51245-51255	Functional	_
205-226	51256-51274	connectivity‐based	_
205-227	51275-51285	signatures	_
205-228	51286-51288	of	_
205-229	51289-51302	schizophrenia	_
205-230	51303-51311	revealed	_
205-231	51312-51314	by	_
205-232	51315-51325	multiclass	_
205-233	51326-51333	pattern	_
205-234	51334-51342	analysis	_
205-235	51343-51345	of	_
205-236	51346-51359	resting‐state	_
205-237	51360-51364	fMRI	_
205-238	51365-51369	from	_
205-239	51370-51383	schizophrenic	_
205-240	51384-51392	patients	_
205-241	51393-51396	and	_
205-242	51397-51402	their	_
205-243	51403-51410	healthy	_
205-244	51411-51419	siblings	_
